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1 
1. INTRODUCTION 
 
Epithelial, melanocytic and mesenchymal skin neoplasms and non-neoplastic lesions are very 
common, in particular in dogs and cats and they are the most commonly diagnosed tumors in 
domestic animals, at least at our institute.  
In 1974, the World Health Organization (WHO) published a text on the international 
histological classification of tumors of domestic animals, which followed, as far as possible, 
the WHO histological classifications of tumors in man. 
A new or second edition of the international histological classification of skin, melanocytic 
and soft tissue tumors of domestic animals was published in 1998 with new entities and some 
new nomenclatures. For the time between 1998 and today, we did not find any statistical 
study that exposes all these tumors according to the new WHO classification. It is therefore 
the purpose of this study to apply the new WHO classification to the epidemiology of skin 
tumor entities in dogs and cats.  
 
LITERATURE  REVIEW 2 
 
2. LITERATURE REVIEW 
 
2.1. World Health Organization (WHO) classification of tumors of domestic animals 
In 1966 the WHO convened a meeting of investigators on comparative oncology to work on 
the development of an international histological classification of tumors of domestic animals 
in parallel with the classification of human tumors (Beveridge and Sobin, 1974). 
The WHO published the original histological classification of tumors of domestic animals in 
1974 with the purpose of establishing a sound basis for comparative oncology by providing a 
widely accepted standard nomenclature of tumors of domestic animals and in order to 
advance veterinary pathology. This classification also contained tumors of the skin, and the 
authors were E. Weiss and K. Frese of the Institute of Veterinary Pathology, Justus Liebig 
University Giessen, Germany (Weiss and Frese, 1974) 
In 1980, the first TNM* classification of tumors in domestic animals was published by the 
WHO, in support of the WHO histological classification of tumors of domestic animals. This 
classification provided a staging of the animal tumors to aid veterinary clinicians in planning 
treatment, to give some indication of prognosis, to assist in the evaluation of treatment results, 
to facilitate the exchange of information between treatment centres, and to contribute 
information on comparative values between man and animal (Owen, 1980). 
In 1998 the WHO published the second edition of the histological classification of tumors of 
the skin and soft tissue in domestic animals to advance the old WHO edition, because new 
entities had been described over the past 24 years. Moreover, the nomenclature previously 
applied to some skin tumors was changed (Goldschmidt et al., 1998, Hendrick et al., 1998). 
 
2.2. General population 
The epidemiology depends first on the prevalence, incidence and distribution of the diseases 
as well as on the causes and risk factors in defined populations (Bomhard, 2001). 
Our animal populations comprise dogs and cats and we describe the population of each type 
separately as follows: 
 
 
__________________________________________________________________________________________ 
* The extent of the primary tumor (T), the condition of the regional lymph nodes (N), and the presence or absence of distant 
metastasis (M) (Matyas, 1982). 
LITERATURE  REVIEW 3 
2.2.1. Dogs  
A study carried out in Hannover, Germany, by Bomhard (2001) showed that the most 
common breeds of dogs were Mongrel, German shepherd, Dachshund, Poodle, Boxer, Cocker 
spaniel, Schnauzer (breed not further specified), Yorkshire terrier, Westhighland white terrier, 
Retriever, Sennenhund, Rottweiler, Dobermann, Airedale terrier and Muensterlaender in this 
order, from about 22 % for Mongrels down to 1 % for Muensterlaender, with other races at 
less than 1 %. An old study by the Institute of Veterinary Pathology in Giessen, Germany, 
carried out between 1950 and 1958 (Frese, 1960), showed no significant differences regarding 
breeds in comparison with Bomhard's results (2001). 
Sex distribution in the dog population showed a frequent slight bias toward females rather 
than males, at rates of 56 % and 44 %, respectively. The percentages of castrated and 
uncastrated animals differ in the literature (Goldschmidt and Shofer, 1992, Bomhard, 2001), 
however, uncastrated animals always outnumber castrated animals. Frese (1960) on the other 
hand, describes a male preponderance over females at about 58 % and 42 %, respectively. 
Regarding the basic population, we have found just a few publications (Frese, 1960, Eskens, 
1983, Bomhard, 2001) which describe the age distribution in the dog population. Most 
animals were between 9 and 10-years-old (Eskens, 1983, Bomhard, 2001) and in another 
study between 6 and 8-years-old (Frese, 1960). More details about these studies are described 
below (see 2.4.2.1.) 
 
2.2.2. Cats 
The most common breed is the European shorthair cat (ESH cat), which contributes more 
than 85 % to the overall cat population, the two other frequent breeds are Persian and Siamese 
cats, which come to about 10% and 3 %, respectively, and the other 2 %, are rare breeds 
(Bomhard, 2001). 
Sex distribution in cat populations showed a frequent slight bias to females rather than males, 
at 54.5 % and 45.5 %, (Goldschmidt and Shofer, 1992), or 53 % female and 47 % male, 
respectively (Bomhard, 2001). The percentages of castrated and uncastrated animals differ 
between various authors. For example, uncastrated animals represent the higher percentage in 
Bomhard's collection (2001), in contrast to the findings of Goldschmidt and Shofer with 
regard to their collection (1992). 
Most cats were between 10 and 12-years-old, with about 15 % of the overall population 
(Bomhard, 2001) (table 41). 
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2.3. Anatomical division  
The general division of skin tumors differs in the literature (Priester and McKay, 1980, 
Eskens, 1983, Goldschmidt et al., 1992, Bomhard, 2001). Bomhard (2001) divided them into 
tumors of the head, neck, limbs, chest, back, abdomen, perianal, tail, and some tumors 
without data regarding locations. The extremities are defined as limbs (arms and legs) 
(Pschyrembel, 2002). 
 
2.4. Tumor statistic 
A general classification of the skin tumors was performed by McClelland as early as 1940. 
Generally, about 1 % of dogs and 0.5 % of cats had one or more primary tumors, and the 
prevalence for malignant tumors in dogs was similar to that in cats. However, the prevalence 
of benign tumors in dogs was over 10 times the prevalence in cats (MacVean et al., 1978). 
The incidence rate of benign and malignant neoplasms in dogs and cats were reported to be 
about 1077 cases per 100,000 dogs/year and 188 cases per 100,000 cats/year. Dogs have 
about six times as many neoplasms as cats. In dogs, 67.6 % of such neoplasms were found in 
the skin and connective tissue, in cats, 44.8 % were found in these sites (Goldschmidt and 
Shofer, 1992, Scott et al., 2001). 
On the other hand, Goldschmidt and Shofer (1992) between 1985 and 1990 collected a total 
of 65,000 surgical pathology specimens from dogs and 13,250 from cats. The prevalence rates 
of skin tumors and tumor-like lesions were 45 % in dogs and 24 % in cats (Goldschmidt and 
Shofer, 1992). 
Eskens (1983) reported that the skin tumor rates from necropsies and biopsies were different. 
He collected 3492 skin tumors from 9178 biopsies, which were 38.1 % of all biopsies, and 74 
skin tumors from 1120 necropsies in dogs, which were 6.6 % of all necropsies. 
 
2.4.1. Tissue of origin 
Skin tumors are divided into mesenchymal, epithelial and melanocytic tumors as in the WHO 
classification, and some authors in their statistics use the term "tumor-like lesion" as a 
separate term (Goldschmidt and Shofer, 1992). Generally, neoplasms are composed of one 
tissue type only, but there are exceptions such as teratoma and mixed neoplasms which 
consist of multiple tissues (Cullen et al., 2002). 
Mesenchymal tumors are more common and make up about 55 % of tumors in dogs and 46 % 
of tumors in cats (Willemse, 1991, Goldschmidt and Shofer, 1992). Epithelial tumors are less 
common than mesenchymal tumors in dogs (35 %) and cats (43 %). Melanocytic tumors are 
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relatively more common in dogs (4 %) than in cats (1 %) and tumor-like lesions are somewhat 
higher in dogs (11 %) than in cats (9 %) (Goldschmidt and Shofer, 1992). In another study, 
follicular tumors and tumor-like lesions together represent 10.4 % and 8.1 % of all skin 
tumors in dogs and cats, respectively (Abramo et al., 1999). 
 
2.4.2. Prevalence of individual types of skin tumors 
There have been many statistical studies about skin tumors, some of them old such as the 
study by Frese (1960), and others have followed the old WHO classification such as the study 
of Eskens (1983). Because of the differences regarding skin tumors in dogs and cats, we will 
describe the skin tumors of every kind of animal separately. 
2.4.2.1. Tumors in dogs 
From 400 canine skin und subcutaneous tumors that were classified by Frese (1960), without 
indication of sources (biopsy or post-mortem sections), 2.75 % (11 cases) were unclassified 
tumors (10 malignant and one benign tumor), the other 389 were classified as in table 41. The 
nomenclature used at that time dated before the first WHO classification, and followed a 
human tumor classification. 
4507 cases out of 4544 skin tumors collected as biopsies by Eskens (1983), were classified as 
in table 41 and the other 0,81 % (37 cases) were impossible to classify. The nomenclature in 
this publication followed the first WHO classification of 1974. 
Goldschmidt and Shofer (1992) had different populations for the different skin tumors, 
namely 10.300 epithelial and 14500 mesenchymal tumors and 3160 tumor-like lesions and an 
unknown number of melanocytic tumors. They described the general percentage of the skin 
tumors as follows: epithelial tumors 35 %, melanocytic tumors 4 %, mesenchymal tumors 
50% and tumor-like lesions 11 %. The percentages of the individual types of tumor are 
represented in table 41. The nomenclature in this publication followed the first WHO 
classification of 1974 with minor modifications and additions. 
47008 skin and subcutaneous tumors and tumor-like lesions collected as biopsies by Bomhard 
(2001) were divided into two groups, 46729 skin tumors and tumor-like lesions, including 
cysts and naevus, and 279 tumors, including ceruminal gland and anal sac gland tumors. 
These cases were collected over ten years (1988 -1997). The results are represented in table 
41. The nomenclature in this publication followed the first WHO classification, with 
deviations in some points. 
Disregarding the circumstances and just looking at the period of the previous studies (1960, 
1983, 1992, 2001) we have found in three of them (Eskens 1983, Goldschmidt 1992 and 
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Bomhard 2001) benign histiocytoma at the top of the collections, then mast cell tumor in the 
second place, whereas histiocytoma was in the second place after hepatoid gland adenoma in 
Frese’s collection (1960), and mast cell tumor was in the fourth place. 
Hepatoid gland adenoma has gradually become less frequent, dropping from about 18 % 
(Frese, 1960) to 9 % (Eskens, 1983, Goldschmidt and Shofer, 1992) and to less than 6 % 
(Bomhard, 2001). In contrast, the number of fibrosarcoma cases gradually increased in these 
collections, with less than 4 % found by Frese (1960), about 5 % by Eskens (1983) and 8 % 
by Goldschmidt and Shofer (1992) and Bomhard (2001). 
Squamous cell carcinoma at over 7 % was relatively frequent in Frese's study (1960), and at 
2-3 % was low in the three other collections (Eskens, 1983, Goldschmidt and Shofer, 1992, 
Bomhard, 2001). Basal cell tumor was relatively low (2 %) in Frese’s study (1960), while it 
ranged between 4 and 6 % in the results of Eskens (1983), Goldschmidt and Shofer (1992) 
and Bomhard (2001). 
Lipoma cases were relatively lower (about 3 %) in the two first studies (Frese, 1960, Eskens, 
1983) and relatively higher (6-8 %) in the last two (Goldschmidt and Shofer, 1992, Bomhard, 
2001). 
Some tumors were similar in all these studies such as the intra-cutaneous cornifying 
epithelioma (about 2 %), hemangioma (3-4 %) and sebaceous adenoma (4-7 %). However, 
other tumors, e.g. melanocytic tumors, varied between 11 % (Frese, 1960), 5.5 % (Eskens, 
1983), 4 % (Goldschmidt and Shofer, 1992), and 6 % (Bomhard, 2001), and so do the other 
tumors (table 41). 
 
2.4.2.1.1. Sex predilection  
As is evident in table 42, hepatoid gland tumors were primarily neoplasms in males rather 
than females, with almost 89 % and 11 %, respectively, as was found by Frese (1960), 
Goldschmidt and Shofer (1992) and Bomhard (2001). This predilection has also been reported 
in most other publications (Weiss and Frese, 1974, Madewell and Theilen, 1987, Gross et al., 
1992, Yager and Wilcock, 1994, Scott et al., 2001, Goldschmidt and Hendrick, 2002). 
Histiocytomas were also slightly more frequent in males (52-69 %) than in females (31-48 
%), similar to melanomas, which were more frequent in males (about 50-61 %) than in 
females (39-50%) (Frese, 1960, Goldschmidt and Shofer, 1992, Bomhard, 2001). In contrast, 
leiomyomas and leiomyosarcomas were more common in females (76 %) than males (24 %) 
(Bomhard, 2001). Lipomas were also more common in females (68 %) than in males (32 %) 
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(Weiss and Frese, 1974, Goldschmidt and Shofer, 1992, Bomhard, 2001), and Fibromas also 
had a predilection for female animals (Scott et al., 2001). 
Some tumors vary from author to author; basal cell tumors, for example, are more common in 
males according to Frese (1960) and Bomhard (2001), in contrast to Goldschmidt and Shofer 
(1992). 
Most other skin tumors show no clear sex predilection in the literature (Weiss and Frese, 
1974, Goldschmidt and Shofer, 1992, Bomhard, 2001). 
 
2.4.2.1.2. Anatomical location 
There are some tumors related to specific organs in the skin such as anal sac tumors in 
perianal site, meibomian gland tumors on the inner aspect of the eyelid, ceruminous gland 
tumors in the ear canal, eccrine (atrichial) tumors in the footpad, subungual keratoacanthoma 
and subungual squamous cell carcinoma, which arise from the nailbed epithelium of the 
forelimbs or hindlimbs. Moreover, hepatoid gland tumors from hepatoid glands, which are 
located primarily at the perianal region, on the dorsal and ventral aspect of the tail, in the 
parapreputial area in males, at the abdominal mammary region in females, on the posterior 
region of the hindlimbs, and on the midline of the back and thorax (Gross et al., 1992, 
Goldschmidt and Shofer, 1992, Goldschmidt et al., 1998, Goldschmidt and Hendrick, 2002). 
Some skin cysts are also related to specific areas such as subungual epithelial inclusion cysts, 
which are located within the bone of the third phalanx, and tumor-like lesions such as 
pressure point comedones, which occur primarily on the elbow (Goldschmidt et al., 1998). 
Some other tumors and tumor-like lesions can be present in one location more commonly than 
in another, and this group of tumors includes most of the skin tumors. An example of this 
group is the sebaceous adenoma, which is found mainly at the head (49.5 %) (Goldschmidt 
and Shofer, 1992). Another example is the trichoblastoma of the dog, which is located 
primary on the head and neck (Goldschmidt and Hendrick, 2002) 
 
2.4.2.1.3. Breed disposition 
Some skin tumors have been described as being more common in some breeds, the more 
common example being malignant histiocytosis, which was first discribed in a Miniature 
schnauzer dog (Scott et al., 1979), then was frequently reported in Bernese mountain dogs 
(Moore and Rosin, 1986, Ramsey et al., 1996) and has also been reported in various dog and 
cat breeds (Court et al., 1993, Goldschmidt and Hendrick, 2002). Nodular dermatofibrosis of 
the German shepherd dog is a rare breed-specific syndrome (Goldschmidt et al., 1998). 
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Another example is the mast cell tumor, which was found more commonly in Boxer, Pug and 
Boston than in other breeds (Madewell and Theilen, 1987, Goldschmidt and Shofer, 1992, 
Yager and Wilcock, 1994, Scott et al., 2001). Furthermore, subungual squamous cell 
carcinoma showed breed disposition in Giant schnauzer and Gordon setter and many other 
breeds (Goldschmidt and Shofer, 1992, Goldschmidt and Hendrick, 2002). 
 
2.4.2.1.4. Age distribution 
Generally, it is known that cancer essentially represents an illness of the higher age, however, 
it is yet to be discussed whether the frequency of the malignome continues to increase up to 
the highest age-groups or whether it sinks again after a highpoint in a certain age-group 
(Frese, 1960). 
Individually, there are some tumors which are found in young animals more commonly than 
in old animals. The more common examples are canine cutanous histiocytoma and papilloma, 
the majority of which occurr in young dogs, but dogs of any age can be affected (Goldschmidt 
and Shofer, 1992, Goldschmidt and Hendrick, 2002). Regarding tumor-like lesions, there are 
also two examples, dermoid cyst and the follicular cyst, which are both more frequently found 
in young animals than in adults (Bomhard, 2001).  
 
2.4.2.2. Tumors in cat 
Goldschmidt (1992) has described different types of various skin tumors: 1400 epithelial 
tumors, 1550 mesenchymal tumors, 280 tumor-like lesions and an undefined number of 
melanocytic tumors in cats. He reports the percentage of the skin tumors as follows: 
mesenchymal tumors 47 %, epithelial tumors 43 %, tumor-like lesions 9 %, and melanocytic 
tumors 1 %. The prevalences of individual skin tumors are presented in the table 43. 
12387 skin tumors, subcutaneous tumors and tumor-like lesions were mentioned by Bomhard 
(2001), who divided them in two groups, namely 12087 skin tumors and tumor-like lesions 
including cysts and naevus, and 300 tumors including ceruminal gland and anal sac gland 
tumors. Some tumors, as intra-cutaneous cornifying epitheliomas were mentioned by 
Bomhard (2001) (as in table 43), however, intra-cutaneous cornifying epitheliomas were not 
normally found in cats (Goldschmidt et al., 1998), but were common in dogs (Goldschmidt et 
al., 1998, Goldschmidt and Hendrick, 2002). Malignant histiocytomas (as in table 43) 
constitute 0.21 % of all the collection of Bomhard (2001), and that equals three cases. 
Fibrosarcoma is the most common tumor of the skin and subcutaneous connective tissue in 
the cat in the greater part of the literature (Stiglmair-Herb, 1987, Joerger, 1988, Goldschmidt 
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and Shofer, 1992, Gross et al., 1992, Bomhard, 2001, Goldschmidt and Hendrick, 2002), 
however, the prevalence varies and is about 44 % in Stiglmair-Herb (1987) and Bomhard 
(2001) and about 17 % in Goldschmidt and Shofer (1992). This tumor has increased in 
prevalence over the last decade, because of its association with vaccination (Goldschmidt and 
Hendrick, 2002) and is more prevalent in European cats (Miller et al., 1991). 
Basal cell tumor is more common in cats than in dogs (Goldschmidt and Hendrick, 2002), and 
it is in the second place with about 11.4 % -18.5 % of all skin tumors in the studies of 
Stiglmair-Herb (1987), Joerger (1988), Goldschmidt and Shofer (1992) and Bomhard (2001), 
and is reported as the most common skin tumor at 26.1 % by Miller et al. (1991). 
Other common tumors are squamous cell carcinoma, apocrine adenoma, mast cell tumor and 
lipoma (Stiglmair-Herb, 1987, Joerger, 1988, Miller et al., 1991, Goldschmidt and Shofer, 
1992, Bomhard, 2001). 
 
2.4.2.2.1. Sex predilection 
No tumors with a marked sex predilection have been found in cats, however, Goldschmidt 
and Shofer (1992) report that some tumors show a slight deviation towards one of the sexes in 
either species. More than 60% of basal cell tumors, sebaceous carcinomas, cutaneous 
malignant melanomas, malignant fibrous histiocytomas, and peripheral nerve sheath tumors 
were found in females. However, apocrine adenoma, trichoepithelioma, cutaneous melanoma, 
lipoma, cutaneous hemangiosarcoma, cutaneous lymphangioma, cutaneous mast cell tumor, 
ceruminous cysts were less than 49 % in females. Other tumors and tumor-like lesions ranged 
around the percentages of the general population, which were 54.5 % females and 45.5 % 
males (Goldschmidt and Shofer, 1992). 
 
2.4.2.2.2. Anatomical location 
Some tumors are related to specific organs in the skin such as anal sac tumors in perianal 
sites, meibomian gland tumors on the inner aspect of the eyelid, ceruminous gland tumors in 
the ear canal, and eccrine tumors in the footpad (Goldschmidt and Shofer, 1992, Goldschmidt 
et al., 1998, Goldschmidt and Hendrick, 2002). Moreover, feline vaccine-associated 
fibrosarcoma arise at vaccination sites on the neck, thorax, lumbar region, flank and limbs 
(Goldschmidt and Hendrick, 2002), and feline ventral abdominal angiosarcoma arise in 
ventral abdominal region (Swayne et al., 1989, Goldschmidt et al., 1998). Also, some other 
tumors and tumor-like lesions can occur in one location more frequently than in others, and 
this group of tumors includes the majority of skin tumors. As an example of this group, 57.2 
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% of apocrine adenomas and 50.0% of apocrine ductal adenomas have been found at the head 
(Goldschmidt and Shofer, 1992). 
 
2.5. Skin tumors 
The following nomenclature and classification follows, as closely as possible, the new WHO 
classification. An understanding of the embryogenesis of the skin is helpful in understanding 
this tumor nomenclature (Goldschmidt et al., 1998). 
2.5.1. Epithelial and melanocytic tumors of the skin 
2.5.1.1. Epithelial tumors without squamous or adnexal differentiation 
2.5.1.1.1. Basal cell tumors (basal cell epithelioma) 
Basal cell tumor was a benign neoplastic proliferation of cells that recapitulate the basal cell 
layer of the normal epidermis. In the new WHO classification system, the majority of the 
tumors that were previously described as a basal cell tumors in the dog and the spindle cell 
type of basal cell tumor in the cat has been reclassified as trichoblastoma (Goldschmidt et al., 
1998, Goldschmidt and Hendrick, 2002). 
A basal cell tumor, as the term is currently used, is a dermal mass composed of islands of 
tumor cells in a moderately fibrous stroma, and the dermal tumor have an association with the 
overlying epidermis. Neoplastic cells are either small and round or polyhedral, with little 
cytoplasm and ovoid nuclei. Most tumors show little nuclear pleomorphism and variable 
mitotic activity. Central cystic degeneration of the tumor lobules may be found. Melanin 
pigment can also be found within the cytoplasm of tumor cells. Melanophages may be present 
in the stroma and within the cyst center. 
Basal cell tumor differs from basal cell carcinoma by the lack of invasion and the associated 
fibroplasia at the periphery of the benign tumors (Goldschmidt et al., 1998, Goldschmidt and 
Hendrick, 2002). 
 
Historical development of basal cell tumor classification (Diagram 1 & 2) 
Moulton (1961) mentioned that solid basal cell tumor was the common form and some tumors 
formed elongated cords and loops, but did not form lumina. Trichoepithelioma was 
considered a subtype of basal cell tumor and described as basal cell tumors which form 
structures resembling hair (Moulton, 1961). However, Sedlmeier et al. (1967) have described 
more clearly the histological structures and have described the pure solid, bud-like, medusoid 
and ribbon-like subtypes of the solid type. Other types are the adenoid, cystic and keratotic 
types, and they have pointed out that the mixed forms are not seldom. A clear definition of the 
LITERATURE  REVIEW 11 
adenoid type is found in this study, which is described as glandular-like structures with no 
real lumen but connective tissues, usually with mucoid degeneration (Sedlmeier et al., 1967). 
Weiss and Frese (1974) stated in the first WHO classification that there were slight 
differences in the arrangement of types and subtypes of the tumors compared to previous 
categorization. There were solid, ribbon-like, medusoid, adenoid, cystic, basosquamous 
varieties. Superficial multicentric, morphoea, and fibroepithelial types had been described in 
man, but had not been shown to occur in animals (Weiss and Frese, 1974). 
Stannard and Pulley (1978) use the term basal cell epithelioma instead of basal cell tumor, 
and they describe the adenoid tumor type more precisely as a subtype of the ribbon type as 
follows:    “the  stroma  between  the  strands  of  cells  in  the  ribbon  type  frequently  undergoes 
mucinous degeneration, giving a distinct glandular appearance to the tumor. When this is a 
prominent feature, the term adenoid basal cell epithelioma has been used”. They summarize 
basal cell tumors as: solid, cystic, ribbon (adenoid), and medusoid, and they point out that 
mixed-form is not uncommon. 
Seiler (1982) describes tumors in three dogs that resemble the granular basal cell tumor 
(carcinoma) of man. 
Diters and Walsh (1984) describe the trabecular type in the cat under solid basal cell tumor 
without mentioning the term “trabecular” and describe one histological figure which appears 
identical with the trabicular type of basal cell tumor as follows:  “solid  basal  cell  tumor 
characterized by variably sized and shaped tumor masses with peripherally radiating epithelial 
buds”. 
Pulley and Stannard (1990) give a description similar to that mentioned previously (Stannard 
and Pulley, 1978). 
Gross et al. (1992) describe trichoblastomas separately from basal cell tumors. 
Yager and Wilcock (1994) define sebaceous epithelioma as a maturational variant of basal 
cell tumor. 
The new international WHO histological classification of tumors of domestic animals by 
Goldschmidt et al. (1998) reclassifies the majority of basal cell tumors in the dog and the 
spindle cell type of basal cell tumor in the cat as trichoblastomas (ribbon, trabecular, granular 
cell and spindle cell trichoblastoma). The medusoid type is subsumed under the ribbon type, 
and sebaceous epithelioma under sebaceous gland tumors. Keratotic basal cell tumor is 
classified under tumors of the epidermis as basosquamous carcinoma. 
Meuten (2002), in his fourth edition, follows the new WHO classification with an additional 
separate medusoid type under the trichoblastoma. 
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In brief: 
 
Diag. 1: Old classifications 
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Diag. 2: New classification 
Basal cell 
tumors
Pure solid
Cystic
keratotic
With 
sebaceous 
differentiati
Granular 
cell
Adenoidtrabecular
Solid
Medosoid
Ribbon
Trichoblastomas
Basosquamous carcinomaSebaceous epithelioma
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2.5.1.1.2. Basal cell carcinoma  
This is a low-grade malignant proliferation of cells that recapitulate the basal cell layer of the 
normal epidermis or the adnexa. This neoplasm shows no differentiation of any adnexal 
structures and may have epidermal contiguity that can be multifocal. Histologic variants of 
basal cell carcinoma are infiltrative and clear cells (Goldschmidt et al., 1998). 
 
2.5.1.1.2.1. Infiltrative basal cell tumor 
These may have an association with the overlying epidermis, with cords of primitive basaloid 
cells extending into the dermis and occasionally into the subcutis. The tumor cells have small, 
hyperchromatic nuclei with scant cytoplasm, and mitotic figures may be numerous, mostly 
accompanied by an extensive proliferation of stromal fibroblasts. This tumor has no adnexal 
differentiation, a fact that allows it to be differentiated from sebaceous epithelioma and 
malignant trichoepithelioma (Goldschmidt et al., 1998). 
 
2.5.1.1.2.2. Clear cell basal cell tumor 
This is an uncommon and newly classified variant, in which the tumor cells are large and 
polygonal and have clear or finely granular cytoplasm. Its nuclei are ovoid and uniform with 
small nucleoli and a variable number of mitoses (Goldschmidt et al., 1998, Goldschmidt and 
Hendrick, 2002). 
 
2.5.1.2. Tumors of the epidermis 
This group of tumors includes papilloma (papillomatosis) and inverted papilloma as benign 
tumors (Campbell et al., 1988, Shimada et al., 1993). Actinic keratosis (Hargis and 
Thomassen, 1979), multicentric squamous cell carcinoma in situ or bowen-like disease (Baer 
and Helton, 1993), squamous cell carcinoma and basosquamous carcinoma represent the 
malignant tumors (Goldschmidt et al., 1998). Squamous cell carcinoma has two uncommon 
histologic variants, acantholytic and spindle cell squamous cell carcinoma (Goldschmidt et 
al., 1998, Goldschmidt and Hendrick, 2002). Another variant described as signet-ring 
squamous cell carcinoma has been reported (Espinosa et al., 2003) 
The benign, virus-induced fibropapilloma of the cattle, as in the old WHO classification, is 
not found in the new WHO classification. 
Actinic keratosis and multicentric squamous cell carcinoma in situ were not classifid in the 
old WHO classification and were reported in the time between the old and new classifications 
(Hargis and Thomassen, 1979, Gross and Brimacomb, 1986, Baer and Helton, 1993). 
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Basosquamous carcinoma, which was classified in the old WHO classification as a variant of 
basal cell tumor (Weiss and Frese, 1974), is considered an epidermal tumor in the new WHO 
classification (Goldschmidt et al., 1998).  
 
2.5.1.3. Tumors with adnexal differentiation 
2.5.1.3.1. Follicular tumors 
This group consists of the following tumors: infundibular keratinizing acanthoma, 
tricholemmoma, trichoblastoma, trichoepithelioma and pilomatricoma. 
Only trichoepithelioma and pilomatricoma (under the name of necrotizing and calcifying 
epithelioma {Malherbe}) were classified under follicular tumors in the old WHO 
classification (Weiss and Frese, 1974). Infundibular keratinizing acanthoma was classified 
separately in the old WHO classification under epithelial tumors and tumor-like lesions, and 
not as hair follicle tumor as it is in the new WHO classification. 
Some other hair follicle tumors such as trichofolliculoma in animals have been reported as 
common tumors in guinea pigs and constitute 45 % of all skin tumors in these animals (Frank 
and Frese 1988). However, they have also been reported as rare benign neoplasms of dogs 
and cats (Gross et al., 1992, Scott et al., 2001). Trichofolliculoma was mentioned in the old 
WHO classification as a tumor of man and at that time had not yet been described in animals 
(Weiss and Frese, 1974), however, it is not mentioned in the new WHO classification. 
 
2.5.1.3.1.1 Infundibular keratinizing acanthoma 
 This tumor is also called intra-cutaneous cornifying epithelioma (Goldschmidt et al., 1998). It 
was designated as keratoacanthoma in the U.S.A., however, this name was not accepted in the 
old WHO classification (Weiss and Frese, 1974). According to the new WHO classification, 
the diagnosis of keratoacanthoma should be reserved for tumors of subungual origin 
(Goldschmidt et al., 1998). This tumor must be differentiated from squamous cell carcinomas, 
trichoepitheliomas, and epidermal inclusion cysts (Stannard and Pulley, 1975). Cysts with 
epithelial proliferation were considered an early stage of infundibular keratinizing acanthoma 
in the old WHO classification (Weiss and Frese, 1974). 
 
2.5.1.3.1.2 Tricholemmoma 
This tumor has recently been classified in the new WHO classification; it is characterized by 
external root sheath differentiation and has two types, the inferior and the isthmic type. The 
first cases in dogs were reported by Diters and Goldschmidt (1983), who described the bulb or 
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inferior type, and by Walsh and Corapi (1986), who described the isthmic type. Some authors 
use the term trichilemmoma instead of tricholemmoma (Murphy and Elder, 1990). 
 
2.5.1.3.1.3 Trichoblastoma 
Trichoblastomas have mostly been reported as basal cell tumors in the literature (Sedlmeier et 
al., 1967, Stannard and Pulley, 1978, Madewell and Theilen, 1987, Goldschmidt and Shofer, 
1992, Bomhard, 2001, Goldschmidt and Hendrick, 2002) and they are mentioned separately 
by Gross et al. (1992). Trichoblastoma is a new term used in the WHO classification. It has 
been reclassified from the majority of those tumors that were previously categorized as basal 
cell tumors in the dog, horse and sheep, and as spindle cell form of a basal cell tumor in the 
cat (Goldschmidt and Hendrick, 2002). Trabecular trichoblastoma was also categorized as a 
type of trichoblastoma, which is more frequent in cats (Goldschmidt et al., 1998, Goldschmidt 
and Hendrick, 2002) but the authors did not explain why and that this tumor is reclassified 
from basal cell tumor. 
Trichoblastoma is a benign tumor and has different types including ribbon, trabecular, 
granular cell and spindle cell (Goldschmidt et al., 1998) and medusoid types (Goldschmidt 
and Hendrick, 2002). Some authors state that the mixed forms are not uncommon (Sedlmeier 
et al., 1967, Stannard and Pulley, 1978). 
The ribbon, medusoid and granular cell types are mostly seen in dogs, while trabecular and 
spindle cell type are more frequent in cats (Goldschmidt and Hendrick, 2002). 
Generally, trichoblastomas are common in dogs and cats, uncommon in horses and rare in 
other species (Goldschmidt and Hendrick, 2002). The granular cell type is very rare and only 
a few cases have been reported in dogs and rats (Seiler, 1982, Courtney, 1992, Yoshitomi and 
Boorman 1994). The granular cell trichoblastoma in many aspects resembles granular cell 
myoblastoma (Seiler, 1982), however, both tumors generally are of different origin 
(mesenchymal and epithelial origin), as they are classified in the new WHO classification 
(Goldschmidt et al., 1998, Hendrick et al., 1998). This variation may lead to histologic 
confusion with tumors containing areas of sebaceous cell differentiation (Seiler, 1982). 
In human pathology the first description of trichoblastoma was given by Headington and 
French (1962). Trichoblastomas are rare skin tumors (Yu et al., 2005). Five main patterns 
have been described in human trichoblastomas, namely large nodular, small nodular, 
cribriform, racemiform, and retiform, which may be found as an exclusive pattern, but also as 
combinations of two or more patterns within one tumor (Ackerman et al., 1993). Many 
sporadic cases of other variants have been reported, namely clear cell variants, trichoblastoma 
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with apocrine and sebaceous differentiation (Tronnier, 2001, Usmani et al., 2002, Yu et al., 
2005) and melanotrichoblastoma (Kanitakis et al., 2002). Furthermore, trichoblastic 
carcinomas have also been reported (Rofagha et al., 2001, Kazakov et al., 2004). Granular cell 
trichoblastoma is not found in the literature on human pathology, but granular cell basal cell 
carcinoma has been reported (Dundr et al., 2004). 
Malignant variants in domestic animals are not mentioned in the new WHO classification. 
Only one report of follicular stem cell carcinoma with metastasis, lymphatic invasion and 
necrosis in a dog has been published (Mikaelian and Wong, 2003). 
 
2.5.1.3.1.4 Trichoepithelioma 
Only a benign tumor was classified in the old WHO classification, however, two dogs with 
malignant variants with metastases in lymph node and lung have been reported (Sells and 
Conroy, 1976). The malignant trichoepithelioma (matrical carcinoma) is included in the new 
WHO classification (Goldschmidt et al., 1998). 
 
2.5.1.3.1.5 Pilomatricoma 
It is also called pilomatrixoma or necrotizing and calcifying epithelioma of Malherbe, and this 
benign tumor is included in both WHO classifications (Weiss and Frese, 1974, Goldschmidt 
et al., 1998). An aggressive malignant tumor with metastases in bone, lung and lymph nodes 
has been reported (Rodriguez et al., 1995). However, the malignant variant was missing in the 
old WHO classification, and it is called malignant pilomatricoma or pilomatrix carcinoma in 
the new WHO classification (Goldschmidt et al., 1998).  
 
2.5.1.3.2. Nailbed tumors 
This is a newly classified group of tumors arising from the nailbed epithelium and it consists 
of one benign (Subungual keratoacanthoma) and one malignant tumor (Subungual squamous 
cell carcinoma) (Goldschmidt et al., 1998, Goldschmidt and Hendrick, 2002). 
The old sources of subungual keratoacanthoma in animals are mentioned by Walder and Barr 
(1984). Subungual keratoacanthoma is an uncommon tumor and has been described only in 
dogs and cats (Goldschmidt and Hendrick, 2002). In humans, it is also a rare tumor and can 
spontaneously regress, and it must be differentiated from squamous cell carcinoma (Sinha et 
al., 2005). This tumor may cause lysis of the phalangeal bone in animals and humans 
(Goldschmidt et al., 1998, Sinha et al., 2005). 
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2.5.1.3.3. Sebaceous and modified sebaceous gland tumors 
This group consists of three subgroups, namely sebaceous, meibomian and hepatoid tumors. 
They are further divided as follow: Sebaceous adenoma, sebaceous ductal adenoma, 
sebaceous epithelioma, sebaceous carcinoma, meibomian adenoma, meibomian ductal 
adenoma, meibomian epithelioma, meibomian carcinoma, hepatoid gland adenoma (perianal 
gland adenoma, circumanal gland adenoma), hepatoid gland epithelioma (perianal gland 
epithelioma, circumanal gland epithelioma) and hepatoid gland carcinoma (perianal gland 
carcinoma, circumanal gland carcinoma) (Goldschmidt et al., 1998). 
Meibomian gland tumors were categorized in the old WHO classification under the tumors of 
the eye and adnexa (Kircher et al., 1974). 
Hepatoid gland tumors were categorized in the old WHO classification under two organs, the 
skin (Weiss and Frese, 1974) and the lower alimentary tract (Head, 1976). 
Among these types, there is a newly classified tumor named epithelioma, which is 
characterized by a preponderance of basaloid cells with low malignancy behaviour. 
Sebaceous and meibomian ductal adenomas have also been newly classified and are 
characterized by the presence of majority of ducts (Goldschmidt et al., 1998, Goldschmidt and 
Hendrick, 2002). 
Weiss and Frese (1974) subdivide hepatoid gland adenomas into adenomas with secondary 
vascularization and adenomas with transitional cell forms, which are more common. Those 
hepatoid gland adenomas with vascularization are characterized by large glandular areas with 
small vessels and islands of soft tissue surrounded by reserve cells, and their recurrence is 
more frequent than that of others. Goldschmidt and Hendrick (2002) describe that some 
hepatoid gland adenomas show extremily ectatic vessels within the interlobular stroma. 
 
2.5.1.3.4. Apocrine and modified apocrine gland tumors 
This group consists of three subgroups, apocrine, ceruminous and anal sac gland tumors, 
which are divided as follows: Apocrine adenoma, complex and mixed apocrine adenoma, 
apocrine ductal adenoma, apocrine carcinoma, complex and mixed apocrine carcinoma, 
apocrine ductal carcinoma, ceruminous adenoma, complex and mixed ceruminous adenoma, 
ceruminous gland carcinoma, complex and mixed ceruminous carcinoma, anal sac gland 
adenoma (adenoma of the apocrine glands of the anal sac) and anal sac gland carcinoma 
(carcinoma of the apocrine glands of the anal sac) (Goldschmidt et al., 1998). 
Apocrine ductal adenomas were called papillary syringadenoma in the old WHO 
classification (Weiss and Frese, 1974). 
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Anal sac tumors were categorized under tumors of the lower alimentary tract in the old WHO 
classification (Head, 1976). 
Ceruminous gland tumors are included in the new classification, but are not found in the old 
WHO classification. 
Signet-ring-cell carcinoma is a rare tumor mentioned in the old WHO classification (Weiss 
and Frese, 1974), but it is not included in the new one. 
Canine clear cell variant of apocrine gland adenoma has been reported (Nile et al., 2005), but 
is not found in either WHO classification. 
Clear cell or balloon-cell sweat gland carcinoma was first reported as follicular stem cell 
carcinoma by Mikaelian and Wong (2003), and then has been rediagnosed as clear cell or 
balloon-cell sweat gland carcinoma by Walder (2005). 
 
2.5.1.3.5. Eccrine (atrichial) tumors  
This group of tumors was classified under sweat gland tumors in the old WHO classification 
and includes spiradenoma and adenocarcinoma (Weiss and Frese, 1974). This rare group of 
footpad tumors includes eccrine adenoma and eccrine carcinoma (Goldschmidt et al., 1998, 
Goldschmidt and Hendrick, 2002). 
 
2.5.1.4. Tumors metastatic to the skin 
In the old WHO classification, this group was also categorized under secondary tumors of the 
skin (Weiss and Frese, 1974). Pulmonary carcinoma with digital metastasis is the most 
common tumor metastatic to the skin in cats, while mammary carcinoma with cutaneous 
metastasis is most often seen in dogs. An implantation metastasis secondary to prior surgery 
of prostatic carcinoma, transitional cell carcinoma and colonic carcinoma might be found in 
the skin (Goldschmidt et al., 1998). Many other cases of tumors metastatic to the skin were 
reported for dogs such as duodenal adenocarcinoma (Juopperi et al., 2003), pharyngeal 
carcinomas, oral melanomas, pancreatic ductal adenocarcinoma, jejunal adenocarcinoma 
(Scott et al., 2001) and malignant seminomas (Spugnini et al., 2000, Takiguchi et al., 2001). 
Gastric carcinoma with metastasis to the skin has been found in a cat (Scott et al., 2001). 
2.5.1.5. Cysts 
This group is found in both WHO classifications with many differences, and is described in 
detail because of its significance in our work. 
The classifications of skin cysts in the old and the new WHO classifications are summarized 
as follows: 
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2.5.1.5.1. Dermoid cyst 
This cyst has been classified in both, the old and new WHO classification. It is also known as 
pilonidal cyst (Goldschmidt and Shofer, 1992) and has been defined as a congenital dermal 
and/or subcutaneous cyst lined by epidermis with mature dermal and appendageal structures 
in the cyst wall and hair and keratin in its lumen (Goldschmidt et al., 1998). It has rarely been 
observed in dogs and cats (Scott et al., 2001). 
Dermoid sinus has also been reported as a different lesion in dogs (Cornegliani et al., 2001, 
Hillbertz, 2005). This lesion is also called dermoid cyst (Gross et al., 1992). However, there 
are anatomical differences between a dermoid sinus and a dermoid cyst. A dermoid sinus is an 
inherited abnormality in Rhodesian ridgeback dogs derived from a neural tube, which is an 
invagination of the skin, connecting it with the dura mater in the vertebral canal or to an 
intervening structure. It is characterized by the presence of a tuft of hair protruding from each 
sinus and sometimes complicated by infection with drainage (Blood and Studdert, 1999). In 
contrast, a dermoid cyst is a closed epithelium-lined sac or capsule containing a semi-solid or 
liquefied substance (Goldsmith and Shofer, 1992). Dermoid sinus has also been reported in a 
Golden retriever dog (Cornegliani et al., 2001), and nasal dermoid sinuses in dogs have also 
been frequently reported (Bailey et al., 2001, Burrow, 2004). 
 
2.5.1.5.2. Epidermal cyst 
This has been classified in both WHO classifications, and is also called infundibular, 
epidermoid and epidermal inclusion cyst. It is defined as a simple cyst lined by stratified 
squamous epithelium, and all four layers of the normal epidermis or infundibulum, including 
granular cell layer, are present (Goldschmidt et al., 1998). The cyst cavity contains lamellar, 
New WHO classification 
  
1 Infundibular cyst (epidermoid cyst, 
epidermal cyst, epidermal inclusion cyst). 
2 Dilated pore. 
3 Isthmus cyst. 
4 Panfollicular (trichoepitheliomatous) cyst.  
5 Dermoid cyst (dermoid sinus). 
6 Sebaceous duct cyst. 
7 Apocrine cyst and apocrine cystomatosis. 
8 Ciliated cyst. 
9 Subungual epithelial inclusion cyst. 
Old WHO classification 
 
1- Epidermal cyst. 
2- Dermoid cyst. 
3- Follicular cyst. 
4- Cyst with epithelial 
proliferation. 
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often concentrally arranged keratin and, if serial sections are employed, has often been found 
to be connected to a rudimentary hair follicle (Scott et al., 2001). A true epidermal cyst has 
been found secondary to traumatic implantation of the epidermis into the dermis 
(Goldschmidt and Shofer, 1992). Persistent epidermal cysts may develop into squamous 
carcinomas (Jubb et al., 1993). 
 
2.5.1.5.3. Follicular cyst 
This cyst was categorized in the old WHO classification. It develops through the retention of 
follicular or glandular products (congenital or acquired), and is filled with horny cells or 
lamellae, hair and cholesterol crystals. Sebaceous or apocrine sweat glands or atrophic hair 
follicles may be seen running into the base of the cyst. The majority of cutaneous cysts in 
animals are follicular cysts (Weiss and Frese, 1974), and they can be further categorized by 
the level of the follicle from which they have developed into infundibular, isthmus, matrical, 
panfollicular cysts (Scott et al., 2001). The term follicular cyst is not mentioned in the new 
WHO classification; however, the subtypes infundibular, isthmus and panfollicular are 
described separately in the new WHO classification (Goldschmidt et al., 1998). 
 
2.5.1.5.4. Apocrine cyst 
This cyst was mentioned under follicular cysts in the old WHO classification (Weiss and 
Frese, 1974), and is classified separately in the new WHO classification. It is an intradermal 
cyst lined by apocrine secretory epithelium and filled with clear secretion. Multiple cysts at 
multiple sites are referred as apocrine cystomatosis (Goldschmidt et al., 1998) and this kind of 
cyst is common in dogs (Weiss and Frese, 1974). 
 
2.5.1.5.5. Sebaceous duct cyst 
This cyst has been classified under follicular cysts in the old WHO classification (Weiss and 
Frese, 1974). It is defined as a cyst lined by a thin squamous epithelium of the sebaceous duct 
and surrounded by hyperplastic sebaceous glands (Goldschmidt et al., 1998) and this kind of 
cyst is very rare in dogs (Weiss and Frese, 1974). 
 
2.5.1.5.6. Matrical cyst 
It derives from the matrical or inferior segment of the hair follicle and is lined by deeply 
basophilic, basaloid epithelial cells that abruptly keratinize, forming shadow cells. This cyst is 
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regarded as a variant of pilomatricoma (Gross et al., 1992), and is not found in the new WHO 
classification. 
 
2.5.1.5.7. Cyst with epithelial proliferation 
It is considered an early stage of intracutaneous cornifying epithelioma (Frese and Weiss, 
1969), and should be classified as an infundibular keratinizing acanthomas in the new WHO 
classification (Weiss and Frese, 1974). 
 
2.5.1.5.8. Cysts with precarcinomatous epithelial transformation 
These are very rare in animals, and show transformation into squamous and basal cell 
carcinoma (Frese and Weis, 1969). Squamous cell carcinomas arisen from follicular cysts 
have also been reported (Scott et al., 2001). These cysts are not mentioned in either WHO 
classification. 
 
2.5.1.5.9. Branchial cyst 
This cyst has been found in the ventral cervical region and derives from the second branchial 
pouch. A thin wall lined by pseudostratified, nonciliated, columnar epithelial cells is 
characteristic of this cyst (Karbe and Nielsen, 1965, Clark and Kostolich, 1989, Scott et al., 
2001). It is extremely rare in dogs and cats (Scott et al., 2001) and individual cases in some 
other animals, namely mice, cattle and horses have been reported (Smith and Gunson, 1977, 
Hance and Robertson, 1992, France et al., 2000). However, this cyst has not been classified in 
either WHO classification. 
 
2.5.1.5.10. Subungual epithelial inclusion cyst 
Intraosseous epidermoid cyst in animals was first described in the thoracic vertebral body of a 
dog by Liu and Dorfman (1974) and has also been reported in the mandible in horses (Camus 
et al., 1996). In the old WHO classification, the subungual cyst was previously categorized 
under the tumors of bones and joints as a very rare lesion (Misdorp and Heul, 1976). The 
authors give no reference as to previous publications on this subject, and the first possible 
publication on this type of cyst is reported by Bindseil et al. (1984). 
This cyst is identical with the infundibular cyst and is found within the bone of the third 
phalanx (Goldschmidt et al., 1998). It is the most common skin cyst type of the toe in dogs 
(Frank et al., 1995) and probably arises from traumatically displaced epidermal cells (Jubb et 
al., 1993). 
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2.5.1.5.11. Dilated pore 
This is a newly classified cyst, which was first described in man by Winer (1954), and in the 
cat by Scott and Flanders (1984). It is defined as a flasklike cystic structure with a wide 
external opening and laminated keratinaceous content (Luther et al., 1989), characterized by 
hyperplastic epithelium forming the deeper portion of the cyst wall (Goldschmidt et al., 
1998). The outer wall of the cyst exhibits irregular hyperplasia, frequently with a scalloped 
configuration (Gross et al., 1992). It constitutes 9 % of all skin cysts of the cat (Luther et al., 
1989). 
 
2.5.1.5.12. Isthmus cyst 
This is a newly classified cyst, named also isthmus-catagen cyst and tricholemmal cyst (Gross 
et al., 1992). It is defined as a simple cyst lined by keratinizing stratified squamous epithelium 
lacking a granular layer, which resembles the middle segment of the anagen follicle and the 
lower segment of the catagen follicle (Goldschmidt et al., 1998). 
 
2.5.1.5.13. Panfollicular cyst 
This is a newly classified cyst, named also trichoepitheliomatous cyst (Goldschmidt et al., 
1998) and hybrid or mixed cyst (Gross et al., 1992), and it is characterized by two or three 
types of follicular differentiation in the same lesion (Scott et al., 2001). A third type of cell 
lining the cyst wall consists of primitive, small basophilic cells which show abrupt 
keratinisation to shadow cells (Goldschmidt et al., 1998). Small foci of inner root sheath 
differentiation with cells that have clear cytoplasm and trichohyalin granules may be present 
in the transitional zones (Gross et al., 1992, Goldschmidt et al., 1998). 
 
2.5.1.5.14. Ciliated cyst 
This is a newly classified cyst defined as a simple cyst lined by ciliated epithelial cells. 
Occasional goblet cells are interspersed between the ciliated cells (Goldschmidt et al., 1998), 
and the cyst contains a fluid (Goldschmidt and Shofer, 1992). This cyst represents a 
developmental defect of the thyroglossal ducts or respiratory tract and is found at the neck of 
cats (Goldschmidt and Shofer, 1992). 
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2.5.1.6. Hamartomas 
This is a newly classified group, which was not found in the old WHO classification. 
Hamartomas are defined as circumscribed congenital lesions of the skin, characterized by 
hyperplasia of one or more skin components, and are commonly reported in dogs and cats 
(Scott et al., 2001). The term hamartoma was chosen to describe these lesions, rather than the 
term naevus, in order to avoid any possible confusion with the melanocytic nevi in humans 
(Goldschmidt et al., 1998). Despite this new nomenclature, some authors still use the term 
nevi (Scott et al., 2001). Hamartomas are subclassified into epidermal (pigmented epidermal 
naevus), follicular, sebaceous, apocrine and fibroadnexal hamartomas (adnexal naevus, focal 
adnexal dysplasia, folliculosebaceous hamartoma), which are congenital proliferations of 
benign epidermal cells, hair follicles, sebaceous glands, apocrine glands, and the 
pilosebaceous units with fibrous tissue, respectively (Goldschmidt et al., 1998). 
 
2.5.1.7. Tumor-like lesions 
This group is not found under the epithelial tumors of the old WHO classification; however, 
some tumor-like lesions are found in other groups such as sebaceous hyperplasia, which was 
categorized under sebaceous gland tumors (Weiss and Frese, 1974). The following seven 
types of epithelial tumor-like lesions are included in the new WHO classification: 
 
2.5.1.7.1. Squamous papilloma 
This is a newly classified tumor-like lesion defined as a non-neoplastic papillated mass 
composed of epidermis and supporting dermal stroma (Goldschmidt et al., 1998). This lesion 
should be distinguished from a viral papilloma (Goldschmidt and Hendrick, 2002) (Table 1). 
 
Tab. 1: Differentiation between viral and squamous papilloma (Goldschmidt and Hendrick, 
2002). 
Viral papilloma Squamous papilloma 
Epidermal differentiation may show 
orthokeratosis or parakeratosis 
Epidermal differentiation is normal 
Enlarged keratohyaline granules Normal size to keratohyaline granules 
Koilocytes present Koilocytes absent 
Keratinocytes show viral cytopathic effect Keratinocytes normal 
Intranuclear inclusions may be present No intranuclear inclusions 
Elongated rete slant inward Elongated rete slant outward  
Dermal capillaries more prominent than in 
squamous papillomas 
Dermal capillaries less prominent 
(Goldschmidt et al., 1998) 
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2.5.1.7.2. Pressure point comedones 
Pressure point parts of the body are subject to pressure when the animal is recumbent, wears 
harness or saddlery, or during restraint. They are usually found in the bony prominences such 
as the point of the elbow (Blood and Studdert, 1999). Pressure point comedones are also a 
newly classified tumor-like lesion, which appear in the form of multiple simple cysts lined by 
the stratified squamous epithelium of the follicular infundibulum with accumulations of hair 
and keratin within the cyst lumina. These lesions occur primarily on the elbow (Goldschmidt 
et al., 1998). 
 
2.5.1.7.3. Cutaneous horn 
A newly classified tumor-like lesion, defined in the new WHO classification as a 
circumscribed exophytic lesion composed of dense, compact keratin with hyperplastic 
epidermis, which is primarily orthokeratotic and may include foci of parakeratosis 
(Goldschmidt et al., 1998). Many other authors define cutaneous horn as a general clinical 
term, and cutaneous horn may arise from many skin lesions such as papillomas, dilated pores, 
infundibular keratinizing acanthomas, basal cell tumors, squamous cell carcinomas, 
keratinous cysts, actinic keratosis (Gross et al., 1992, Scott et al., 2001) and Multicentric 
squamous cell carcinoma in situ (Rees and Goldschmidt, 1998). 
 
2.5.1.7.4. Warty dyskeratoma 
This is a newly classified tumor-like lesion, which is defined as isolated follicular 
dyskeratosis in human pathology (Murphy and Elder, 1990) and is a rare lesion in dogs (Scott 
et al., 2001). The term dyskeratosis is defined as premature and faulty keratinisation of 
individual cells, which can be seen in a number of inflammatory and neoplastic dermatoses 
(Jubb et al., 1993). Warty dyskeratoma is defined as a focal or multifocal endophytic 
proliferation of the epidermis exhibiting marked intralesional dyskeratosis and acantholysis 
(Goldschmidt et al., 1998).  
 
2.5.1.7.5. Sebaceous hyperplasia 
This lesion is also named senile nodular sebaceous hyperplasia (Weiss and Frese, 1974, 
Goldschmidt et al., 1998). It has been classified in both WHO classifications and is found 
under sebaceous gland tumors in the old WHO classification. 
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2.5.1.7.6. Fibroepithelial "polyp" 
This lesion is also named cutaneous tag, skin tag and acrochordon (Goldschmidt et al., 1998). 
It has been classified in both WHO classifications and is found under tumor-like lesions of 
fibrous tissue in the old WHO classification, under the name of cutaneous fibrous polyp 
(Weiss, 1974). This lesion is very rare (Weiss, 1974, Gross et al., 1992) and sometimes 
known as pendulous soft fibroma (Jubb et al., 1993). 
 
2.5.1.7.7. Fibropruritic nodule 
This is a newly classified tumor-like lesion, which is also named neurodermatitis (Jubb et al., 
1993) or acral lick granuloma (Goldschmidt et al., 1998). It forms focal or multifocal 
hyperplastic dermal nodules associated with chronic self-trauma and inflammation 
(Goldschmidt et al., 1998). This lesion is common in dogs, and has been among the 10 most 
common cases in one study of skin disease (Sischo et al., 1989). It is primarily found in limbs 
(White, 1990). 
 
2.5.1.8. Melanocytic tumors 
2.5.1.8.1. Melanocytoma and Malignant melanoma 
Melanocytoma is also called dermal melanoma or benign melanoma (Goldschmidt et al., 
1998). The old WHO classification of melanocytic tumors only referred to oral and skin 
melanomas in dogs (Weiss and Frese, 1974). Benign and malignant melanomas have been 
classified in both WHO classifications with some differences in their variants. For example, 
the balloon cell variant of the new WHO classification was not found in the old WHO 
classification, while the dendritic and whorled types in the old WHO classification have not 
been categorized in the new one (Weiss and Frese, 1974, Goldschmidt et al., 1998). 
 
2.5.1.8.2. Melanoacanthoma 
This is a newly classified melanocytic tumor, with features of a compound melanocytoma and 
of a benign epithelial neoplasm. It is a rare tumor in dogs (Goldschmidt et al., 1998), also 
called Melanocytoma-Acanthoma (Gross et al., 1992). This tumor was first reported and 
classified in dogs by Gross et al. (1992), without details as to age, breed and determination of 
site predilection. One other case was reported in a two-year-old female German shepherd dog, 
where it was located in the dermis of the dorsal trunk (Espinosa et al., 2000). 
 
LITERATURE  REVIEW 26 
2.5.1.8.3. Melanocytic hyperplasia 
This is a newly classified skin lesion that is also called lentigo, lentigo simplex (Goldschmidt 
et al., 1998) or macular melanosis (Scott et al., 2001). It is composed of a non-neoplastic 
proliferation of melanocytes within the epidermis, primarily in the basal cell layer 
(Goldschmidt et al., 1998). It was first described in dogs by Kraft and Frese (1976), and it is 
mostly found in female dogs, primarily in the last two mammary teats (Kraft and Frese, 
1976a). Lentigo simplex, when present in orange cats, is usually found in animals younger 
than one year (Scott et al., 2001), and is represented by multifocal pigmentation of the lips, 
nose, gingiva, and eyelids (Nesbitt, 1998). A generalized lesion has been reported in a silver 
shorthair cat (Nash and Paulsen, 1990). 
 
2.5.2. Mesenchymal Tumors of Skin and Soft Tissues 
2.5.2.1. Tumors of Fibrous Tissue 
This group has been classified in both WHO classifications (Weiss, 1974, Hendrick et al., 
1998), with the following differences: 
- Canine  haemangiopericytoma was  classified  under  “tumors  of  fibrous  tissue”  in  the 
old WHO classification, and under “unclassified tumors” in the new one. 
- Calcinosis  circumscripta  was  classified  under  “tumors  of  fibrous  tissue”  in  the  old 
WHO classification, and reclassified under “miscellaneous tumors” in the new one. 
- Cutaneous fibrous polyp was classified  under  “tumors  of  fibrous  tissue”  in  the  old 
WHO classification, while in the new WHO classification it is classified as 
fibroepithelial polyp under the category of epithelial tumor-like lesions. 
- Undifferentiated sarcomas were classified under this group in the old WHO 
classification, but they have not been included in the new WHO classification. 
- Keloid and hyperplastic scars were found in the old WHO classification and are absent 
in the new WHO classification. 
- Sub-typing of fibrosarcoma into feline postvaccinal and canine well-differentiated 
maxillary and mandibular fibrosarcomas is found only in the new WHO classification. 
- Collagenous hamartoma, nodular dermatofibrosis of the German shepherd dog, 
nodular fasciitis, myxosarcoma and malignant fibrous histiocytoma are found only in 
the new WHO classification. 
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2.5.2.1.1. Benign 
2.5.2.1.1.1. Fibroma 
Fibroma has two subtypes, fibroma durum (firm) and fibroma molle (soft) (Weiss, 1974, Scott 
et al., 2001). This sub-typing is not mentioned in the new WHO classification. Fibroma is 
defined as a benign tumor of mature fibrocytes producing abundant collagen (Hendrick et al., 
1998). 
 
2.5.2.1.1.2. Collagenous hamartoma 
This common newly classified lesion was first distinguished from fibromas by Scott (1984). It 
is a nodular, poorly circumscribed focus of redundant collagen in the superficial dermis 
(Hendrick et al., 1998). This lesion has been recognized in many breeds of dogs (Hendrick et 
al., 1998, Scott et al., 2001). 
 
Tab. 2: Comparison between collagenous hamartoma and fibroma (Gross et al., 1992) 
 Collagenous hamartoma Fibroma 
Location Superficial dermis In the dermis and often encroach on 
the subcutis 
Size Usually less than 1 cm in diameter Usually larger than collagenous 
hamartoma 
Cellularity  Less cellular More cellular 
Growth 
form* 
Lack of discrete growth habit, and 
often included trapped adnexae 
Circumscribed nodule compresses 
adjacend structures 
Pattern Has a similar fiber pattern to that of 
the adjacent dermis 
Repetitive, whirled or interlacing 
pattern of collagen fibers 
* Wilcock and Yager (1994) 
 
2.5.2.1.1.3. Nodular dermatofibrosis of the German shepherd dog 
This is a newly classified lesion, also called multiple collagenous hamartoma (Scott et al., 
2001). It is a rare breed-specific syndrome of multiple fibrous nodules in the dermis and 
subcutis (Hendrick et al., 1998) consisting of bundles of dense collagen fibers with few 
fibrocytes (Lium and Moe, 1985). Female German shepherd dogs are preferentially affected, 
but is has occasionally been found in other breeds (Hendrick et al., 1998). This lesion may 
coincide with unilateral or bilateral renal adenomas or carcinomas, with the presence of at 
least 30 to 50 nodules in the same animal and of several hundred in advanced cases. In these 
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advanced cases multiple leiomyomas are also mostly found in the uterus (Lium and Moe, 
1985, Moe and Lium, 1997). 
 
2.5.2.1.1.4. Nodular fasciitis 
This is a newly classified non-neoplastic, enigmatic inflammatory lesion with many clinical 
and histological features suggestive of a locally invasive fibrosarcoma (Hendrick et al., 1998) 
or cutaneous histiocytosis (Goldschmidt and Hendrick, 2002). This lesion was first described 
in dogs by Bellhorn and Henkind (1967), and has also been reported in cats (Scott et al., 
2001). It is most often found in the corneal and scleral regions of the eye, and in this site is 
also called nodular granulomatous episcleritis (Goldschmidt and Hendrick, 2002) or 
pseudosarcomatous fasciitis (Scott et al., 2001). 
 
2.5.2.1.1.5. Myxoma 
It has been classified in both WHO classifications (Weiss, 1974, Hendrick et al., 1998) and is 
also named myxofibroma (Weiss, 1974, Gross et al., 1992). 
 
2.5.2.1.1.6. Equine sarcoid 
This lesion has been classified in both WHO classifications (Weiss, 1974, Hendrick et al., 
1998). It is the result of a non-productive infection with bovine papillomavirus in horses 
(Goldschmidt and Hendrick, 2002). The same lesion has been described in cats as follows: 
 
Feline sarcoid: 
It is a newly reported rare neoplasm, histologically resembling the equine sarcoid (Scott et al., 
2001). An association with papillomavirus infection has been confirmed (Schulman et al., 
2001), however, papillomavirus-DNA has been detected in mesenchymal tumor cells and not 
in the hyperplastic epithelium (Teifke et al., 2003). This tumor has been frequently reported 
as cutaneous fibropapilloma in cats (Gumbrell et al., 1998, Schulman et al., 2001, Hanna and 
Dunn, 2003), and similar lesions have been reported in the mouth of cats (Rest et al., 1997). 
Feline sarcoid has only recently been reported and is not found in either WHO classification. 
 
2.5.2.1.2. Malignant 
2.5.2.1.2.1. Fibrosarcoma 
It is mentioned in both WHO classifications, with two new subtypes, one in cats and the other 
in dogs, which have both been described in the new WHO classification. These subtypes are 
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feline postvaccinal and canine well-differentiated maxillary and mandibular fibrosarcoma 
(Weiss, 1974, Hendrick et al., 1998). 
 
2.5.2.1.2.2. Myxosarcoma 
It is a newly classified tumor arising from primitive pleomorphic fibroblasts which produce 
excessive mucin (Hendrick et al., 1998). However, only the benign tumor was classified in the 
old WHO classification. 
 
2.5.2.1.2.3. Malignant fibrous histiocytoma 
This is a newly classified tumor (Hendrick et al., 1998) also named extraskeletal giant cell 
tumor, giant cell tumor of soft parts or dermatofibrosarcomas. It is uncommon in cats, rare in 
dogs (Scott et al., 2001). This tumor has a high rate of metastasis (90%) (Waters et al., 1994) 
and has many different variants: storiform-pleomorphic, inflammatory and giant cell variants. 
This tumor presumably arises from primitive mesenchymal cells, shows evidence of a 
fibroblastic/myofibroblastic phenotype (Hendrick et al., 1998), and its relation with malignant 
histiocytosis has been discussed (Kerlin and Hendrick, 1996). A benign variant in dogs and 
cats has been described (Scott et al., 2001). It has not been classified in the new WHO 
classification. In humans, malignant fibrous histiocytoma is the most common soft tissue 
tumor of adults (Murphy and Elder, 1990). 
 
2.5.2.2. Tumors of Adipose Tissue 
Lipoma and liposarcoma were classified in the old WHO classification, however, many 
variants were not described there, and other variants are not mentioned in the new WHO 
classification (Weiss, 1974, Hendrick et al., 1998). 
 
2.5.2.2.1. Benign 
2.5.2.2.1.1. Lipoma 
Lipoma is mentioned in both WHO classifications. The infiltrative lipoma is a newly added 
variant (Hendrick et al., 1998) that is uncommon in dogs and rare in cats (Gross et al., 1992). 
Infiltrative lipoma has a high recurrence rate (Bergman et al., 1994, McChesney et al., 1980) 
and may result from trauma to a simple lipoma (McChesney et al., 1980). 
Other lipomas such as myxoid lipoma (Weiss, 1974), fibrolipoma (Gross et al., 1992), 
chondrolipoma (Goldschmidt and Shofer, 1992) intermuscular lipoma (Thomson et al., 1999), 
and pigmented lipoma (Scott et al., 2001) are not described in the new WHO classification. 
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2.5.2.2.1.2. Angiolipoma 
This is a newly classified variant of lipoma consisting of small, well-differentiated blood 
vessels within the tumor. This tumor is rare and is found in dogs, but has also been reported in 
cats (Hendrick et al., 1998, Liggett et al., 2002). 
 
2.5.2.2.2. Malignant 
2.5.2.2.2.1. Liposarcoma 
Two variants have been classified in both WHO classifications: well differentiated and 
pleomorphic liposarcomas (Weiss, 1974, Hendrick et al., 1998). The myxoid variant is a 
newly classified one that is identified by the presence of scattered lipoblasts and a bubbly 
appearance to the stromal mucin (Hendrick et al., 1998) and it has been reported in dogs 
(Messick and Radin, 1989). 
 
2.5.2.3. Tumors of Smooth Muscle 
This group has been classified in both WHO classifications with few differences and includes 
leiomyoma and leiomyosarcoma (Weiss, 1974, Hendrick et al., 1998). The variant called 
mixed fibroleiomyoma is included only in the new WHO classification. Fibroleiomyomas are 
commonly seen in the female genital tract (Hendrick et al., 1998), however, dermal tumor has 
also been reported (Liu and Mikaelian, 2003). 
Arrector pili hamartoma, angioleiomyoma and angioleiomyosarcoma have been recently 
reported in dogs and cats (Liu and Mikaelian, 2003), and are not described in the new WHO 
classification. 
 
2.5.2.4. Tumors of Striated Muscle 
This group has been categorized in both WHO classifications with few differences, and 
includes rhabdomyoma and rhabdomyosarcoma (Weiss, 1974, Hendrick et al., 1998). A 
variant of rhabdomyosarcoma named embryonal rhabdomyosarcoma of the urinary bladder is 
only described in the new WHO classification (Hendrick et al., 1998). This tumor variant is 
also called botryoid sarcoma or sarcoma botryoides (Kuwamura et al., 1998, Takiguchi et al., 
2002). 
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2.5.2.5. Tumors of Vascular Tissue 
2.5.2.5.1. Benign 
Hemangioma and lymphangioma have been described in both WHO classifications (Weiss, 
1974, Hendrick et al., 1998). 
Scrotal vascular hamartoma in the new WHO classification was also described under this 
group in the old WHO classification as a tumor-like lesion; it shows varicosis and ectasia of 
scrotal veins. This lesion is similar to angiokeratoma (Mibelli) of man (Weiss, 1974). 
Cutaneous bovine angiomatosis is a newly classified lesion (Hendrick et al., 1998) that was 
reported early (Cotchin and Swarbrick, 1963) but was not described in the old WHO 
classification. This lesion is found in the skin and most other organs in bovine (Watson and 
Thompson, 1990). This lesion is also known as vascular hamartoma (Sheahan BJ, Donnelly, 
1981), angiomatous vascular malformation (Cho et al., 1979) and as hemangiomas (Kirkbride 
et al., 1973). A similar lesion to cutaneous bovine angiomatosis has also been reported in 
canine (Kim et al., 2005). 
Angiokeratoma is a rare variant of hemangioma in dogs, containing both vascular and 
epithelial components. It occurs most often on the eyelid and conjunctiva, but can also arise in 
the superficial dermis at any site (Yager and Wilcock, 1994, Vala and Esteves, 2001). 
However, this tumor has not been mentioned in either WHO classification. 
 
2.5.2.5.2. Intermediate 
2.5.2.5.2.1. Kaposi-like vascular tumor 
It is a newly classified tumor (Hendrick et al., 1998). Only few cases have been reported in 
female dogs (Goldschmidt and Hendrick, 2002) and in one male dog (Vincek et al., 2004). 
 
2.5.2.5.3. Malignant 
Hemangiosarcoma and lymphangiosarcoma are described in both WHO classifications 
(Weiss, 1974, Hendrick et al., 1998). 
One variant in cats, named feline ventral abdominal angiosarcoma is mentioned in the new 
WHO classification. The tumor origin, from blood vessel or lymphatic vessel, is controversial 
(Hendrick et al., 1998). Some publications have confirmed that this tumor is of lymphatic 
origin, and they recommend using the term feline ventral abdominal lymphangiosarcoma 
(Swayne et al., 1989, Galeotti et al., 2004). 
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Epithelioid haemangioendothelioma, which has been described in the skin and in some other 
organs in humans (Weiss and Bridge, 2002), has also been reported in the lung of a dog 
(Machida et al., 1998). This type of tumor is not mentioned in the new WHO classification. 
 
2.5.2.6. Tumors of Peripheral Nerves 
This group of tumors is found in both WHO classifications, with different nomenclatures. The 
old WHO classification describes three tumor types: neurinoma (schwannoma), 
neurofibroma, and neurofibrosarcoma (Weiss, 1974). However, the new WHO classification 
renames schwannoma and neurofibroma together as benign peripheral nerve sheath tumors of 
the skin and subcutis, and neurofibrosarcoma is renamed malignant peripheral nerve sheath 
tumor of the skin and subcutis. Together with these, two new lesions were described in the 
new WHO classification, namely traumatic neuroma and granular cell tumor (Hendrick et al., 
1998). 
Traumatic neuroma is described as a non-neoplastic lesion that occurs after transection of a 
nerve by trauma or surgery (Hendrick et al., 1998). 
 
2.5.2.6.1. Granular cell tumor 
It is the most frequently reported primary lung tumor of horses, and it has also been reported 
in dogs, cats and birds (Pusterla et al., 2003). It is also called granular cell myoblastoma 
(Cooper and Valentine, 2002), myoblastoma or putative Schwann cell tumor (Pusterla et al., 
2003). The histogenesis of granular cell tumor has remained unresolved since the original 
description by Abrikossoff (1926). It was believed to be of skeletal muscle, smooth muscle, 
endothelial, perineural fibroblasts, perineural epithelial, or epithelial cells (Patnaik, 1993). It 
is mentioned under tumors of peripheral nerves in the new WHO classification because of its 
presumptive Schwann cell origin (Hendrick et al., 1998). Some other authors mention this 
tumor as a neoplasm of uncertain origin (Cooper and Valentine, 2002) 
 
2.5.2.7. Tumors of Synovium 
This group is found in both WHO classifications, and in the old WHO classification was 
classified under tumors of bones and joints as tumors of joints and related structures, which 
included synovial sarcoma, fibrous histiocytoma and malignant giant cell tumor of soft tissue 
(Misdorp and Van Der Heul, 1976). In the new WHO classification, it is mentioned under the 
tumor group of bones and joints as well as under mesenchymal tumors of the skin and soft 
tissues (Hendrick et al., 1998). According to the new WHO classification, this group consists 
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of only one tumor, the synovial sarcoma. Primary tumors of the synovium are uncommon in 
dogs. However, synovial sarcomas occur most frequently in the stifle joint (Harasen, 2002). 
In a recent study, the most common primary synovial tumors are histiocytic sarcomas (more 
than 51 %), while only 14 % are recognized as synovial cell sarcomas. In addition, 
myxosarcomas and fibrosarcomas are also described as primary synovial tumors (Craig et al., 
2002), and these tumors are not included under the synovial tumors in the new WHO 
classifications. 
 
2.5.2.8. Tumors of Mesothelium 
This group has been newly classified in the WHO classification under different organs, skin 
and soft tissues (Hendrick et al., 1998), alimentary (Head et al., 2003) and respiratory system 
(Dungworth et al., 1999). These tumors are not found in all the groups and organs of the old 
WHO classification, and according to the new WHO classification comprise only 
mesothelioma. This tumor is rare, intermediate in malignancy (Hendrick et al., 1998) and 
frequently reported in cattle (Wolfe et al., 1991, Beytun, 2002). It has also been recorded in 
dogs and cats (Head et al., 2002). 
 
2.5.2.9. Mast Cell Tumors 
It is named also mastocytoma, and has been described only as a malignant skin tumor (Weiss, 
1974). In the new WHO classification, it is classified according to animal species (Hendrick 
et al., 1998). The classification into well-differentiated, poorly differentiated, and malignant 
mastocytosis was found under tumors of haematopoietic and lymphoid tissues in the old 
WHO classification (Jarrett and Mackey, 1974). 
 
2.5.2.9.1. Feline 
Mast cell tumor is the second most common skin tumor in the cat (Miller et al., 1991) and it is 
mostly benign (Hendrick et al., 1998). There is no grading as in dogs, and the cellular 
pleomorphism alone is not indicative of an aggressive behavior of the cutaneous mast cell 
tumor (Johnson et al., 2002). However, mitotic activity seems to be the most effective 
prognostic tool for feline cutaneous mast cell tumor (Johnson et al., 2002, Lepri et al., 2003).  
 
2.5.2.9.1.1. Feline, "histiocytic"  
It is mentioned in the new WHO classification (Hendrick et al., 1998). It is a rare variant, 
which occurs mostly in young Siamese cats (Wilcock et al., 1986, Hendrick et al., 1998, 
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Goldschmidt and Hendrick, 2002). It has also been reported in Himalayan (Larocca, 2000) 
and in Persian cats (Wilcock et al., 1986) and is mostly benign (Wilcock et al., 1986, Lepri et 
al., 2003) and may be regressed (Wilcock et al., 1986). The overall appearance of this tumor 
is granulomatous (Wilcock et al., 1986, Gross et al., 1992, Hendrick et al., 1998). 
Another variant, the pleomorphic cutaneous mast cell tumor with mostly benign behaviour, 
has been reported (Johnson et al., 2002) and is not categorized in the new WHO classification. 
 
2.5.2.9.2. Canine 
Mast cell tumor is the most common mesenchymal cutaneous neoplasm of dogs, as mentioned 
in the old WHO classification, in contrast to the new one, which describes histiocytomas as 
the most common canine skin tumor (Weiss, 1974, Hendrick et al., 1998). It is a malignant 
tumor that can develop in many other organs. The main change with regard to this tumor is 
the grading system (I, II, III) in the new WHO classification (Hendrick et al., 1998). The 
grading is histomorphologic and has great significance for the assessment of the survival time 
of the affected animals (Patnaik et al., 1984). 
 
2.5.2.9.3. Mast cell tumor in other species 
Mast cell tumors occasionally arise in horses, cattle, pigs, and ferrets (Hendrick et al., 1998, 
Goldschmidt and Hendrick, 2002), and have also been reported in donkeys and mules (Kay et 
al., 2003). 
 
2.5.2.10. Histiocytic Tumors 
The old WHO classification mentions only canine cutaneous histiocytoma. Reticulosarcoma 
(cutanous reticulosis) is also mentioned as a tumor resembling malignant histiocytic 
neoplasm, and it is suspected to be of lymphocytic origin (Weiss, 1974); it has later been 
designated atypical histiocytoma, and has been confirmed as a cutaneous plasmacytoma (Baer 
et al., 1989, Rakich et al., 1989, Gross et al., 1992). 
Histiocytic sarcoma is also called localized histiocytic sarcoma (Scott et al., 2001). 
Rottweilers and Bernese mountain dogs are mainly affected, and it is more often found in the 
skin and skeletal muscles than in other organs (Affolter and Moore, 2002). It has been 
classified by Scott et al. (2001), but is not included in either WHO classification. 
Atypical histiocytoma that is histologically similar to benign cutaneous histiocytoma has been 
reported by Kipar (1994), but it is not mentioned in either WHO classification. 
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2.5.2.10.1. Canine cutaneous histiocytoma 
It is the most common cutaneous neoplasm of dogs in the new WHO classification, in contrast 
to the old WHO classification, which described mast cell tumor as the most common 
mesenchymal skin tumor (Weiss, 1974, Hendrick et al., 1998). 
 
2.5.2.10.2. Xanthoma and cutaneous histiocytosis 
They are not to be found in the old WHO classification (Weiss, 1974). Cutaneous 
histiocytosis is classified under intermediate histiocytic tumors in the new WHO classification 
(Hendrick et al., 1998). However, both lesions have been described as non-neoplastic lesions 
by Goldschmidt and Hendrick (2002). 
 
2.5.2.10.3. Systemic histiocytosis 
A newly classified tumor that is limited to the Bernese mountain dog (Hendrick et al., 1998, 
Scott et al., 2001). 
 
2.5.2.10.4. Malignant histiocytosis 
This is a newly classified tumor (Hendrick et al., 1998) also called disseminated histiocytic 
sarcoma (Scott et al., 2001), which mostly affects Rottweilers and Bernese mountain dogs. 
This tumor has more often been found in the internal organs than in the skin (Affolter and 
Moore, 2002) and has also been reported in cats (Gafner and Bestetti, 1988, Court et al., 
1993). 
 
2.5.2.11. Miscellaneous Tumors 
This group is found in both WHO classifications under the same name, but with totally 
different tumor types. This group consists of cutaneous lymphosarcoma and canine 
transmissible venereal tumor in the old WHO classification (Weiss, 1974). Meanwhile, only 
calcinosis circumscripta is described in the new WHO classification (Hendrick et al., 1998). 
 
2.5.2.11.1. Benign 
2.5.2.11.1.1. Calcinosis circumscripta 
This lesion is mentioned in both WHO classifications in different categories. In the old WHO 
classification, it was mentioned as a tumor-like lesion under tumors of fibrous tissue. This 
lesion has been described in dogs (Weiss, 1974, Hendrick et al., 1998) and cats (Scott et al., 
2001, Head et al., 2002). 
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In the new WHO classification, it is described as a lesion identical with tumoral calcinosis in 
humans (Hendrick et al., 1998). However, the designation is not accepted by Pool and 
Thompson (2002), who prefer to use the term multicentric periarticular calcinosis in animals 
for a lesion that looks like tumoral calcinosis in humans. Multicentric periarticular calcinosis 
can only be distinguished from calcinosis circumscripta by its para-articular location (Pool 
and Thompson, 2002). Calcinosis circumscripta is also called apocrine cystic calcinosis, 
multiloculated subcutaneous granuloma (Bettini et al., 2005) or calcium gout (Head et al., 
2002). 
 
2.5.2.12. Unclassified Tumors 
This group is found in both WHO classifications; however, the old WHO classification gives 
no further details (Weiss, 1974, Hendrick et al., 1998). 
 
2.5.2.12.1. Malignant 
2.5.2.12.1.1. Canine hemangiopericytoma 
This tumor was classified under fibrosarcomas in the old WHO classification, and it is also 
called fibrosarcoma with perithelioma-like structures, perithelioma, haemangiosarcoma 
(Weiss, 1974), and spindle cell tumor of canine soft tissue (Yager and Wilcock, 1994). The 
actual histogenesis is uncertain (Hendrick et al., 1998, Goldschmidt and Hendrick, 2002) 
despite ultrastructural and immunohistochemical confirmation of the pericytic origin (Xu, 
1986, Perez, 1996). This tumor is mainly found in dogs, but there are other tumors with a 
similar morphology, which rarely occur in cats and are most likely of peripheral nerve sheath 
origin (Goldschmidt and Hendrick, 2002). Hemangiopericytoma is an uncommon neoplasm in 
humans and its pericytic origin has been confirmed ultrastructurally (Enzinger and Weiss, 
1995). 
 
2.5.2.12.1.2. Malignant mesenchymoma 
It has occasionally been seen in the spleen, and even less frequently in the subcutis and 
retroperitonium (Hendrick et al., 1998). This term is found in both WHO classifications in 
different locations and with some differences in definitions. In the old WHO classification, it 
is found under miscellaneous tumors of the bone and defined as a malignant tumor consisting 
of both osteosarcomatous and liposarcomatous tissues, also named osteoliposarcoma 
(Misdorp and Van der Heul, 1976). In the new WHO classification, this tumor is found under 
miscellaneous tumors of the bone and joint and defined as a malignant tumor characterized by 
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the presence of multiple types of differentiation such as osteosarcomatous and 
liposarcomatous (Slayter et al., 1994). It is also classified under mesenchymal tumors of the 
skin and soft tissues and can have regions of more than two mesenchymal cell types and 
contain well-differentiated leiomyosarcoma, osteosarcoma and liposarcoma in the same 
neoplasm. Collision tumors and poorly differentiated tumors are not included in this category 
(Hendrick et al., 1998). 
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3. MATERIALS AND METHODS 
We collected 816 skin tumors and tumor-like lesions from 768 dogs, and 194 skin tumors and 
tumor-like lesions from 194 cats. All the sections and data were in the archives of institute of 
veterinary pathology at Justus-Liebig-University, Giessen, Germany. The biopsies were 
received at the institute between January and April 2000 for diagnostic purposes. Biopsies 
were fixed in 10% formalin, processed (Tissue Tek® Vacuum infiltration processor, Fa. Vogel 
Wilhelm GmbH, Giessen), embedded in paraffin (Histo-Comp® tissue embed device, Fa. 
Vogel Wilhelm GmbH, Giessen), sectioned at 4 m thickness (Rotation microtome HM340 
E, Fa. Microm Laborgeraete GmbH, Walldorf; Microtome blade: Stainless steel S35, Fa. 
Feather Safety Razor Co., Ltd. Medical Division, Japan) and stained with Haematoxylin and 
Eosin (HE), then covered with foil in the covering machine (TissueTec®, Mod. 4765, Vogel 
Wilhelm GmbH, Giessen). Some sections were stained additionally with other special stains 
including Periodic Acid Schiff stain (PAS), Toluidin and Masson’s trichrome stains. In some 
cases melanin bleach was used. 
Immunohistological techniques were also applied for the identification of cytokeratin, 
vimentin, actin, desmin, S100, neurofilament, Melan A, neuron specific enolase (NSE), 
synaptophysin, CD79α and smooth muscle actin using the avidin-biotin complex (ABC) 
method, and glial fibrillary acidic protein (GFAP), factor VIII-related antigen, MHC II, 
lysozyme, CD3, CD45R and MAC387 using the peroxidase-antiperoxidase (PAP) method. 
Diagnosis was registered at that time according to the old WHO classification of the tumors 
of the skin and soft tissues (Weiss and Frese, 1974, Weiss, 1974). Sections were looked at 
twice again, and rediagnosed according to the new WHO classification of the tumors of the 
skin and soft tissues (Goldschmidt et al., 1998, Hendrick et al., 1998). Data were registered in 
Excel-table format. 
 
3.1. Hematoxylin and Eosin (HE): Stain Protocol for Shandon Varistain 24-3 
Sections: Sections from paraffin blocks were attached to glass slides (Star Frost® 
geschnitten, Fa. Engelbrecht Medizin- und Labortechnik GmbH, Edermuende), dried at room 
temperature, and then deparaffinized. The deparaffinization process took place in the staining 
machine as described in the staining procedure below. 
 
Solutions: 
Kardasewitsch solution (5 % alcoholic ammonia solution): 
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25 % ammonia solution, mix with 4 times the volume of 70% ethanol 
Eosin solution: 
300 ml stock solution 
20 g eosin (Eosin, Fa. Carl Roth GmbH & Co KG, Karlsruhe), dilute in 1000 ml distilled 
water and 1000 ml 2-propanol 
300 ml distilled water 
300 ml ethanol 96 % 
1 ml glacial acetic acid (acetic acid Rotipuran® > 99.7 %, Fa. Carl Roth GmbH & Co KG, 
Karlsruhe) 
Hematoxylin: 
100 ml hematoxylin (Papanicolaous-solution 1b hematoxylin solution S, Fa. Merck KGaA, 
Darmstadt) mixed with 400 ml distilled water 
HCl-alcohol (acid alcohol 1 %): 
99 ml 70% alcohol mixed with 1ml conc. hydrochloric acid (hydrochloric acid 32 % Carl 
Roth GmbH & Co. KG, Karlsruhe) 
 
Procedure: 
This process runs in the staining machine (Varistain 24-3, Fa. Shandon GmbH, Frankfurt am 
Main) as follows: 
Step Substance Time [Min:Sec] 
1 Xylene isomer >98 %  2:00 
2 Xylene isomer >98 % 2:00 
3 Isopropanol (2-Propanol) 2:00 
4 Isopropanol (2-Propanol) 2:00 
5 Ethanol 96 % 2:00 
6 Ethanol 96 % 1:00 
7 Ethanol 70%  0:30 
8 5 % Ammonia solution (Kardasewitsch) 4:00 
9 Tap water 4:00 
10 Tap water 2:00 
11 Hematoxylin 4:00 
12 Tap water  5:00 
13 Acid alcohol 1 % (HCL-Alcohol) 0:01 
14 Eosin 1:30 
15 Ethanol 96 % 1:00 
16 Ethanol 96 % 0:30 
17 Ethanol 96 % 0:30 
18 Isopropanol 0:30 
19 Isopropanol 0:30 
20 Xylene isomere 0:30 
21 Xylene isomere 0:30 
22 Xylene isomere 0:30 
23 Covering  
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Results: 
Nuclei: Blue-black 
Cytoplasm: Varying shades of pink 
Muscle fibers: Deep pinky red 
Fibrin: Deep pink 
Red blood cells: Orange/red 
 
3.2. Special stains 
Deparaffinize: 
Slides from paraffin blocks were deparaffinized just prior to special staining as follows: 
1. Rinse 5 min in xylene 
2. Rinse 5 min in absolute isopropanol 
3. Rinse 5 min in 96 % ethanol 
4. Rinse 5 min in 70% ethanol 
5. Rinse 5 min in 50% isopropanol 
6. Rinse briefly in distilled water 
 
3.2.1. Periodic Acid Schiff stain (PAS) with or without pre-processing with diastase 
Sections: Deparaffinized sections 
 
Solutions: 
Diastase treatment (Saliva) 
0.5 % aqueous periodic acid solution 
Graumann’s Schiff reagent: 
5 g P-rosanilin acridene-free in 150 ml 1 normal HCl solution. Add 850 ml distilled water 
with 5 g potassium disulfide. The solution becomes yellowish within 24 hours, then shake for 
2 min with 3 g active coal. This working solution is stable for 2 months (keep in refrigerator). 
Sulfide water: 
300 ml distilled water 
15 ml 10% potassium disulfide (K2S2O5, Merck KGaA, Darmstadt) 
15 ml 1 normal HCl 
 
Pre-processing with diastase: 
Dip in diastase at room temperature for 2 hours 
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Procedure: 
Steps Substance Time 
 [Min:Sec] 
1 Periodic acid solution 0,5 % 10:00 
2 Rinse with tap water 10:00 
3 Rinse with distilled water 2 x 2:00 
4 Schiff reagent (at 60 C○) 30:00 
5 Fresh sulfide water 3 x 2:00 
6 Rinse with tap water 10:00 
7 Rinse with distilled water 2:00 
8 Haemalaun  3:00 
9 Rinse with tap water 3:00 
10 50% isopropanol 3:00 
11 70% isopropanol 3:00 
12 96 % ethanol 3:00 
13 Absolute isopropanol 2 x 3:00 
14 Xylene 3:00 
15 Covering  
 
Results: 
PAS positive: stained red (Polysaccharide and neutral muco-substances) 
Diastase resistant: stained red 
Diastase not resistant: not stained (Glycogen) 
 
3.2.2. Toluidin 
Sections: Deparaffinized sections 
 
Solutions: 
1 % toluidin blue (aqueous) (Dr. K. Hollborn & Soehne GmbH & Co KG, Leipzig), 96 % 
ethanol with two drops of glacial acetic acid, absolute alcohol and xylene. 
 
Procedure:  
Stain one hour with 1 % toluidin blue, then differentiate in 96 % alcohol mixed with two 
drops of glacial acetic acid, dip briefly in absolute alcohol. 
Rinse for 5 min in xylene, then cover 
 
Results: 
Mast cells and some mucins: Purple/red  
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Nuclei: Pale blue 
 
3.2.3. Masson’s trichrome 
Sections: Deparaffinized sections 
 
Solutions: 
Weigert's iron hematoxylin solution (Carl Roth GmbH & Co. KG, Karlsruhe) 
Acid fuchsin solution:  
1 g acid fuchsin (Carl Roth GmbH & Co. KG, Karlsruhe) 
1 ml glacial acetic acid (Carl Roth GmbH & Co. KG, Karlsruhe) 
100 ml distilled water  
Phosphomolybdic acid solution: 
1 g phosphomolybdic acid (Carl Roth GmbH & Co. KG, Karlsruhe) 
100 ml distilled water 
Aniline blue solution:  
2.5 g aniline blue (Carl Roth GmbH & Co. KG, Karlsruhe) 
2.5 ml glacial acetic acid (Carl Roth GmbH & Co. KG, Karlsruhe) 
100 ml distilled water 
1 % acetic acid solution:  
1 ml glacial acetic acid (Carl Roth GmbH & Co. KG, Karlsruhe) 
99 ml distilled water 
 
Procedure:  
1. Stain in Weigert's iron hematoxylin solution for 5 min 
2. Rinse briefly in running tap water 
3. Differentiate in 1 % acetic acid until the connective tissue is approximately colorless 
4. Rinse in distilled water, 2 x 5 min 
5. Stain in acid fuchsin solution for 5 min 
 One part A (1 g acid fuchsin, 100 ml distilled water and 1 ml glacial acetic acid) 
 Two parts B (1 g ponceau de xylidine on 100 ml distilled water and 1 ml glacial acetic 
acid) 
6. Rinse briefly in distilled water 
7. Differentiate in 1 % phosphomolybdic acid solution for 5 min 
8. Transfer sections directly (without rinse) into 1 % aniline blue solution and stain for 1.5 
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min 
9. Rinse briefly twice in distilled water and dip in glacial acetic acid for 5 min, then dip for 3 
minutes in absolute alcohol 
10. Rinse 5 min in xylene, then cover 
 
Results:  
Collagen: Blue 
Nuclei: Black 
Muscle, cytoplasm, keratin: Red 
 
3.2.4. Melanin bleach 
Sections: Deparaffinized sections 
 
Solutions: 
1 % potassium permanganate (KMnO5, Merck KGaA, Darmstadt) 
2 % potassium disulfide (K2S2O5, Merck KGaA, Darmstadt) 
 
Procedure:  
Treat sections with 1 % potassium permanganate for 30 min 
Rinse in water 
Treat sections with 2 % potassium disulfide for 20 min 
Rinse in running water, examine and re-bleach if necessary until the sections become white 
Counterstain in hematoxylin and eosin (HE) as follow: 
3 min haemalaun (Carl Roth GmbH & Co. KG, Karlsruhe) 
3 min rinse under running tap water 
10 min eosin (Carl Roth GmbH & Co. KG, Karlsruhe) 
Dip briefly in ascending alcohol concentrations (1 sec each) as follows: 
50% isopropanol (Carl Roth GmbH & Co. KG, Karlsruhe) 
70% isopropanol (Carl Roth GmbH & Co. KG, Karlsruhe) 
96 % ethanol (Carl Roth GmbH & Co. KG, Karlsruhe) 
Absolute isopropanol 
Rinse briefly in xylene, then cover 
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3.3. Immunhistology 
For the immunohistological examination, sections of 2-3 m thickness on SuperFrost®/Plus 
slides (041300, Menzel Glaeser Braunschweig) were prepared and afterwards dehydrated for 
at least one hour in front of the ventilator or over night at room temperature. 
Swine, rabbit, horse and rat serum: 
Keep the blood of swine, rabbits, horses and rats for 2 to 4 hours at room temperature, then 
centrifuge for 10 min at 1500 rpm to collect the serum. Filtrate the serum to be sterile, 
conserve by adding 0.05 % merthiolate and store at -20°C. 
Shandon Coverplate™ Technology: 
The Shandon Coverplate (Thermo Electron Co., Dreieich) is a plastic device that fits over a 
standard microscope slide allowing specimens to be immunostained with a minimum amount 
of reagent. This technology was used in our immunohistological staining. 
 
3.3.1. General processes 
Many processes were identical in all types of immunhistological staining procedures used in 
our study. These are described in the following. The specificities of the different types of 
immunohistological staining in our study are each described thereafter. 
 
3.3.1.1. Deparaffinize 
Slides from paraffin blocks were deparaffinized as follows: 
1. Rinse three times, 3 min each in xylene 
2. Rinse two times, 3 min each in isopropanol 
3. Rinse 3 min in 96 % ethanol 
4. Rinse 3 min in 80% ethanol 
 
3.3.1.2. Inhibition of the endogeneous peroxidase 
Incubate for 30 min at room temperature in methanol with 0.5 % fresh H2O2 (30%) 
 
3.3.1.3. Pre-processing 
3.3.1.3.1. Protease 
5 min NaCl - PBS (pH: 7.4, 0.15 M) at 37°C in incubator 
5 min 0.05 % protease (Type XXIV) (Sigma-Aldrich Chemie GmbH, Taufkirchen) solved in 
NaCl – PBS (pH: 7.4, 0.15 mol/l) 37°C 
3 x 5 min ice-cold TBS to stop the reaction 
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3.3.1.3.2. Citrate 
Citrate buffer (pH: 6,0, 10 mM): preheat to 97°C and set slides in the solution for 10-15 min. 
Cool slides down in the solution at room temperature for 15 min, then convert in TBS 
 
3.3.1.4. Dilute the antibody 
Dilute the antibody in TBS with 1 % BSA as in table 3: 
Tab. 3: Antibody dilution 
Antibody and negative contro Pre-dilution Dilution 
Anti-cytokeratin -- 1:50 
T1 (negative control) -- 1:50 
Anti-vimentin -- 1:50 
T1 (negative control) -- 1:50 
Anti–muscle actin -- 1:200 
T1 (negative control) -- 1:200 
Anti-desmin -- 1 : 800 
T1 (Negative control) -- 1 : 800 
Anti-neurofilament -- 1 : 400 
T1 (negative control) -- 1 : 400 
Anti-GFAP -- 1 : 500 
KK (negative control) -- 1 : 1829 
Anti – melan A -- 1 : 25 
TBS with 1 % BSA (negative 
control) 
-- -- 
Anti – factor VIII -- 1 : 1000 
KK (negative control) 1:10 1 : 2631 
Mouse anti-MHCII -- 1 : 25 
T1 (negative control) -- 1 : 25 
Anti - lysozyme -- 1 : 600 
KK (negative control) 1:10 1 : 1285 
Anti - CD3 -- 1 : 200 
Rabbit serum (negative control) 1:10 1 : 6000 
Anti – CD45R -- 1 : 1000 
T1 (negative control) -- 1 : 1000 
Anti-CD79 αcy -- 1 : 50 
T1 (negative control) -- 1 : 50 
Anti-NSE -- 1 : 100 
T1 (negative control) -- 1 : 100 
Anti-synaptophysin -- 1 : 100 
T1 (negative control) -- 1 : 100 
Anti – S100 -- 1 :400 
KK (negative control) 1:10 1 :133 
Anti–MAC387 -- 1 :1000 
T1 (negative control) -- 1 :1000 
Anti-smooth muscle actin -- 1 : 500 
T1 (negative control) -- 1 : 500 
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3.3.1.5. General processes after incubation with the ABC complex or the PAP complex 
1) Rinse 3 x 5 min in TBS with 1 % BSA buffer 
2) Incubate all slides for 10 min at room temperature and under constant stirring in fresh and 
filtrated DAB (0.05 % DAB in 0.1 M imidazol/HCl buffer pH: 7.08 with 0.01 % H2O2 (30%)) 
3) Rinse for 3 x 5 min in TBS 
4) Rinse for 1 x 5 min in distilled water 
5) Rinse 5 min in Kardasewitch, then rinse thoroughly in distilled water 
6) Counterstain with papanicolaous hematoxylin (1:10, dilute in distilled water), duration 
according to desired color intensity 
7) Rinse for 5 min in tap water and for 1 min in distilled water  
8) Dehydrate and cover 
Slides should be dehydrated and covered at the end of the following process: 
Rinse 3 min in 50% ethanol 
Rinse 3 min in 70% ethanol 
Rinse 3 min in 80% ethanol 
Rinse 3 min in 96 % ethanol 
Rinse 2 x 3 min in isopropanol 
Rinse 3x 3 min in rotihistol 
Rinse 10 min in xylene, and then cover in covering-machine (TissueTec®, Mod. 4765, Vogel 
Wilhelm GmbH, Giessen) 
 
3.3.2. Immunhistological stains 
3.3.2.1. Cytokeratin 
Antibody: Mouse anti-cytokeratin pan (clone: Lu5) 
Provenance: Neomarkers Dunn Labortechnik GmbH, Asbach 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with Protease (see 3.3.1.3.1.) 
4) Insert slides in Shandon Racks 
5) Blocking serum for 10 min at room temperature, horse serum. 
6) Incubate primary antibody over night at 4°C in the refrigerator 
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Dilute the antibody in TBS with1 % BSA (see 3.3.1.4.) 
7) Rinse 3 x 5 min in TBS buffer 
8) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS with 1 % BSA buffer 
9) Rinse the sections 3 x 5 min in TBS buffer 
10) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer  
Attention! It has to be prepared 30 min before use 
11) Then as above (see 3.3.1.5.) 
 
3.3.2.2. Vimentin 
Antibody: Mouse anti-vimentin (clone V9) 
 Provenance: Dako Cytomalion GmbH, Hamburg 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Insert slides in Shandon Racks 
4) Blocking serum for 10 min at room temperature, horse serum. 
5) Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS with1 % BSA (see 3.3.1.4.) 
 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS with1 % BSA buffer 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer  
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
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3.3.2.3. Actin 
Antibody: Mouse anti-actin (clone HHF-35) 
Provenance: Dako Cytomation GmbH, Hamburg 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Insert slides in Shandon Racks  
4) Blocking serum for 10 min at room temperature, horse serum. 
5) Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS with 1 % BSA (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS with 1 % BSA buffer 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer  
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.4. Desmin 
Antibody: Mouse anti-desmin (clone D33) 
Provenance: Dako Cytomation GmbH, Hamburg 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Insert slides in Shandon Racks 
4) Blocking serum for 10 min at room temperature, dilute horse serum 1:5 in TBS 20 min 
5) Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
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7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS buffer 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer  
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.5. Neurofilament 
Antibody: Mouse anti-neurofilament (clone 2F11) 
Provenance: Dako Cytomation GmbH, Hamburg  
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Insert slides in Shandon Racks 
4) Blocking serum for 10 min at room temperature, horse serum. 
Incubate primary antibody over night at 4°C in the refrigerator. 
Dilute the antibody in TBS with 1 % BSA (see 3.3.1.4.) 
5) Rinse 3 x 5 min in TBS buffer 
6) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS buffer 
7) Rinse the sections 3 x 5 min in TBS buffer 
8) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer  
Attention! It has to be prepared 30 min before use 
9) Then as above (see 3.3.1.5.) 
 
3.3.2.6. Glial fibrillary acidic protein (GFAP) 
Antibody: Rabbit anti-GFAP (rabbit polyclonal) 
Provenance: Dako Cytomation GmbH, Hamburg  
Sections: Deparaffinized sections (see 3.3.1.1.) 
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Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Insert slides in Shandon Racks 
4) Blocking serum for 10 min at room temperature, swine serum 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS with 20% SS (see 3.3.1.4.) 
5) Rinse 3 x 5 min in TBS buffer 
6) Incubate the secondary antibody for 30 min at room temperature, Goat anti-Rabbit IgG  
Preparation: 9 µl for 1 ml TBS with 20% SS 
7) Rinse the sections 3 x 5 min in TBS buffer 
8) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl A+ 9 µl B dilute 1 ml TBS 
9) Then as above (see 3.3.1.5.) 
 
3.3.2.7. Melan A 
Antibody: Mouse  anti-melan A (clone A103) 
Provenance: Dako Cytomation GmbH, Hamburg 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with citrate (see 3.3.1.3.2.) 
4) Insert slides in Shandon Racks 
5) Blocking serum for 10 min at room temperature, horse serum 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS with 1 % BSA (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS buffer 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer 
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Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.8. Factor VIII 
 Antibody: Rabbit anti-factor VIII (rabbit polyclonal) 
Provenance: Dako Cytomation GmbH, Hamburg  
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with Protease (see 3.3.1.3.1.) 
4) Insert slides in Shandon Racks  
 
5) Blocking serum for 10 min at room temperature, swine serum 
Incubate primary antibody over night at 4°C in the refrigerator. 
Dilute the antibody in TBS with 20% SS (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Goat anti-
Rabbit IgG 
Preparation: 9 µl for 1 ml TBS with 20% SS 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl A + 9 µl B dilute 1 ml TBS 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.9. MHC II 
 Antibody: Mouse anti-human HLA-DR, alpha chain (clone TAL.1B5) 
Provenance: Dako Cytomation GmbH, Hamburg 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with citrate (see 3.3.1.3.2.) 
4) Insert slides in Shandon Racks  
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5) Blocking serum for 10 min at room temperature, rat serum 10% in TBS 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Rat anti-Mouse IgG 
Preparation: dilute 1:1000 in TBS 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the mouse PAP complex for 30 min at room temperature 
Preparation: dilute 1:500 in TBS 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.10. Lysozyme 
 Antibody: Rabbit anti-lysozyme (rabbit polyclonal) 
Provenance: Dako Cytomation GmbH, Hamburg  
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with Protease (see 3.3.1.3.1.) 
4) Insert slides in Shandon Racks  
5) Blocking serum not applied 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS/5 % dog serum (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, swine anti-rabbit IgG 
Preparation: dilute 1:100 in TBS with 5 % dog serum 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the PAP from rabbit for 30 min at room temperature 
Preparation: dilute 1:100 in TBS with 5 % dog serum 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.11. CD3 
Antibody: Rabbit anti-CD3 (clone pAb) 
Provenance: Dako Cytomation GmbH, Hamburg 
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Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with Protease (see 3.3.1.3.1.) 
4) Insert slides in Shandon Racks  
5) Blocking serum for 15 min at room temperature, dilute swine serum 1:5 in TBS 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS/20 % SS (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Goat anti-
Rabbit IgG (H+L) 
Preparation: 9 µl for 1 ml TBS buffer / 20 % SS 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer 
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.12. CD45R 
Antibody: CD45R (clone B220 (Ly 5)) 
Provenance: Linaris GmbH, Bettingen Stadt Wertheim 
Sections: Deparaffinized sections from cat (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.): 
2) Rinse for 5 min in TBS 
3) Pre-processing with citrate (see 3.3.1.3.2.) 
4) Insert slides in Shandon Racks  
5) Blocking serum for 10 min at room temperature, horse serum 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS with 1 % BSA (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Rabbit anti-
Rat IgG (H+L) 
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Preparation: 9 µl for 1 ml TBS buffer 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer 
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.13. CD79α 
Antibody: Mouse anti-B-cell CD79αcy (clone HM57) 
Provenance: Dako Cytomation GmbH, Hamburg 
Sections: Deparaffinized sections from cat (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with citrate (see 3.3.1.3.2.) 
4) Insert slides in Shandon Racks 
5) Blocking serum for 10 min at room temperature, horse serum 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS with 1 % BSA (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS buffer 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer 
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.14. Neuron Specific Enolase (NSE) 
Antibody: Anti-NSE (monoclonal antibody) 
Provenance: “Zymed” Invitrogen GmbH, Karlsruhe 
Sections: Deparaffinized sections (see 3.3.1.1.) 
MATERIALS AND METHODS 55 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with citrate (see 3.3.1.3.2.) 
4) Insert slides in Shandon Racks  
5) Blocking serum for 10 min at room temperature, horse serum 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS with 1 % BSA (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS buffer 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer 
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.15. Synaptophysin 
Antibody: Anti-synaptophysin (clone SY38) 
Provenance: Dako Cytomation GmbH, Hamburg 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with citrate (see 3.3.1.3.2.) 
4) Insert slides in Shandon Racks 
5) Blocking serum for 10 min at room temperature, horse serum 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS with 1 % BSA (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS buffer 
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8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer 
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.16. S100 
 Antibody: Anti-S100 (rabbit polyclonal) 
Provenance: Dako Cytomation GmbH, Hamburg 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Insert slides in Shandon Racks 
4) Blocking serum for 30 min at room temperature, dilute swine serum 1:5 in TBS 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS (see 3.3.1.4.) 
5) Rinse 3 x 5 min in TBS buffer 
6) Incubate the secondary antibody for 30 min at room temperature, Swine anti-Rabbit IgG 
Preparation: 9 µl for 1 ml TBS buffer 
7) Rinse the sections 3 x 5 min in TBS buffer 
8) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer  
Attention! It has to be prepared 30 min before use 
9) Then as above (see 3.3.1.5.) 
 
3.3.2.17. MAC387 
Antibody: Anti-Myeloid/Histocyte Antigen (clone MAC387) 
Provenance: Dako Cytomation GmbH, Hamburg 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with Protease (see 3.3.1.3.1.) 
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4) Insert slides in Shandon Racks  
5) Blocking serum for 30 min at room temperature, rat serum 1:10 dilute in TBS 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Swine anti-Rabbit IgG 
Preparation: 9 µl for 1 ml TBS buffer 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer 
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
 
3.3.2.18. Smooth muscle actin 
Antibody: Mouse anti-smooth muscle actin (clone 1A4) 
Provenance: Dako Cytomation GmbH, Hamburg 
Sections: Deparaffinized sections (see 3.3.1.1.) 
Procedure: 
1) Inhibition of the endogeneous peroxidase (see 3.3.1.2.) 
2) Rinse for 5 min in TBS 
3) Pre-processing with citrate (see 3.3.1.3.2.) 
4) Insert slides in Shandon Racks  
5) Blocking serum for 10 min at room temperature, horse serum 
Incubate primary antibody over night at 4°C in the refrigerator 
Dilute the antibody in TBS with 1 % SS (see 3.3.1.4.) 
6) Rinse 3 x 5 min in TBS buffer 
7) Incubate the secondary antibody for 30 min at room temperature, Biotinylated Horse anti-
Mouse IgG (H+L) 
Preparation: 9 µl for 1 ml TBS buffer 
8) Rinse the sections 3 x 5 min in TBS buffer 
9) Incubate the ABC complex for 30 min at room temperature 
Preparation: 9 µl Avidin + 9 µl Biotin for 1 ml TBS buffer  
Attention! It has to be prepared 30 min before use 
10) Then as above (see 3.3.1.5.) 
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4. RESULTS 
 
4.1. Tumors in dogs 
In this part, we will expose 816 skin tumors and tumor-like lesions of 768 dogs in different 
aspects as follows. 
 
4.1.1. Sex distribution 
For 7 dogs out of 768 dogs, the sex was not stated, and the remainder was distributed as in 
table 4. 
 
Tab. 4: Sex distribution (n=761) 
Sex Castrated Non castrated Total % 
♂ 45 384 429 56.4 
♀ 48 284 332 43.6 
Total 93 668 761 100.0 
 
4.1.2. Anatomical location 
For 13 out of 816 canine skin tumors and tumor-like lesions, there were no data regarding 
their location, the remainder are described in table 5. 
 
Tab. 5: The distribution of canine tumors and tumor-like lesions of the skin (n=803) 
Location No. of tumors % 
Limb 279 34.7 
Head 191 23.8 
Perianal 77 9.6 
Chest 66 8.2 
Neck 63 7.8 
Back 54 6.7 
Abdominal 45 5.6 
Mammary region 17 2.1 
Tail 8 1.0 
Whole body 3 0.4 
Total 803 100.0 
 
4.1.3. Breed disposition 
Data regarding breed were reported in 745 cases, involving 109 different dog breeds in this 
collection. 
Mongrels were the most common dogs followed by other breeds as in table 6.  
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Tab. 6: Breed disposition 
Breed No %  Breed No % 
Mongrel 192 25.8  Bobtail 7 0.9 
German shepherd dog 54 7.2  Husky 7 0.9 
Boxer 33 4.4  Staffordshire terrier 7 0.9 
Golden retriever 30 4.0  German wirehaired pointer 6 0.8 
Westhighland white terrier 27 3.6  Newfoundland 6 0.8 
Cocker spaniel 26 3.5  Setter 6 0.8 
Bernese mountain dog 25 3.4  Terrier (breed not further 
specified) 
6 0.8 
Rottweiler 20 2.7  Beagle 5 0.7 
Roughhaired dachshund 19 2.6  Longhair dachshund 5 0.7 
Dobermann 19 2.6  Irish setter 5 0.7 
Poodle 17 2.3  Scotch terrier 5 0.7 
Labrador 16 2.1  Bernhardiner 4 0.5 
Dachshund 11 1.5  Border colli 4 0.5 
Muensterlaender 11 1.5  Collie 4 0.5 
Standard schnauzer 11 1.5  Dalmatin 4 0.5 
Yorkshire terrier 9 1.2  German shorthaired pointer 4 0.5 
Pitbull  9 1.2  Schnauzer (breed not further 
specified) 
4 0.5 
Hovawart 8 1.1  Gordon setter 4 0.5 
Giant schnauzer 8 1.1  Shi-tzu 3 0.4 
Airedale terrier 8 1.1  American staffordshire terrier 3 0.4 
Jack russel terrier 8 1.1     
 
The following 17 dog breeds showed two cases (0.3 %) for each: Bouvier, Bordeaux dog, 
Bulldog, Siberian husky, Kuvasz, Small munsterlander, Pekinese, Pinscher, Retriever, 
Canadian shepherd dog, Springer spaniel, Terrier (breed not further specified), Fox terrier, 
Hunting terrier, Kerry blue terrier, Tibetan terrier and Wachtel dog. 
The following 51 dog breeds showed only one case (0.1 %) for each: Afghan, Akita, 
Appenzeller, Basset, Bayrischer Gebirgsschweisshund, Berger de brie, Bracke, 
Schwarzwaldbracke, Briard, Chihuahua, Chow-chow, Bearded collie, Dogge, American 
bulldog, German dogge, French bulldog, Tibet dogge, Epagneul, Eurasier, Hannoverscher 
Schweisshund, Huetehund, Altdeutscher huetehund, Lahaso apso, Leonberger, Malamute, 
Maltese dog, Mastiff, Large munsterlaender, Otterhund, Pastor majorkin, Miniature pinscher, 
Pon, Poodle, Pointer, Large poodle, Miniature poodle, Jagd retriever, Samojede, American 
shepherd dog, Canadian shepherd, Australian shepherd, Belgian shepherd, Miniature 
schnauzer, English setter, Bedlington terrier, Cairn terrier, Softcoated wheaten terrier, 
Staffordshire bull terrier, Welsh terrier, Weimaraner, Irish wolfhound, Wolfshound and 
Wolfsspitz. 
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4.1.4. Age distribution 
10 cases out of 768 cases were of unknown age; the remainder 758 was distributed as in table 
7. 
 
Tab. 7: Age distribution of dogs (n=758) 
Age in 
years 
Number 
of cases 
%  Age in 
years 
Number 
of cases 
% 
to 1 year 58 7.7  11 66 8.7 
2 57 7.5  12 46 6.1 
3 33 4.4  13 18 2.4 
4 45 5.9  14 21 2.8 
5 46 6.1  15 9 1.2 
6 53 7.0  16 3 0.4 
7 54 7.1  17 1 0.1 
8 66 8.7  18 1 0.1 
9 84 11.1  19 0 0.0 
10 97 12.8  Total 758 100.0 
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Diag. 3: Age distribution in years (n=758).
 
 
4.1.5. Origin of tumors and tumor-like lesions 
Epithelial, mesenchymal and melanocytic origins are the three main groups close to the WHO 
classification, and tumor-like lesions were distributed among these groups and the results are 
represented in diagram 4. 
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Diag. 4: Origin of tumors and tumor-like lesions (n=816)
 
Diagram 4 shows three tumor groups, 403 tumors (49.3 %) of epithelial, 370 tumors (45.3 %) 
of mesenchymal and 43 tumors (5.3 %) of melanocytic origin. 
 
4.1.6. Prevalence of individual groups of skin tumors 
816 skin tumors and tumor-like lesions are divided into groups according to the new WHO 
classification, as in the table 8. 
There are three tumor groups for which there are no cases, and these are tumors metastatic to 
the skin, tumors of striated muscle and tumors of mesothelium. 
 
Tab. 8: Prevalence of individual groups of skin tumors (n=816) 
Tumor Number of tumors % 
Tumors with adnexal differentiation 217 26.6 
Histiocytic tumors 141 17.3 
Cysts 85 10.4 
Tumors of fibrous tissue 63 7.7 
Mast cell tumors 56 6.9 
Tumor-like lesions 51 6.3 
Tumors of  adipose tissue 46 5.6 
Melanocytic tumors 43 5.3 
Tumors of vascular tissue 26 3.2 
Tumors of the epidermis 24 2.9 
Hamartomas 22 2.6 
Unclassified tumors 19 2.3 
Miscellaneous tumors 13 1.6 
Epithelial tumors without sqamous or adnexal differentiation 5 0.6 
Tumors of synovium 2 0.2 
Tumors of peripheral nerves 2 0.2 
Tumors of smooth muscle 1 0.1 
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4.1.7. Prevalence of individual types of skin tumors 
110 types represent the skin tumors and tumor-like lesions in all animal species according to 
the new WHO classification, 54 types are listed in table 9, in descending order as to numbers 
and percentages of the tumors. 
8 types were represented only by one case (0.1 %) each, and they were apocrine hamartoma, 
complex and mixed apocrine carcinoma, hepatoid gland carcinoma, leiomyosarcoma, 
malignant trichoepithelioma, multicentric squamous cell carcinoma in situ, myxoma, and 
pressure point comedones. 
Many of the skin tumors were specific for some animal species, and many were not reported 
or are rare in dogs. However, the tumors that were not found in the dogs of our collection 
were anal sac gland adenoma, angiolipoma, basal cell carcinoma, benign peripheral nerve 
sheath tumor of skin and subcutis, ceruminous adenoma, ceruminous gland carcinoma, 
complex and mixed ceruminous carcinoma, complex and mixed ceruminous adenoma, eccrine 
adenoma, eccrine carcinoma, granular cell tumor, inverted papilloma, Kaposi-like vascular 
tumor, leiomyoma, liposarcoma, lymphangiosarcoma, malignant fibrous histiocytoma, 
malignant mesenchymoma, malignant pilomatricoma, meibomian ductal adenoma, 
melanoacanthoma, mesothelioma, rhabdomyoma, rhabdomyosarcoma, sebaceous ductal 
adenoma, systemic histiocytosis and tricholemmoma. The tumor-like lesions that were not 
found in the dogs of our collection were traumatic neuroma, scrotal vascular hamartoma, 
nodular dermatofibrosis of the German shepherd dog, nodular fasciitis, melanocytic 
hyperplasia, epidermal hamartoma, cutaneous horn, dilated pore, ciliated cyst, warty 
dyskeratoma and xanthoma. 
Some other tumors were found in the skin and subcutaneous tissue in our collection, but were 
not considered in our collection because they are not classified under skin and soft tissue 
tumors in the new WHO classification. These were 8 lymphosarcoma, 5 extramedullary 
plasmocytoma, 4 which could not be classified, three meibomian gland hyperplasias, two 
chondrosarcomas, and one of each osteosarcoma, hepatoid gland hyperplasia and anal sac 
gland hyperplasia. 
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 Tab. 9: Prevalence of 54 types of skin and soft tissue tumors and tumor-like lesions. 
Tumor n %  Tumor n % 
Canine cutaneous 
histiocytoma 
134 16.4  Papilloma 8 1.0 
Mast cell 56 6.9  Squamous papilloma 8 1.0 
Lipoma 46 5.6  Fibroadnexal hamartoma 8 1.0 
Hepatoid gland adenoma 44 5.4  Apocrine ductal adenoma 7 0.9 
Infundibular cyst 37 4.5  Hemangiosarcoma 7 0.9 
Fibrosarcoma 32 3.9  Squamous cell carcinoma 7 0.9 
Sebaceous hyperplasia 23 2.8  Anal sac gland carcinoma 5 0.6 
Malignant melanoma 22 2.7  Apocrine adenoma 5 0.6 
Trichoepithelioma 22 2.7  Apocrine carcinoma 5 0.6 
Melanocytoma 21 2.6  Basal cell tumor 5 0.6 
Meibomian adenoma 20 2.5  Hepatoid gland epithelioma 5 0.6 
Canine hemangiopericytoma 19 2.3  Myxosarcoma 5 0.6 
Hemangioma 19 2.3  Sebaceous epithelioma 5 0.6 
Infundibular keratinizing 
acanthoma 
19 2.3  Dermoid cyst 4 0.5 
Apocrine cyst 18 2.2  Isthmus cyst 4 0.5 
Sebaceous adenoma 17 2.1  Malignant histiocytosis 4 0.5 
Subungual squamous cell 
carcinoma 
17 2.1  Sebaceous hamartoma 4 0.5 
Trichoblastoma 16 2.0  Complex and mixed apocrine 
adenoma 
3 0.4 
Pilomatricoma 14 1.7  Cutaneous histiocytosis 3 0.4 
Calcinosis circumscripta 13 1.6  Apocrine ductal carcinoma 2 0.2 
Collagenous hamartoma 13 1.6  Malignant peripheral nerve 
sheath tumor of the skin and 
subcutis 
2 0.2 
Fibroma 11 1.3  Meibomian carcinoma 2 0.2 
Fibropruritic nodule 11 1.3  Meibomian epithelioma 2 0.2 
Panfollicular cyst 10 1.2  Myxoma 2 0.2 
Sebaceous duct cyst 10 1.2  Sebaceous carcinoma 2 0.2 
Follicular hamartoma 9 1.1  Subungual epithelial inclusion 
cyst 
2 0.2 
Basosquamous carcinoma 8 1.0  Subungual keratoacanthoma 2 0.2 
Fibroepithelial “polyp” 8 1.0  Synovial cell sarcoma 2 0.2 
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4.1.8. Entities of skin tumors and tumor-like lesions 
4.1.8.1. Basal cell tumor (basal cell epithelioma) 
We collected five cases (0.6 %), 4 from males (80%) and one from a female (20%) aged 7, 8, 
10, 11 and 12 years, with a mean age of 9.6 years. The tumors were located as follows: two at 
the limbs and one in each, head and perianal, and one tumor was without data of location. 4 
tumors showed cystic degeneration and only one was pure solid. The races of these dogs were 
two Roughhaired dachshunds, one Poodle, one Airedale terrier and one Mongrel. 
The case of perianal tumor had an association with the overlying epidermis, and showed 
cystic degeneration. This tumor was mixed in one area with hyperplastic hepatoid gland. 
 
4.1.8.2. Follicular tumors  
These were 72 tumors and they had been diagnosed as in the table 10. 
  
65 
T
ab
. 1
0:
 F
ol
lic
ul
ar
 tu
m
or
s (
n=
72
) 
Fo
lli
cu
la
r t
um
or
 
n 
%
 
♂ 
% 
♀ 
%
 
Lo
ca
tio
n 
Br
ee
d 
Ag
e 
in
 
ye
ar
s 
(m
ea
n)
 
In
fu
nd
ib
ul
ar
 
ke
ra
tin
iz
in
g 
ac
an
th
om
a 
 
19
 
26
 
58
 
42
 
5 
ba
ck
, 4
 li
m
b,
 3
 n
ec
k,
 2
 
ea
ch
 h
ea
d 
an
d 
pe
ria
na
l, 
an
d 
1 
ea
ch
 c
he
st
 a
nd
 ta
il*
 
8 
M
on
gr
el
s, 
4 
G
er
m
an
 sh
ep
he
rd
 d
og
s, 
2 
C
ol
lie
s, 
1 
of
 e
ac
h 
B
ay
ris
ch
er
 g
eb
irg
ss
ch
w
ei
ss
hu
nd
, B
er
ge
r d
e 
br
ie
, H
ov
aw
ar
t, 
G
ol
de
n 
R
et
rie
ve
r a
nd
 W
ac
ht
el
 
8*
 
Tr
ic
ho
le
m
m
om
a 
0 
0 
  
  
  
  
  
Tr
ic
ho
bl
as
to
m
a 
16
 
22
 
69
 
31
 
9 
he
ad
, 2
 n
ec
k,
 2
 li
m
bs
 
an
d 
1 
pe
ria
na
l*
* 
4 
M
on
gr
el
s, 
2 
G
er
m
an
 sh
ep
he
rd
 d
og
s, 
2 
W
es
th
ig
hl
an
d 
w
hi
te
 te
rr
ie
rs
, a
nd
 o
ne
 fo
r e
ac
h 
H
ov
aw
ar
t, 
Ep
ag
ne
ul
, 
M
ue
ns
te
rla
en
de
r, 
Po
od
le
, E
ng
lis
h 
Se
tte
r, 
Ir
is
h 
Se
tte
r, 
Te
rr
ie
r a
nd
 Y
or
ks
hi
re
 T
er
rie
r. 
8*
* 
Tr
ic
ho
ep
ith
el
io
m
a 
22
 
31
 
50
 
50
 
7 
ba
ck
, 5
 c
he
st
, 2
 li
m
b 
on
e 
of
 e
ac
h 
he
ad
, n
ec
k,
 
pe
ria
na
l a
nd
 ta
il*
**
 
6 
M
on
gr
el
s, 
6 
G
er
m
an
 sh
ep
he
rd
 d
og
s, 
2 
M
ue
ns
te
rla
en
de
rs
 
an
d 
on
e 
of
 e
ac
h 
B
er
ne
se
 m
ou
nt
ai
n 
do
g,
 B
or
de
rc
ol
lie
, 
G
er
m
an
 sh
or
th
ai
re
d 
po
in
te
r, 
O
tte
rh
un
d,
 P
oo
dl
e,
 S
et
te
r, 
C
oc
ke
r s
pa
ni
el
**
* 
8 
M
al
ig
na
nt
 
tri
ch
oe
pi
th
el
io
m
a 
1 
1 
10
0 
0 
un
kn
ow
n 
W
es
th
ig
hl
an
d 
w
hi
te
 te
rr
ie
r 
11
 
Pi
lo
m
at
ric
om
a 
14
 
19
 
36
 
64
 
4 
ba
ck
, 4
 li
m
b,
 2
 o
f e
ac
h 
ab
do
m
en
 a
nd
 p
er
ia
na
l 
an
d 
on
e 
he
ad
**
**
 
3 
M
on
gr
el
s, 
3 
A
ire
da
le
 te
rr
ie
rs
, 2
 Ja
ck
 R
us
se
l T
er
rie
rs
, a
nd
 
on
e 
of
 e
ac
h 
B
ob
ta
il,
 T
ib
et
 d
og
ge
, L
ar
ge
 p
oo
dl
e,
 G
ia
nt
 
sc
hn
au
ze
r a
nd
 S
hi
-tz
u*
**
* 
6 
M
al
ig
na
nt
 
pi
lo
m
at
ric
om
a 
0 
0 
  
  
  
  
  
T
ot
al
 
72
 
10 0 
  
  
  
  
  
* 
O
ne
 w
ith
ou
t l
oc
at
io
n 
da
ta
 a
nd
 o
ne
 w
ith
ou
t a
ge
 d
at
a.
 , 
**
 O
ne
 w
ith
ou
t a
ge
 d
at
a 
an
d 
tw
o 
w
ith
ou
t l
oc
at
io
n 
da
ta
., 
**
* 
4 
w
ith
ou
t l
oc
at
io
n 
da
ta
 a
nd
 o
ne
 w
ith
ou
t b
re
ed
 d
at
a.
 
**
**
 O
ne
 w
ith
ou
t l
oc
at
io
n 
da
ta
 a
nd
 o
ne
 w
ith
ou
t b
re
ed
 d
at
a.
 
 
RESULTS 
 
66 
 
4.1.8.2.1. Trichoblastomas 
Because of the significance of trichoblastomas in our study, we demonstrate these tumors in 
detail. 
15 dogs were aged between one and 14 years, with a mean age of 8 years. Three cases were 
observed in animals at an age of 6 years, two at 10 and 12 years and one case of 1, 2, 4, 5, 8, 
11, 13 and 14 years, respectively. 
Trabecular type was not found, and one mixed form of ribbon with granular cell type was 
found. The cells in two ribbon trichoblastomas showed clear cytoplasm, 4 ribbon 
trichoblastomas were medusoid, 4 were mixed ribbon and medusoid, one was mixed with 
spindle cell type, and the other 4 tumors were pure ribbon type (Table 11). 
 
Tab. 11: Trichoblastoma types (n=16) 
Tumor variant n % 
Ribbon* 14 88 
Spindle 1 6 
Granular 1 6 
Trabecular 0 0 
*The ribbon type includes medusoid type. 
 
For two tumors there were no data regarding location, the other 14 tumors were distributed as 
in table 12. 
 
Tab. 12: Trichoblastoma, locations (n=14) 
Location n % 
Head 9 64 
Neck 2 14 
Limbs 2 14 
Perianal 1 7 
 
The case of granular cell trichoblastoma was found in the auricle of a 10-year old male 
Epagneul dog. Histologically, two distinct types of neoplastic epithelium were present, 
basaloid and granular cells. Usually, the basaloid cells are arranged in ribbons and clusters 
embedded in a moderate amount of fibrovascular stroma. These cells were typical of those 
seen in ribbon-type trichoblastomas. The granular cells were arranged in clusters of uniform 
appearance, closely packed, and somewhat polygonal. Nuclei often were eccentric and were 
more angular than those of the trichoblastoma. Very few mitoses were present, but less 
frequently than in the trichoblastoma. The cytoplasm was plentiful and slightly eosinophilic 
with a fine granular appearance. The fine cytoplasmic granules were moderately PAS positive 
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and did not express with vimentin, lysozyme and S100, however, the cells expressed 
cytokeratin.  
 
4.1.8.2.1.1. Clear cell trichoblastomas 
Two cases of trichoblastomas were diagnosed in young dogs and were described as follows: 
A hazelnut-sized tumor of the mandiblular region was found in a 2-year-old, intact, female 
Westhighland white terrier. The other tumor was almond-sized and found between the toes of 
a 1-year-old, intact, male Mongrel dog.  They were exophytic and non-ulcerated skin nodules, 
with a lobular white cut surface. 
Both tumors consisted of epithelial cells mostly of moderate size and uniform appearance but 
some scattered cells were of large size. About 30% to 40% of the tumor cells in both cases 
were basaloid and arranged in ribbons, clusters and islands. However, the predominating 
tumor cells had pale, sometimes vacuolated cytoplasm and possessed a central, ovoid to 
round, sometimes hyperchromatic, but mostly hypochromatic nucleus and showed growth 
patterns is of either a solid mass, cords or sometimes nests of cells. The tumor cells showed a 
moderate mitotic rate. A few scattered large cells that had abundant cytoplasmic vacuoles 
which indented the nuclei were present in both cases and were consistent with sebaceous 
differentiation. In one of these tumors, the tumor cells were close to the base of a hair follicle. 
The cells showed significant amounts of PAS-positive cytoplasmic granules which were not 
resistant to diastase and considered to be glycogen. The same granules were also present in 
the normal cells of the lower part of external root sheath of the hair follicles in the same 
slides. Additionally, some clear cells were arranged in islands that sometimes were 
surrounded by an eosinophilic, acellular, vitreous sheath which stained positively with 
periodic acid-Schiff  (PAS)  and  blue  with  Masson’s  trichrome  stains.  Furthermore,  some 
islands showed few central cells that had eosinophilic cytoplasm. 
 
4.1.8.3. Cysts 
Generally, 85 skin cysts were found in 83 dogs, of which 46 (55 %) were females and 37 (45 
%) were males. The dogs were 17 (21 %) Mongrels, 8 (10%) Boxer, 6 (7 %) Westhighland 
white terrier, 5 (6 % ) German shepherd dog, 4 (5 %)  each Dobermann and Cocker spaniel, 
three (4 %) each Bobtail, Pit bull terrier, Poodle and Golden retriever, two (2 %) each Bernese 
mountain dog, Labrador and Munsterlaender (breed not further specified) and Gordon setter, 
one (1 %)  each Bouvier, Bracke, Chow-chow, Collie, Dachshund, Roughhaired dachshund, 
German wirehaired pointer, Hovawart, Newfoundland, Miniature pinscher, Miniature poodle, 
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Rottweiler, Standard schnauzer, Giant schnauzer, Bull terrier, Jack russel terrier and 
Staffordshire terrier. For two dogs there were no data regarding their breed. 
For 6 skin cysts, there were no data on location, the other 79 are reported in table 13. 
 
Tab. 13: Skin cysts, locations (n=79) 
Location n. of cysts % 
Limb 24 30 
Head 20 25 
Neck 8 10 
Mammary region 7 9 
Chest 6 8 
Back 6 8 
Perianal 4 5 
Abdominal 3 4 
All body 1 1 
Tail 0 0 
Total 79 100 
 
82 dogs were divided as in diagram 5, with a mean age of 9 years. For one dog no age was 
given. 
 
0
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Age in years
Diag. 5: Skin cysts, age distribution (n=82)
 
Sex, location, breed, mean age and number of cases of every cyst type of 85 skin cysts are 
demonstrated in the table 14. 
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4.1.8.4. Hamartomas  
Generally, we collected 22 epithelial and 13 mesenchymal hamartomas. Epithelial 
hamartomas were found in 22 dogs, 11 (52 %) of which were males and 10 (48 %) females, 
and for one dog the sex was not stated. These dogs were 10 Mongrels, 2 German shepherd 
dogs, and one each Saint bernard, Boxer, Briard, Roughhaired dachshund, Dobermann, Pit 
bull terrier, Golden retriever, Jagd retriever, Rottweiler, and Jack russel terrier. 
No hamartoma was found at head, mammary region or chest, and for one hamartoma there 
were no location data. The other 21 hamartomas were distributed as in table 15. 
 
Tab. 15: Hamartomas (n=21) 
Location n. of cysts % 
Limb 13 62 
Neck 3 14 
Back 2 10 
Perianal 1 5 
Abdominal 1 5 
Tail 1 5 
Total 21 100 
 
The ages of 21 dogs with hamartomas were as shown in diagram 6, and one case was without 
age data. 
 
0
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n
1 2 3 4 5 6 7 8 9 10 11 12 13
Years
Diag. 6: Hamartomas, age distribution (n=21)
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Mesenchymal hamartomas in the WHO classification are scrotal vascular hamartoma and 
collagenous hamartoma; scrotal vascular hamartoma was not found in this collection. The 
collagenous hamartoma is exposed with the other epithelial types in table 16.
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4.1.8.5. Tumor-like Lesions 
Because of the great differences between these lesions, they will be demonstrated separately. 
Cutaneous horn and warty dyskeratoma were not found in our collection. 
 
4.1.8.5.1. Squamous papilloma  
8 lesions were found in 5 females (62.5 %) and three males (37.5 %). 4 lesions were located 
at limbs, three at the head and one at the neck. These lesions were found in one of the 
following breeds, namely German shorthaired pointer, Hovawart, Mongrel, Munsterlaender 
(breed not further specified), German shepherd dog, Canadian shepherd dog, Airedale terrier 
and Bull terrier. The ages of these dogs varied between one and 12 years, with a mean age of 
5 years, and only one was without data regarding age. 
 
4.1.8.5.2. Pressure point comedones 
There was only one pressure point comedone in our collection found at the left elbow of a 14-
year-old male Terrier. 
 
4.1.8.5.3. Sebaceous hyperplasia 
23 dogs were present in this group, 11 of them were females (52 %), 10 males (48 %) and for 
two dogs the sex was not stated. The lesions were found as follows: 11 at limbs, 6 head, two 
back, one of each neck and tail, and two lesions had unknown locations. One dog was without 
breed data, the other 22 dogs were 5 Mongrels, 4 Poodles, two Labrador retrievers, two 
Yorkshire terriers, and one of each Boxer, Roughhaired dachshund, Dobermann, Retriever, 
Cocker spaniel, American staffordshire terrier, Kerry blue terrier, Scotch terrier, and 
Westhighland white terrier. The dogs were between two and 14-years-old with a mean of 10 
years as demonstrated in diagram 7. Two dogs had no age data. 
 
RESULTS 74 
0
1
2
3
4
5
6
7
8
No
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Years
Diag. 7: Age distribution in sebaceous hyperplasia (n=21)
  
4.1.8.5.4. Fibroepithelial "polyp" 
This lesion was found in 6 females (75 %) and two males (25 %), and the dogs were two each 
of Mongrel, Labrador retriever, Pit bull terrier and the remainder were one Rottweiler and one 
Husky. 7 lesions were found at different locations as follows: 3 at limbs, two at back, and one 
at each mammary gland region and neck, and for one lesion there was no data of location. The 
ages of the animals were from 5 to 18 years, with a mean age of 9 years. 
 
4.1.8.5.5. Fibropruritic nodule 
11 cases were found in 7 males (64 %) and 4 females (36 %), 5 of which were found in 
Mongrels and one each in German wirehaired pointer, Leonberger, Rottweiler, English setter, 
Cocker spaniel, and Westhighland white terrier. 10 lesions were located as follows: 4 limbs, 3 
back, and one each at chest, mammary gland region and tail. One case was of unknown 
location. The ages of the animals were from two to 12 years, with a mean of 7 years. 
 
4.1.8.6. Tumors of the Epidermis  
Inverted papilloma and actinic keratosis were not observed in our collection. 
 
4.1.8.6.1. Papilloma 
8 cases were found in 5 males (62.5 %) and three females (37.5 %), 6 of which were located 
at the head and two at the limbs. This lesion was found in two Mongrels, and one in 
Dobermann, Hovawart, Golden retriever, Standard schnauzer, Weimaraner and for one dog 
the breed was not stated. The age of these animals was between two and 6 years, with a mean 
age of 4 years. 
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4.1.8.6.2. Multicentric squamous cell carcinoma in situ 
Only one instance of this lesion was found at the thigh of a 9-year-old male Airedale terrier. 
 
4.1.8.6.3. Squamous cell carcinoma 
6 cases were found in 4 females (67 %) and two males (33 %), 4 of which were located at the 
head, one was found at each, mammary gland region and neck. This tumor was found one in 
each German shorthaired pointer, Poodle, Rottweiler, German shepherd dog, Terrier (breed 
not further specified), and one dog without data of breed. The animals were between 7 to 11-
years-old, with a mean of 9 years. 
 
4.1.8.6.4. Basosquamous carcinoma 
8 cases were found in 5 males (62.5 %) and three females (37.5 %), two tumors located each 
at the abdomen and limbs, and one located each at back, chest, head and neck. The tumor was 
present in two Mongrels and one Saint bernard, Poodle, Rottweiler, Samojede, German 
shepherd dog, and Cocker spaniel. Animal age was between two and 10 years, with a mean 
age of 7 years. 
 
4.1.8.7. Nailbed tumors 
4.1.8.7.1. Subungual keratoacanthoma 
Two tumors were found in one 14-year-old female and one 8-year-old male. Both dogs were 
Standard schnauzers and the lesions were located at the limbs (Subungual). 
 
4.1.8.7.2. Subungual squamous cell carcinoma 
The tumor was found in 18 cases, 11 (61 %) of which were females and 7 (39 %) males. The 
dogs were 9 Schnauzers (5 Standard schnauzers, two each of Giant schnauzer and Schnauzer 
{breed not further specified}), two each of Scotch terrier and Mongrel, and one each of 
Bernese mountain dog, Longhaired dachshund, Labrador retriever, Poodle and Rottweiler. 
Animal aged between three and 12 years with mean of 9 years. 
 
4.1.8.8. Sebaceous and modified sebaceous gland tumors  
These tumors were present in 98 cases; the sebaceous and meibomian ductal adenomas were 
not found in this collection. The other 9 types are listed in table 17, 18, 19.  
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The percentages of the three main groups, sebaceous, meibomian and hepatoid were 
calculated separately. 
 
Tab. 17: Sebaceous tumors (n=24) 
Tumor n % ♂ % ♀ % Location Breed Age in years 
(mean) 
Sebaceous 
adenoma 
17 71 65 35 7 head, 5 limb and 
one in each 
mammary gland 
region neck and 
perianal* 
3 of each Mongrel, 
Cocker spaniel, 2 
Yorkshire terrier and 1 
of each Boxer, 
Dachshund, Husky, 
Labrador, 
Muensterlaender, 
Pekinese, Standard 
schnauzer, Irish setter, 
and Westhighland white 
terrier 
9 
Sebaceous 
epithelioma  
5 21 100 0 3 head and 2 neck 1 of each Siberian husky, 
Labrador, Mongrel, 
Newfoundland and 
Golden retriever 
10 
Sebaceous 
carcinoma  
2 8 100 0 one of each head 
and limb 
1 of each Hovawart and 
Labrador 
12 
* Two cases without location data. 
 
Tab. 18: Meibomian tumors (n=24) 
Tumor n % ♂ % ♀ % Location Breed Age in 
years 
(mean) 
Meibomian 
adenoma  
20 83 65 35 20 head (eyelid) 6 Mongrel, 2 of each Irish setter 
and Cocker spaniel, and 1 of each 
German wirehaired pointer, 
Husky, Rottweiler, German 
shepherd dog, Standard 
schnauzer, Airedaleterrier, Welsh 
terrier and Westhighland white 
terrier* 
10 
Meibomian 
epithelioma  
2 8 0 100 2 head (eyelid) One of each Mongrel and Gordon 
setter 
9 
Meibomian 
carcinoma  
2 8 100 0 2 head (eyelid) Golden retriever** 13 
* Two cases without breed data. ** One case without breed data. 
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Tab. 19: Hepatoid gland tumors (n=50) 
Tumor n % ♂ % ♀ % Location Breed Age in 
years 
(mean) 
Hepatoid 
gland 
adenoma  
44 88 84 16 41 perianal, 2 
abdomen and 1 
back 
12 Mongrel, 4 Dachshund, 2 of 
each Husky, Cocker spaniel, 
Roughhaired dachshund, 
Westhighland white terrier and one 
of each Beagle, Bernese mountain 
dog, Chihuahua, Border collie, 
Longhair dachshund, Dobermann, 
Hovawart, Muensterlaender, Pastor 
Majorkin, Pekinese, Poodle, 
Schnauzer**, Standard schnauzer, 
Shi-tzu, Terrier** and Yorkshire 
terrier* 
10 
Hepatoid 
gland 
epithelioma 
5 10 100 0 4 perianal and 1 
head 
1 of each Husky, Newfoundland, 
Poodle, German shepherd dog and 
Springer Spaniel 
11 
Hepatoid 
gland 
carcinoma 
1 2 0 100 1 perianal 1 Bernese mountain dog 15 
* 4 cases without breed data. 
** Breed not further specified 
 
4.1.8.9. Apocrine, modified apocrine gland tumors and eccrine tumors 
These lesions were found in 28 dogs. Some types, including ceruminous and eccrine tumors 
and anal sac gland adenoma, were not found in our collection. The other tumors are listed in 
table 20. 
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4.1.8.10. Melanocytic Tumors 
43 melanocytic tumors were found in our collection. Melanoacanthoma and melanocytic 
hyperplasias were not found. 
In some heavily pigmented cases, melanin bleach was used to facilitate the evaluation of the 
malignancy. In addition, two suspected cases of amelanotic malignant melanomas were 
confirmed immunohistologically, which expressed vimentin, Melan A and S100, and were 
negatively for cytokeratin, CD3 and CD79α. 
 
4.1.8.10.1. Melanocytoma 
20 tumors were found in 12 males (60%) and 8 females (40%), and one dog was without data. 
19 tumors were located as follows: 8 at the head, 5 at limbs (two at thigh, one each at arm, 
paw, shoulder), 5 at back and two in abdomen and for one tumor there were no data of 
location. The dogs were 5 Mongrels and two of each Golden retriever and Roughhaired 
dachshund, and one Bernese mountain dog, Boxer, Dachshund, Poodle, Rottweiler, German 
shepherd dog, Canadian shepherd dog, Giant schnauzer, Softcoated wheaten terrier and 
Yorkshire terrier, and one dog was without breed data. Age varied between 4 and 14-years-
old with a mean of 8 years, and for one dog there were no age data. 
 
4.1.8.10.2. Malignant melanoma 
22 tumors were found in 12 females (55 %) and 10 males (45 %). The tumors were located as 
follows: 9 at head, 7 at limbs (all at paw), two perianal, and one at abdomen, back and neck 
and one tumor was without data of location. The dogs were 7 Mongrels, two of each Poodle, 
German shepherd dog and Cocker spaniel, and one of each Bayrischer gebirgsschweisshund, 
Bordeaux dog, Lahaso apso, Golden retriever, Rottweiler, Giant schnauzer, Setter, Scotch 
terrier and Wolfshound. The ages varied between 3 and 14 years with a mean of 10 years. 
  
4.1.8.11. Tumors of Fibrous Tissue  
Collagenous hamartoma was also listed above with the other hamartomas (see 4.1.8.4). 
Nodular dermatofibrosis of the German shepherd dog, nodular fasciitis and malignant fibrous 
histiocytoma were not found in this collection. The other types are represented in table 21. 
One case of an atypical tumor located in the axillary region of a male, 12-year-old, Mongrel 
dog. This case showed a different size of empty areas in myxofibroma-like tumor. By use of 
immunohistological techniques, the wall of the empty areas expressed Factor VIII, and the 
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tumor cells that were found in the myxofibroma-like tumor expressed factor VIII and 
vimentin. This case was sorted as a myxoma in the table 21. 
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4.1.8.12. Tumors of adipose tissue 
Neither angiolipoma nor any of the liposarcomas were found in this collection. A total of 46 
lipomas were found in 29 females (63 %) and 17 males (37 %), two of which were diagnosed 
as infiltrative lipomas. The tumors were located as follows: 13 at the chest, 10 at the limbs, 8 
at the abdomen, three each at the back, the mammary gland region, the neck, two at the head 
and one  each at the perianal and the tail and one tumor was without data of location. The 
dogs were 17 Mongrels, and three Roughhaired dachshunds, Westhighland white terriers, 2 
Bernese mountain dogs, and one Akita, Saint bernard, Bobtail, Longhaired dachshund, 
Dobermann, Huetehund, Husky, Labrador, Malamute, Maltese dog, Mastiff, Munsterlaender 
(breed not further specified), Small munsterlaender, Retriever, Rottweiler, German shepherd 
dog, Miniature schnauzer, Setter, Cocker spaniel, Terrier (breed not further specified) and Fox 
terrier. The ages were from 4 to 16-years-old with a mean of 9 years. 
 
4.1.8.13. Tumors of muscle 
Of this group, only one leiomyosarcoma was found in our collection, and it was found at the 
neck of an 11-years-old male Cocker spaniel. The tumor was examined 
immunohistologically, and expressed smooth muscle actin, vimentin and few cells expressed 
S100. The tumor cells were expressed negatively with cytokeratin, CD3, CD79α, IgG, 
lysozyme, Melan A and desmin. 
 
4.1.8.14. Tumors of vascular tissue 
Vascular tissue tumors are presented in table 22. Scrotal vascular hamartoma, Kaposi-like 
vascular tumor and lymphangiosarcoma were not found in our collection. 
 
Tab. 22: Vascular tissue tumors (n=26) 
Tumor n % ♂ % ♀ % Location Breed Age in years 
(mean) 
Hemangioma  19 73 58 42 5 limb, 3 neck, 
2 of each 
abdomen, back 
and chest, and 
1 of each head, 
mammary 
gland region 
and tail* 
6 German shepherd dog 3 of each 
Roughhaired dachshund and 
Mongrel, and 1 of each Bernese 
mountain dog, Boxer, 
Dachshund, German shorthaired 
pointer, Hovawart, Belgischer 
shepherd and Shi-tzu 
9 
Hemangiosarcoma  7 27 86 14 4 neck, 1 of 
each chest, 
limb and head 
2 of each German shepherd dog, 
Westhighland white terrier and 
Mongrel, and 1 Basset 
11 
* Two cases without data of location. 
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4.1.8.15. Tumors of Peripheral Nerves  
Two malignant peripheral nerve sheath tumors (MPNST) of the skin and subcutis were found, 
the other types were not found in this collection. The tumors were found in two males, one 
10-year-old German shepherd dog and one 9-year-old beagle. One tumor was located at limb 
and one at the neck. Both tumors were examined immunohistologically and the results are 
reported in table 23. In the case of the beagle, the nerve remnant was found and it reacted 
positively with S100 and neurofilament. In the case of the German shepherd dog, the tumor 
was histologically identical with that described in the literature, i.e., the arrangement of the 
cells in small interwoven bundles (Hendrick et al., 1998, Goldschmidt and Hendrick, 2002) 
and the occurrence of spindle-shaped cells that exhibit nuclear palisading (Scott et al., 2001). 
 
Tab. 23: Immunohistological examination of MPNST 
Tumor/Immunohis. Vimentin S100 Neurofilament Desmin Smooth 
muscle 
actin 
Actin GFAP NSE 
MPNST, Beagle ++++ -* -* - + ++ ++ ++++ 
MPNST, German 
shepherd dog 
++++ ++ - - + ++ - +++ 
*Only the nerve remnant reacted positively (+++) 
 
4.1.8.16. Tumors of the synovium and mesothelium 
Mesothelium tumors were not found in this collection, and only two synovial cell sarcomas 
were found at the limbs (knee joint and toe) of two males, a 7-year-old Bernese mountain dog 
and an 8-year-old Mongrel. 
 
4.1.8.17. Mast cell tumors 
56 cases are summarized in table 24. In all cases of grade III, the diagnosis of mast cell tumor 
was confirmed by using Toluidin stain, which demonstrated the metachromasy of the granules 
in the neoplastic mast cells. 
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4.1.8.18. Histiocytic tumors 
These tumors were represented also in the table 25, and note that for one canine cutaneous 
histiocytoma there were no data of sex, for two no data of location, for 5 no data of breed and 
for three no data of age. Xanthoma and systemic histiocytosis were not found in our 
collection. 
Many suspected cases were confirmed immunohistologically, which expressed vimentin, 
lysozyme, MAC387 and MHC II. In many cases some other immunohistological stains, as 
S100, factor VIII-related antigen, IgG, cytokeratin, desmin, Melan A, were applied and were 
negative. 
 
Tab. 25: Histiocytic tumors (n=141) 
Tumor n % ♂ % ♀ % Location Breed Age in 
years 
(mean) 
Canine 
cutaneous 
histiocytoma  
134 95 67 33 54 head, 46 limb, 
11 chest, 6 in each 
abdomen and neck, 
4 back, 2 perianal 
and 1 in each 
mammary gland 
region and tail 
* 3 
Cutaneous 
histiocytosis  
3 2 100 0 2 limb and 1 neck 1 in each 
Newfoundland, 
Cocker spaniel and 
Dachshund 
10 
Malignant 
histiocytosis  
4 3 25 75 3 limb and 1 chest 4 Bernese 
mountain dog 
7 
Total 141 100           
 
* 30 Mongrels, 8 of each Dobermann and Boxer, 7 Golden retrievers, 5 of each Westhighland 
white terrier and Rottweiler, 4 of each Jack russel terrier, German shepherd dog and Cocker 
spaniel, three of each Roughhaired dachshund, Labrador retriever, Bernese mountain dog and 
beagle, two of each Tibetan terrier, Setter, Pit bull terrier, Newfoundland, Bulldog and Border 
collie, and one of each Yorkshire terrier, Wolfsspitz, Terrier (breed not further specified), 
Staffordshire terrier, Stafford bullterrier, Scotch terrier, Schwarzwaldbracke, Giant schnauzer, 
Poodle, Pon, Pinscher, Pitbull, Kuvasz, Hunting terrier, Irish setter, Husky, Hannoverscher 
Schweisshund, Gordon setter, French bulldog, Dogge, German wirehaired pointer, German 
dogge, Dalmatian, Collie, Bordeaux dog, Bobtail, Bearded collie, Australian shepherd dog, 
American staffordshire terrier and American bulldog. 
The diagram 8 shows the age distribution for canine cutaneous histiocytoma. 
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Diag. 8: Age distribution of canine cutaneous histiocytoma 
(n=134)
  
4.1.8.19. Calcinosis circumscripta 
13 lesions were found in 7 females (58 %) and 5 males (42 %), and for one dog the sex was 
not stated. These lesions were located as follows: 9 at limbs (5 paws, two in elbows and one 
in each tarsal joint and shoulder), one at back, chest and neck and one lesion had no data of 
location. 4 dogs were German shepherd dogs, three of each Mongrel and Rottweiler, and one 
each of Appenzeller, Boxer and Irish wolfhound. They were between one and 6-years-old, 
with a mean of three years, and for one dog no age data were available. 
  
4.1.8.20. Canine hemangiopericytoma  
19 cases were found in 10 females (53 %) and 9 males (47 %), and they were located as 
follows: 14 at limbs, two in each chest and head and one in abdomen. The dogs were 6 
Mongrels, two German shepherd dogs, and one of each Boxer, German wirehaired pointer, 
Dobermann, Munsterlaender (breed not further specified), Large munsterlaender, Small 
munsterlaender, Golden retriever, Setter, Hunting terrier and Wachtel dog, and one dog for 
which there were no data of breed. The dogs were between 3 and 12-years-old, with a mean of 
9 years. 
 
4.2. Tumors in cat 
In this part, we present 197 skin tumors and tumor-like lesions of 194 cats as follows: 
 
4.2.1. Sex distribution 
Out of 194 cats, 4 were without data of sex, the remainder was distributed as in table 26. 
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Tab. 26: Sex distribution in cats (n=190) 
Sex Castrated Non castrated Total % 
♂ 53 52 105 55.3 
♀ 28 57 85 44.7 
 
4.2.2. Anatomical location 
Out of 197 feline skin tumors and tumor-like lesions, only two were without data concerning 
location, the remainder was distributed as in table 27. 
 
Tab. 27: Location distribution (n=195) 
Location n % 
Limb 49 25 
Head 48 25 
Back 35 18 
Chest 28 14. 
Neck 16 8 
Abdominal 12 6. 
Perianal 5 3 
Mammary Area 1 1 
Tail 1 1 
All Body 0 0 
 
4.2.3. Breed disposition 
For 49 out of 194 cats no data of breed were available, the remainder was distributed as in 
table 28. 
 
Tab. 28: Breed disposition (n=145) 
Cat breed n  % 
ESH cat 122 84 
Persian 11 8 
Maine-coon cat 6 4 
Karthaeuser „British blue“ 3 2 
Angora cat 1 1 
Birma 1 1 
Siam 1 1 
 
4.2.4. Age of distribution 
11 out of 194 cats were of unknown age; the remainder was distributed as in table 29 and 
diagram 9. 
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Tab. 29: Age distribution in years (n=183) 
Age  1 2 3 4 5 6 7 8 9 10 11 12 
n 2 3 3 3 6 11 7 15 11 25 22 21 
% 1.0 1.5 1.5 1.5 3.5 6.0 4.0 8.0 6.0 14.0 12.0 11.5 
 
Age  13 14 15 16 17 18 19 20 21 22 23 
n 13 14 13 8 2 0 2 1 0 0 1 
% 7.0 8.0 7.0 4.5 1.0 0.0 1.0 0.5 0.0 0.0 0.5 
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Diag. 9: Age distribution in cats (n=183)
 
The diagram shows a gradual increase over the first 10 years with a peak at the age of 10, then 
a gradual drop over the next 7 years of age, and scattered cases are found in the age group 
between 19 and 23 years. 
 
4.2.5. Origin of tumors and tumor-like lesions 
Epithelial, mesenchymal and melanocytic origins were the three main groups according to the 
WHO classification; the tumor-like lesions were distributed under the three groups and the 
results are shown in diagram 10. 
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Diag. 10: Origin of tumors and tumor-like lesions (n=197)
 
The diagram shows the origin of three tumor groups, 106 tumors were of mesenchymal origin 
(54 %), 88 tumors of epithelial origin (45 %), and 3 tumors of melanocytic origin (1 %). 
 
4.2.6. Prevalence of individual groups of skin tumors 
197 skin tumors and tumor-like lesions are divided in groups according to the new WHO 
classification, as in table 30. 
The table shows in descending order the numbers and percentages of the tumors and exposes 
at the top the more common group, namely tumors of fibrous tissue. However, for 9 tumor 
groups no instances were found, namely histiocytic, miscellaneous and unclassified tumors, 
tumors of smooth muscle, tumors metastatic to the skin, tumors of striated muscle, tumors of 
peripheral nerves, tumors of synovium and tumors of mesothelium. 
 
Tab. 30: Prevalence of individual groups of skin tumors (n=197) 
Tumor n % 
Tumors of fibrous tissue 79 40.0 
Tumors with adnexal differentiation 51 26.0 
Tumors of the epidermis 18 9.0 
Epithelial tumors without sqamous or adnexal differentiation 11 5.5 
Tumors of vascular tissue 11 5.5 
Tumors of  adipose tissue 10 5.0 
Mast cell tumors 6 3.0 
Cysts 3 1.5 
Tumor-like lesions 3 1.5 
Melanocytic tumors 3 1.5 
Hamartomas 2 1.0 
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4.2.7. Prevalence of individual types of skin tumors 
110 types of the skin tumors and tumor-like lesions in all animal species in accordance with 
the new WHO classification were reported; 31 types were found in the cats of our collection 
and 19 of these are listed in table 31, in descending order of number and percentages of the 
tumors. The other 12 types were represented by only one case (0.5 %) each; they were 
multicentric squamous cell carcinoma in situ, trichoepithelioma, sebaceous adenoma, 
sebaceous carcinoma, complex and mixed apocrine adenoma, complex and mixed apocrine 
carcinoma, ceruminous adenoma, anal sac gland carcinoma, fibroepithelial “polyp”, 
melanocytoma, myxoma and Feline ventral abdominal angiosarcoma. 
79 types were not found in this collection, and some of them were species-specific or rare or 
not reported in cats. Tumors that were not found in cats in our collection were papilloma, 
inverted papilloma, basosquamous carcinoma, tricholemmoma, malignant trichoepithelioma, 
pilomatricoma, malignant pilomatricoma, subungual keratoacanthoma, sebaceous 
epithelioma, meibomian adenoma, meibomian ductal adenoma, meibomian epithelioma, 
meibomian carcinoma, apocrine ductal carcinoma, complex and mixed ceruminous adenoma, 
complex and mixed ceruminous carcinoma, anal sac gland adenoma, eccrine adenoma, 
eccrine carcinoma, fibroma, melanoacanthoma, malignant fibrous histiocytoma, angiolipoma, 
liposarcoma, leiomyoma, leiomyosarcoma, rhabdomyoma, rhabdomyosarcoma, 
lymphangioma, Kaposi-like vascular tumor, lymphangiosarcoma, granular cell tumor, benign 
and  malignant peripheral nerve sheath tumor of skin and subcutis, synovial cell sarcoma, 
mesothelioma, malignant histiocytosis, and malignant mesenchymoma. Tumor-like lesions 
that were not found in cats in our collection were dilated pore, isthmus cyst, panfollicular 
cyst, dermoid cyst, sebaceous duct cyst, apocrine cyst and cystomatosis, ciliated cyst, 
subungual epithelial inclusion cyst, epidermal hamartoma, sebaceous hamartoma, apocrine 
hamartoma, fibroadnexal hamartoma, squamous papilloma, pressure point comedones, 
cutaneous horn, warty dyskeratoma, fibropruritic nodule, melanocytic hyperplasia, 
collagenous hamartoma, nodular fasciitis, scrotal vascular hamartoma, traumatic neuroma, 
xanthoma, calcinosis circumscripta  
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Tab. 31: Prevalence of 19 types of skin and soft tissue tumors and tumor-like lesions in cats 
(n=185) 
Tumor n % 
Fibrosarcoma 74 37.5 
Squamous cell carcinoma 17 8.5 
Apocrine adenoma 14 7.0 
Basal cell tumor 11 5.5 
Lipoma 10 5.0 
Trichoblastoma 9 4.5 
Ceruminous gland carcinoma 7 3.5 
Hemangiosarcoma 7 3.5 
Apocrine carcinoma 6 3.0 
Feline mast cell tumor 6 3.0 
Apocrine ductal adenoma 4 2.0 
Myxosarcoma 4 2.0 
Infundibular cyst 3 1.5 
Hemangioma 3 1.5 
Subungual squamous cell carcinoma 2 1.0 
Sebaceous ductal adenoma 2 1.0 
Follicular hamartoma 2 1.0 
Sebaceous hyperplasia 2 1.0 
Malignant melanoma 2 1.0 
 
Some other tumors were found in the skin and subcutaneous tissue, but were not considered in 
our collection because they had not been classified under skin and soft tissue tumors in the 
new WHO classification. They were 4 extramedullary plasmocytomas, 4 lymphosarcomas, 
three which could not be classified, and one meibomian gland hyperplasia. 
 
4.2.8. Entities of skin tumors and tumor-like lesions 
4.2.8.1. Basal cell tumors 
11 basal cell tumors were found in 7 males (64 %) and 4 females (36 %), and they were 
located as follows: three at the limbs, two each at the back, chest and neck, and one each at 
head and perianal region. The cats were 5 ESH cats, and one of each Birma, Maine-coon and 
Persian cats, and for three cats there were no data of breed. The cats were aged between 7 and 
23 years with a mean age of 13 years. 8 out of 11 basal cell tumors (73 %) showed cystic 
degeneration (cystic basal cell tumor). 
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4.2.8.2. Tumors of the Epidermis 
17 squamous cell carcinomas were found under this group, and they were found in 9 female 
(56 %), 7 male (44 %), and for one cat the sex was not stated. The tumors located as follows: 
12 at the head (7 auricle, 2 eyelid, 2 mandible region and one cheek), three at the limbs, and 
one each at the mammary gland and perianal regions. The cats were 13 ESH cats, and for 4 
cats there were no data of breed. For two cats there were no age data, the others were between 
one and 16-years-old, with a mean of 9 years. 
One multicentric squamous cell carcinoma in situ was found in the paw of a female 15-year-
old ESH cat. 
 
4.2.8.3. Follicular tumors 
Two follicular tumor types were found in the cats of this collection, namely trichoblastoma 
and trichoepithelioma. 
 
4.2.8.3.1. Trichoblastoma 
There were 9 cases, and they were found in 8 males (89 %) and one female (11 %). 6 tumors 
were located at limbs (4 shoulder and 2 paw), and one each at chest, head and tail. One cat 
was without data regarding breed, the other were 6 ESH cats, two Maine-coon cats. Two cats 
were 13-years-old and one cat was 6, 7, 9, 11, 12, 15 years, respectively, and for one cat there 
were no age data. The mean age was 11 years. 
 
Tab. 32: Trichoblastom variants (n=9) 
Tumor variant n % 
Ribbon 1 11 
Spendle 2 22 
Granular 0 0 
Trabecular 6 67 
Mixed 0 0 
 
4.2.8.3.1.1. Cystic degeneration of trichoblastomas 
Two cases out of 9 feline trichoblastomas in our collection showed this manifestation, and 
these were one case of ribbon and one of trabecular variant in cats. In the case of ribbon 
variant, cystic degeneration was found at the center of solid lobules, with an accumulation of 
light brown necrotic debris. In some instances, the presence of a few brown pigments and 
calcifications at the center of the cysts was detected, which was surrounded by a zone of 
viable, less basophilic tumor cells. The trabecular case exhibited the same changes, but at the 
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same time showed more mucinous degenerations of tumor cells and plenty of mucinous 
substances surrounded the tumor pattern. 
 
4.2.8.3.2. Trichoepithelioma 
The trichoepithelioma reported in our collection was a single case in the shoulder of a 9-year-
old male ESH cat. 
 
4.2.8.4. Nailbed tumors 
Only two subungual squamous cell carcinomas were found in this collection, and they were 
located in the paws of a 10-year-old female ESH cat and a 7-year-old female cat without 
breed data. 
 
4.2.8.5. Sebaceous and modified sebaceous gland tumors 
Three tumor types were found in this collection and represented as in table 33.  
 
Tab. 33: Sebaceous and modified sebaceous gland tumors (n=4) 
Tumor n % ♂ % ♀ % Location Breed Age in 
years 
(mean) 
Sebaceous adenoma  1 25 0 100 1 head 1 Angora 
cat 
10 
Sebaceous ductal 
adenoma  
2 50 50 50 1 in each 
chest and 
back 
2 ESH 
cats 
14* 
Sebaceous carcinoma  1 25 100 0 1 limb 1 Persian 16 
* 1 case without data of age. 
 
4.2.8.6. Apocrine, modified apocrine and eccrine gland tumors 
Eccrin tumors, apocrine ductal carcinoma, complex and mixed ceruminous adenoma, 
complex and mixed ceruminous carcinoma and anal sac gland adenoma were not found in this 
collection. Other apocrine and modified apocrine gland tumors were represented in table 34. 
RESULTS 94 
 
Tab. 34: Apocrine, modified apocrine and eccrine gland tumors (n=35) 
Tumor n % ♂ % ♀ % Location Breed Age in 
years 
(mean) 
Apocrine 
adenoma 
14 40 46 62* 6 head, 3 in each 
back and neck, 
and 1 in each 
chest and limb 
10 ESH cats and 
1 Perser* 
11* 
Complex and 
mixed apocrine 
adenoma 
1 3 100 0 1 head 1 ESH cat 14 
Apocrine ductal 
adenoma 
4 11 25 75 3 head, 1 neck 3 ESH cats** 13 
Apocrine 
carcinoma 
6 17 50 50 2 head, 1 in each 
back, limb, neck 
and perianal 
5 ESH cats** 14 
Complex and 
mixed apocrine 
carcinoma 
1 3 100 0 1 chest Unknown 12 
Ceruminous 
adenoma 
1 3 0 100 1 head 1 ESH cats 12 
Ceruminous 
gland carcinoma 
7 20 57 43 7 head (auricle) 6 ESH cats** 11 
Anal sac gland 
carcinoma 
1 3 100 0 1 perianal 1 ESH cat 15 
* One case without data of sex, two cases without data of age and three cases without data of 
breed. 
** One case without data of breed. 
 
4.2.8.7. Cysts 
Infundibular cyst was the only cyst type that was found in cats in our collection. Three cases 
of infundibular cyst were found in two females and one male. They were located one each at 
chest, back and neck in three ESH cats that were 2, 10 and 14-years-old, respectively. 
 
4.2.8.8. Hamartomas 
Only two follicular hamartomas were found in the cats in our collection. They were found in 
11 and 12-year-old female Mongrel cats. The lesions were located at the back and thigh. 
 
4.2.8.9. Tumor-like lesions 
Two cases of sebaceous hyperplasia were found in two female ESH cats. One cat was 12-
years-old, and the age of the other cat was unknown. The lesions were located at head and 
chest. 
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Other tumor-like lesions were not found in this collection. 
 
4.2.8.10. Melanocytic tumors 
Melanoacanthoma and melanocytic hyperplasia were not found in the cats in our collection. 
Melanocytomas and malignant melanoma were represented as in table 35. 
 
Tab. 35: Melanocytic tumors (n=3) 
Tumor n % ♂ 
% 
♀ % Location Breed Age in years 
(mean) 
Melanocytoma 1 33 100 0 1 head 1 ESH cat 12 
Malignant melanoma 2 67 100 0 2 head 1 ESH cat* 11 
* One case without data of breed. 
 
4.2.8.11. Tumors of fibrous tissue 
Myxoma, fibrosarcoma and myxosarcoma were found in the cats in our collection, and were 
represented as in table 36. Other tumor types were not found in this collection. 
 
Tab. 36: Tumors of fibrous tissue (n=79) 
Tumor n % ♂ % ♀ % Location Breed Age in 
years 
(mean) 
Myxoma 1 1 0 100 1 limb 1 ESH cat 13 
Fibrosarcoma 74 94 59 41 22 back, 15 in each 
limb (7 shoulder, 5 
paw and 3 thigh) 
and chest, 10 
abdomen, 6 neck 
and 5 head* 
43 ESH cats, 5 Persians, 
and 1 in each 
Karthaeuser, Maine-coon 
cat and Siam* 
10* 
Myxosarcoma 4 5 50 50** 3 limb (2 paw, 1 
shoulder) and 1 
perianal 
2 ESH cat** 11** 
* One case without data of location, 23 cases without data of breed and two cases without 
data of age. ** Two cases without data of sex, two cases without data of breed and one case 
without data of age. 
 
4.2.8.12. Tumors of adipose tissue 
10 lipomas were found in 6 males (60%) and 4 females (40%), and located as follows: three 
each at limbs and back, two in abdomen and one each at head and neck. The cats were 9 ESH 
cats and one cat was without data regarding breed. Cats were between 6 and 14-years-old, 
with a mean of 9 years. Other tumor types of adipose tissue were not found in our collection. 
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4.2.8.13. Tumors of Vascular Tissue 
Hemangioma, hemangiosarcoma and lymphangiosarcoma were found in the cats in this 
collection and are represented in table 37. Other tumor types were not found in this collection. 
One suspected case of hemangiosarcoma was confirmed immunohistologically, which 
expressed factor VIII-related antigen, and negative for cytokeratin 
 
Tab. 37: Tumors of Vascular Tissue (n=11) 
Tumor n % ♂ % ♀ % Location Breed Age in 
years 
(mean) 
Hemangioma 3 27 0 100 2 limb and 1 head Unknown 8 
Hemangiosarcoma 7 64 71 29 2 at each chest and 
limb, 1 at each 
abdomen, head and 
neck 
4 ESH cats  11** 
Feline ventral abdominal 
angiosarcoma 
1 9 100 0 1 chest 1 ESH cat 15 
* Three cases without data of breed. 
** One case without age data. 
 
4.2.8.14. Feline mast cell tumors 
6 mast cell tumors were found in three females (50%) and three males (50%), and two tumors 
were located each at limb, head and back. The cats were two each Persian and ESH cats and 
one Maine-coon cat, and one cat was without data of breed. They were between two and 15-
years-old, with a mean value of 9 years. One tumor showed a high mitotic rate (3 to 5 in high 
power field (40X)), the others showed very few mitotic figures. The diagnosis of feline mast 
cell tumor was in all cases confirmed by using Toluidin stain. 
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5. DISCUSSION 
 
Because lesions and masses involving the skin are easily seen by the owner and brought to the 
attention of the veterinarian, these lesions will frequently be removed and submitted for 
histopathologic evaluation. Skin tumors including epithelial, melanocytic and mesenchymal 
neoplasms and non-neoplastic lesions are very common, particulary in the dog and cat, and 
they are the most commonly diagnosed tumors in domestic animals, at least at our institute.  
In 1974, the World Health Organization (WHO) published a text on the international 
histological classification of tumors of domestic animals, which followed, as far as possible, 
the WHO histological classifications of tumors in man. This classification contained also 
tumors of the skin and was reported by Weiss and Frese (1974) and Weiss (1974).  
A new or second edition of the international histological classification of skin, melanocytic 
and soft tissues tumors of domestic animals was published by Goldschmidt et al. (1998) and 
Hendrick et al. (1998) with new entities and some new nomenclatures. For the time between 
1998 and today, we have not found any statistical study that exposes all these tumors 
according to the new WHO classification. Therefore, the purpose of this study is to apply the 
new WHO classification to the epidemiology of skin tumor entities in dogs and cats. 
In this study we will expose the general and the individual prevalence of skin tumors and 
tumor-like lesion according to the new WHO and discuss and compare the results with other 
older studies that were performed by other authors. In addition, we will interpret and classify 
the new terms in the new WHO classification. Afterwards we will expose the classification 
problems of some skin lesions according to the new WHO classification and report some skin 
tumors that are not found in the new WHO classification 
 
5.1. General prevalence of skin tumors and tumor-like lesion 
The present study was carried out on 816 canine and 194 feline skin tumors and tumor-like 
lesions from 768 dogs and 194 cats. The prevalence of skin tumors and tumor-like lesions in 
dogs and cats was different when compared with previous studies carried out by many authors 
(Frese, 1960, Eskens, 1983, Goldschmidt and Shofer, 1992, Bomhard, 2001). This may be 
explained by the fact that we used the new WHO classification in our study (Goldschmidt et 
al., 1998, Hendrick et al., 1998) whereas in the recent study by Bomhard (2001) the 
nomenclature followed the first WHO classification, although deviating in some points, in 
spite of the fact that this work was done in 2001. 
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Because we have not found a specific statistical definition of the terms common, uncommon 
and rare, we divide skin tumors according to the following categorization: Tumors that are not 
found in our collection seem to be rare. Tumors found in less than 1 % (less than 8 cases in 
dogs and two in cats in our study) seem to be uncommon and those found in 1 % or more 
seem to be common.  
 
5.1.1. Prevalence of skin tumors according to the new WHO classification 
5.1.1.1. In dog 
The first 10 common skin tumors and tumor-like lesions were canine cutaneous histiocytoma 
(16.4 %), mast cell tumor (6.9 %), lipoma (5.6 %), hepatoid gland adenoma (5.4 %), 
infundibular cyst (4.5 %), fibrosarcoma (3.9 %), sebaceous hyperplasia (2.8 %), malignant 
melanoma (2.7 %), trichoepithelioma (2.7 %) and melanocytomas (2.6 %). Less common 
tumors, which had a prevalence between 2.6 % and 0.9 %, were meibomian adenoma, canine 
hemangiopericytoma, hemangioma, infundibular keratinizing acanthoma, apocrine cyst, 
sebaceous adenoma, subungual squamous cell carcinoma, trichoblastoma, pilomatricoma, 
calcinosis circumscripta, collagenous hamartoma, fibroma, fibropruritic nodule, panfollicular 
cyst, sebaceous duct cyst, follicular hamartoma, basosquamous carcinoma, fibroepithelial 
“polyp”,  papilloma,  squamous  papilloma  and  fibroadnexal  hamartoma  consecutively. 
Uncommon tumors, with a prevalence of less than 1 %, were apocrine ductal adenoma, 
hemangiosarcoma, squamous cell carcinoma, anal sac gland carcinoma, apocrine adenoma, 
apocrine carcinoma, basal cell tumor, hepatoid gland epithelioma, myxosarcoma, sebaceous 
epithelioma, dermoid cyst, isthmus cyst, malignant histiocytosis, sebaceous hamartoma, 
complex and mixed apocrine adenoma, cutaneous histiocytosis, apocrine ductal carcinoma, 
malignant peripheral nerve sheath tumor of the skin and subcutis, meibomian carcinoma, 
meibomian epithelioma, sebaceous carcinoma, subungual epithelial inclusion cyst, subungual 
keratoacanthoma and synovial cell sarcoma. 9 types were represented only by one case each 
(0.1 %). Single cases that found in our collection seem to be uncommon. These types were 
apocrine hamartoma, complex and mixed apocrine carcinoma, hepatoid gland carcinoma, 
leiomyosarcoma, lymphangioma, malignant trichoepithelioma, multicentric squamous cell 
carcinoma in situ, myxoma, and pressure point comedones. The other 38 types were not found 
in our collection and seem to be rare, and for some of these only a few cases had been 
reported in the literature (Goldschmidt et al., 1998, Hendrick et al., 1998, Goldschmidt and 
Hendrick, 2002). The tumors that were not found in our collection were anal sac gland 
adenoma, angiolipoma, basal cell carcinoma, benign peripheral nerve sheath tumor of skin 
DISCUSSION 99 
and subcutis, ceruminous adenoma, ceruminous gland carcinoma, complex and mixed 
ceruminous carcinoma, complex and mixed ceruminous adenoma, eccrine adenoma, eccrine 
carcinoma, granular cell tumor, inverted papilloma, Kaposi-like vascular tumor, leiomyoma, 
liposarcoma, lymphangiosarcoma, malignant fibrous histiocytoma, malignant 
mesenchymoma, malignant pilomatricoma, meibomian ductal adenoma, melanoacanthoma, 
mesothelioma, rhabdomyoma, rhabdomyosarcoma, sebaceous ductal adenoma, systemic 
histiocytosis and tricholemmoma. The tumor-like lesions that were not found in the dogs of 
our collection were traumatic neuroma, scrotal vascular hamartoma, nodular dermatofibrosis 
of the German shepherd dog, nodular fasciitis, melanocytic hyperplasia, epidermal 
hamartoma, cutaneous horn, dilated pore, ciliated cyst, warty dyskeratoma and xanthoma. 
 
We can expose some tumors with marked changes in prevalence due to the new WHO 
classification compared with the results from Frese (1960), Eskens (1983), Goldschmidt and 
Shofer (1992) and Bomhard (2001) as following: 
 
5.1.1.1.1. Squamos cell carcinoma 
The prevalence of the squamous cell carcinoma in many previous studies, varied between 1.7 
% and 7.25 %, and was 7.25 % according to Frese (1960), 2.31 % according to Eskens 
(1983), 1.7 % according to Goldschmidt and Shofer (1992) and 2.97 % according to Bomhard 
(2001), and it constitutes 3 % of all skin tumors and tumor-like lesion in our study. However, 
according to the new WHO classification, it is subdivided into two types, squamous cell 
carcinoma and subungual squamous cell carcinoma. Squamous cell carcinomas represent 0.9 
% of all skin tumors and tumor-like lesions, and seem to be uncommon; however, subungual 
squamous cell carcinomas are listed under the common skin tumors because they have been 
observed in 2.1 % of all skin tumors and tumor-like lesions in our study. 
 
5.1.1.1.2. Basal cell tumor 
The old term basal cell tumor was mentioned as a common skin tumor and varied between 2 
% and 5.9 %, which was 2 % according to Frese (1960), 5.84 % in Eskens (1983), 3.7 % in 
Goldschmidt and Shofer (1992) and 5.9 % in Bomhard (2001). It was represented in 3.6 % of 
all cases examined in our study. 55.6 % of those cases were reclassified as trichoblastoma and 
27.8 % were reclassified as basosquamous carcinoma according to the new WHO 
classification. Only 16.7 % were diagnosed as basal cell tumors, which constitute 0.6 % of all 
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skin tumors and tumor-like lesion in our study. Therefore, the newly classified basal cell 
tumors seem to be uncommon in dogs. 
 
5.1.1.1.3. Hepatoid gland adenoma 
This adenoma has decreased chronologically from the most common skin tumor at about 18 
% (Frese, 1960) to 9 % (Eskens, 1983, Goldschmidt and Shofer, 1992) to less than 6 % 
(Bomhard, 2001) and to 5.4 % in our study. The tumor is testosterone-dependent (Scott et al., 
2001). Therefore, an increasing rate of early castration will logically have an effect on the 
ratio of these tumors. We think that castration of pet animals has increased over time which 
can explain the decrease of this tumor. 
 
5.1.1.1.4. Sebaceous adenoma 
Sebaceous adenoma was applied to a common skin tumor in the literature as well as in our 
study, which is always placed among the 10 most common skin tumors (Frese, 1960, Eskens, 
1983, Goldschmidt and Shofer, 1992, Bomhard, 2001). However, according to the new WHO 
classification approach applied in our study, more than 22 % of these tumors have been 
classified as sebaceous epitheliomas. The other 78 % have been classified as sebaceous 
adenomas, which are less common than in the above literature. 
 
Tab. 38: Sebaceous adenoma and epithelioma 
 n % ♂ % ♀ % 
Sebaceous adenoma 17 71 65 35 
Sebaceous epithelioma  5 21 100 0 
 
 
5.1.1.1.5. Follicular tumors 
Compared with prevalence studies carried out by many authors (Frese, 1960, Eskens, 1983, 
Goldschmidt and Shofer, 1992), follicular tumors are far more common in this study. This 
may be explained by the new WHO classification approach used in this study as in the case of 
trichoblastoma. 
 
5.1.1.2. In cats 
Only 31 types of skin tumors and tumor-like lesions were found in cats in our collection and 
that may be due to the relative smallness of our collection and the rarity or absence of some 
tumors in cats. Fibrosarcoma was the most common skin tumor (37.5%) followed by other 
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common skin tumors, represented by squamous cell carcinoma (8.5%), apocrine adenoma 
(7.0%), basal cell tumor (5.5 %), lipoma (5.0%), trichoblastoma (4.5%), ceruminous gland 
carcinoma (3.5 %), hemangiosarcoma (3.5 %), apocrine carcinoma (3.0%) and feline mast 
cell tumor (3.0%). Less common tumors and tumor-like lesions (between 1 and 2 %) were 
apocrine ductal adenoma, myxosarcoma, infundibular cyst, hemangioma, subungual 
squamous cell carcinoma, sebaceous ductal adenoma, follicular hamartoma, sebaceous 
hyperplasia and malignant melanoma. The other 12 types were represented by only one case 
(0.5 %) each, and they seem to be uncommon. These tumors were multicentric squamous cell 
carcinoma in situ, trichoepithelioma, sebaceous adenoma, sebaceous carcinoma, complex and 
mixed apocrine adenoma, complex and mixed apocrine carcinoma, ceruminous adenoma, anal 
sac  gland  carcinoma,  fibroepithelial  “polyp”,  melanocytomas,  myxoma  and  Feline  ventral 
abdominal angiosarcoma. 
We found that fibrosarcoma was the most common skin tumor in cats in our study as well as 
in the literature (Stiglmair-Herb, 1987, Joerger, 1988, Goldschmidt and Shofer, 1992, 
Bomhard, 2001), and squamous cell carcinoma in our study takes the place of basal cell 
tumor, which is mentioned as the second most common skin tumor in the cat by the above 
publications. We demonstrate this change by applying the reclassification of 45 % of basal 
cell tumor as trichoblastoma, which together represent the second most common skin tumor, 
which agrees with the results of these authors. 
4 cases of malignant lymphoma were excluded from the skin tumors in our study in 
accordance with the new WHO classification, which classifies them as hematopoietic tumors 
(Valli et al., 2002). However, it was one of the common skin tumors in the cat in the literature 
(Stiglmair-Herb, 1987, Joerger, 1988, Goldschmidt and Shofer, 1992, Bomhard, 2001), and 
would be the same in our study if we did not use the new classification. 
No tumor-like lesions were mentioned in Joerger's study (1988), but infundibular cyst was 
also more common in the other studies than in ours (Goldschmidt and Shofer, 1992, 
Bomhard, 2001), while apocrine adenoma is more common in our study than in others 
(Stiglmair-Herb, 1987, Joerger, 1988, Goldschmidt and Shofer, 1992, Bomhard, 2001), and 
note that apocrine ductal adenoma was not mentioned by Stiglmair-Herb (1987), Joerger 
(1988) and Bomhard (2001) and may have been categorized under apocrine adenoma. 
The statistical ratio of squamous cell carcinoma in the cat was not markedly changed by the 
newly classified subungual squamous cell carcinoma because this newly classified tumor was 
present in 10.5% of all squamous cell carcinomas. 
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Another study carried out by Miller et al. (1991) showed different results, with basal cell 
tumor as the most common skin neoplasm recorded in 26.1 % of the cases. Moreover, mast 
cell tumor and squamous cell carcinoma were more common than fibrosarcoma. This may be 
explained by the fact that this study by Miller et al. (1991) was carried out in Columbia, while 
most of the other studies that were carried by Stiglmair-Herb (1987), Joerger (1988), 
Goldschmidt and Shofer (1992) and Bomhard (2001), were carried out in Germany and the 
United States of America. So these differences may be explained by the vaccination 
behaviour and the prevalence of some infections and predisposing factors existing in these 
countries such as feline leukemia virus and feline sarcoma virus. 
 
5.1.2. Origin of tumors and tumor-like lesions 
5.1.2.1. Dog 
Generally, tumors and tumor-like lesions of the skin were broken down differently by many 
authors (Frese, 1960, Eskens, 1983, Stiglmair-Herb, 1987, Joerger, 1988, Goldschmidt and 
Shofer, 1992, Bomhard, 2001). We divided our collection exactly as in the new WHO 
classification, and therefore we have three groups, including epithelial, melanocytic and 
mesenchymal tumors. The tumor-like lesions were subsumed under these three groups. If we 
divide our collection into four groups as is commonly done by some other authors (Eskens, 
1983, Goldschmidt and Shofer, 1992), we find significant changes in the dominant kind of the 
skin tumors in the dog, as in diagram 11 and 12. 
183 cases of tumor-like lesions were found in our collection, with 22.4 % of all skin tumors 
and tumor-like lesions in dogs, which represents the highest reported percentage of tumor-like 
lesions compared with other statistical studies (Eskens, 1983, Goldschmidt and Shofer, 1992, 
Bomhard, 2001). Most of these lesions were of epithelial origin. We therefore reporte an 
increase in the epithelial group after subdivision of the group of tumor-like lesions according 
to their origins, as in diagram 12. Melanocytic tumors, however, are unchanged, because we 
did not find any tumor-like lesion of this category in our collection. 
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Diag. 11: Origin of tumors and tumor-like lesions (tumor-like lesions counted as 
separate entity, n=816)
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Diag. 12: Origin of tumors and tumor-like lesions according to new WHO 
classification (tumor-like lesion included into the relevant tumor groups, n=816)
 
We can conclude that the dominant group in dogs is that of the epithelial tumors with 49.3 %, 
followed by mesenchymal tumors with 45.3 % and melanocytic tumors with 5.3 % of all skin 
tumors and tumor-like lesion according to the new WHO classification. 
 
5.1.2.1. Cat 
In the cat, mesenchymal tumors were always the dominant group and represented 53.8 % of 
all skin tumors and tumor-like lesions, while 44.7 % of tumors in our study were epithelial in 
origin, and that was in agreement with the findings in the literature (Stiglmair-Herb, 1987, 
Willemse, 1991, Goldschmidt and Shofer, 1992). Melanocytic tumors were found in 1.5 % of 
all skin tumors and tumor-like lesions in cats. All tumor-like lesions in cats were epithelial in 
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origin; these were only 8 cases (4 %) and they made no great difference regarding the 
dominance of these groups when they were divided according to the new WHO classification 
into the mesenchymal, epithelial and melanocytic groups. 
 
5.1.3. Breed disposition 
More than 25 % of the dogs in our collection were Mongrels, followed by German shepherd 
dog (7.2 %), Boxer (4.4 %), Golden retriever (4.0%), Westhighland white terrier (3.6 %), 
Cocker spaniel (3.5 %), Bernese mountain dog (3.4 %), Rottweiler (2.7 %), Roughhaired 
dachshund (2.6 %) and Dobermann (2.6 %) and the remaining breeds mentioned in our 
previous results. Boxer with 16.5 % was the most common breed in the study by Frese 
(1960), followed by Dachshund 13.2 %, Fox terrier 12.4 % and German shepherd dog 11.8 %. 
In another study carried out by Walter and Schwegler (1992), cancer was found in 41.9 % of 
all necropsied Boxers, which showed the highest relative disposition. However, Frese (1960), 
gave no information on sources (biopsy or necropsy) in his study, and biopsy was the source 
in our study. On the other hand, the cases of skin tumors and tumor-like lesions in our study 
as well in the other studies were selected, and that may influence the recognition of breed 
disposition. Less common breeds are usually more expensive, and the owners of these 
animals are more often well-to-do, so that animals of these breeds are examined and treated 
more frequently. This may also apply vice versa to the more common breeds. 
 
The breeds of cats were not available for 49 out of 194 cases in our collection, and we think 
that all or most of them were Mongrel because with 85 % this breed is the most common in 
the cat population (Bomhard, 2001) and also with 84 % the most common in our collection. 
We assume that the senders mostly stated the breeds when they were rare or uncommon 
breeds. However, to be sure, only 145 cases with known breeds were used in the statistical 
breed division in our study. The other less common breeds were Persian (7.6 %), Maine-coon 
cat (4.1 %), Karthaeuser “British blue“ (2.1 %). Angora, Birma, Siam and ESH cats were less 
than 1 %. It is known that some skin tumors were described only in some breeds or were more 
common in some breeds, the most common examples being malignant histiocytosis, which 
was first described in the Bernese mountain dog, but has since been reported in various dog 
and cat breeds (Goldschmidt and Hendrick, 2002, Court et al., 1993), and nodular 
dermatofibrosis of the German shepherd dog (Goldschmidt et al., 1998). Another example is 
mast cell tumor, which is more common in Boxer, Pug and Boston than in other breeds 
(Goldschmidt and Shofer, 1992, Goldschmidt and Hendrick, 2002). 
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Regarding nailbed tumors in Standard schnauzer dogs, 11 Standard schnauzer dogs with 12 
tumors and tumor-like lesions were found in our collection, of which 7 were nailbed tumors 
(58 %). These were 5 subungual squamous cell carcinomas and 2 subungual 
keratoacanthomas which were the only 2 cases in our whole collection. The breed predilection 
of subungual squamous cell carcinomas in Standard schnauzer dogs and many other breeds 
was mentioned by Goldschmidt and Hendrick (2002), however, breed predilection of 
subungual keratoacanthomas in Standard schnauzer dogs has not been reported in veterinary 
literature (Gross et al., 1992, Goldschmidt et al., 1998, Goldschmidt and Hendrick, 2002). 
Cutaneous hemangioma and hemangiosarcomas have a breed predilection for German 
shepherd dogs (31 %) in our results and shows a higher prevalence in the males (63 %) than 
in the females of this breed compared to other breeds. We have not found any study that 
describes and discusses the sex and breed predilection of cutaneous hemangioma and 
hemangiosarcomas of the skin for the German shepherd dog. However, such predilection is 
mentioned by other authors for these tumors when occurring in internal organs (Appleby, 
1991, Goldschmidt and Hendrick, 2002). 
 
5.1.4. Age distribution 
The mean age of animals with skin tumor in our collection was 7.5 years in dogs and 10.6 
years in cats. So our results agree with the results of the other authors who state that skin 
tumors arise above all in old animals (Frese, 1960, Eskens, 1983, Goldschmidt and Shofer, 
1992, Bomhard, 2001). At the same time, the results show an exception for dogs with 
histiocytoma, which have a mean age of 3 years in our study, and this is also reported by 
many other authors (Eskens, 1983, Goldschmidt and Shofer, 1992, Goldschmidt and 
Hendrick, 2002). Histiocytoma was always the most common skin tumor in the dog and 
ranging between 11.5 % and 16.4 % (Eskens, 1983, Goldschmidt and Shofer, 1992, Bomhard, 
2001), and it was 16.4 % in our study. Therefore, this tumor has a considerable impact on the 
general mean age for the occurrence of skin tumors in dogs, and explains the high onset in 
diagram 13. Some other tumors and tumor-like lesions were considered to be more common 
in young animals such as papilloma (Goldschmidt and Shofer, 1992, Bomhard, 2001), 
dermoid cyst and follicular cyst (Bomhard, 2001). In our study papilloma was divided into 
two forms: papilloma and squamous papilloma, and both lesions seem to occur in young dogs 
of a mean age of 4 and 5 years, respectively. Dermoid cyst was also present in young dogs of 
a mean age of 4 years. Follicular cysts, which are reclassified in our study according to the 
new WHO classification into infundibular, sebaceous duct, isthmus, panfollicular cysts and 
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dialated pore, were observed at a mean age of 7 to 11 years, with the exception of the isthmus 
cyst, which seems to occur in young dogs at a mean age of 5 years. 
 
Diag. 13: Age distribution of skin tumors, comparative diagram 
(dogs and cats)
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Diagram 13 shows the age distribution in both dogs and cats. The onset of the curves shows 
marked differences due to the histiocytoma in the dog. For both species the level is highest at 
the age of 10 years.  
 
5.1.5. Sex distribution and predilection 
Our collection shows a significant predominance of male dogs and cats. These results agree 
with the observations by Frese (1960) and Eskens (1983) regarding dogs, and were contrary 
to the observations by Goldschmidt and Shofer (1992) and Bomhard (2001) regarding dogs 
and cats.  
In our study, many tumors and tumor-like lesions show sex predilection for male dogs and 
cats, however, this is more significant for trichoblastomas and basal cell tumors as well as all 
epitheliomas, and these findings will be discussed in detail below (see 5.3.1. and 5.3.5.). 
Apocrine ductal adenoma also shows a significant sex predilection for female dogs and cats 
and will be discussed in detail below (see 5.3.6.). 
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5.1.6. Anatomical location 
The anatomical location of skin tumors is stated differently in the literature (Priester and 
Mckay, 1980, Goldschmidt and Shofer, 1992, Bomhard, 2001). A general division of the skin 
into head, neck, extremities, chest, back, abdomen, perianal, tail, and tumors without data was 
used by Bomhard (2001). In our work, we use this division with some modification. In our 
collection, we have about 20 tumors that were taken from the mammary gland region, and as 
they did not originate from mammary gland, we prefer to sort them under mammary gland 
region. Extremities are defined as limbs (arms and legs) (Pschyrembel, 2002) and we thus use 
the term in our thesis (Diagram 14). 
 
Diag. 14: Anatomical location: 1. Head, 2. Neck, 3. Limbs, 4. Chest, 5. Back, 6. Mammary 
region, 7. Abdomen, 8. Perianal, 9. Tail. 
 
Head: 
The superficial regions of the head are divided into regio paritalis, regio temporalis, regio 
frontalis, regio nasalis, regio infraorbitalis, regio zygomatica, regio orbitalis, regio oralis, 
regio mentum, regio buccalis, regio maxillaris, regio molaris, regio mandibularis, regio 
masseterica, regio parotidea and auricula (Popesko, 1997). 
To facilitate our statistics and in accordance with the use of names in our field, we have used 
some abridged and modified terms for these regions, for example regio paritalis, regio 
temporalis, regio frontalis together are one location, namely regio infraorbitalis; regio 
zygomatica, regio maxillaris, regio molaris and part of regio masseterica together are named 
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cheek. Moreover regio mandibularis, part of regio masseterica, regio parotidea and mentum 
together are named mandibular region. 
 
 
In the literature (Gross et al., 1992, Goldschmidt and Shofer, 1992, Goldschmidt et al., 1998, 
Scott et al., 2001, Goldschmidt and Hendrick, 2002) as well as in our study, there are some 
tumors related to specific organs in the skin, which are found mainly in particular places on 
the body. These are anal sac tumors in perianal site, meibomian gland tumors on the inner 
aspect of the eyelid, ceruminous gland tumors in the ear canal, subungual keratoacanthoma 
and subungual squamous cell carcinoma which arise from the nailbed epithelium of the 
forelimbs or hindlimbs. Moreover, hepatoid gland tumors arise from hepatoid glands, which 
are located primarily at the perianal region, on the dorsal and ventral aspect of the tail, in the 
parapreputial area in males, at the abdominal mammary gland region in females, and can also 
be found in other locations (Goldschmidt and Shofer, 1992, Goldschmidt et al., 1998, 
Goldschmidt and Hendrick, 2002) such as the feet (Gross et al., 1992) and in one case in our 
study at the head. Thus, hepatoid glands are distinct anatomic entities closely related to 
sebaceous glands in their development (Isitor and Weinman, 1979). 
Some skin cysts also relate to specific areas such as the subungual epithelial inclusion cyst, 
which is located within the bone of the third phalanx, and tumor-like lesions such as pressure 
point comedones, which are present primarily at the elbow (Goldschmidt et al., 1998). 
Some other tumors and tumor-like lesions had no specific location at the skin, but they were 
located in one location more frequently than in others in the dogs in our collection. This group 
of tumors included the greater part of skin tumors and tumor-like lesions. These tumors were 
infundibular keratinizing acanthoma, which is commonly located at the back, trichoblastoma, 
Diag. 15: Superficial regions of the 
head in a dog: 1. Nose, 2. Lips, 3. 
Mandibular region, 4. Cheek, 5. 
Eyelid, 6. Temporal, frontal and 
parietal regions, 7. Auricle. 
Modified from Popesko (1997) 
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papilloma, apocrine ductal adenoma, sebaceous adenoma and epithelioma and melanomas, 
which are commonly located at the head. In addition, panfollicular and sebaceous duct cysts, 
sebaceous hyperplasia, fibroadnexal and follicular hamartomas, mast cell tumors, calcinosis 
circumscripta, canine hemangiopercytoma, fibroma and fibrosarcoma, were commonly 
located at the limbs, and apocrine adenoma and hemangiosarcoma at the neck. 
In cats, squamous cell carcinoma, apocrine and melanocytic tumors were commonly found at 
the head and the auricle was the most common location of the squamous cell carcinoma. 
Trichoblastomas were commonly located at the limbs, and fibrosarcomas were found most 
often at injection (vaccination) sites (shoulder, between shoulder blades, chest wall and neck). 
Generally, the most common locations of skin tumors and tumor-like lesions in our study 
were the limbs and the head in both, dogs and cats. 
 
5.2. Definition of the new terms in the new WHO classification 
To avoid any mistake, we divide these tumors as follows: 
Reclassified tumors: 
Trichoblastomas were reclassified from basal cell tumors of the dog and cat because they 
originate in the hair germ of the developing follicle and not the basal cells (Goldschmidt and 
Hendrick, 2002). Sebaceous, meibomian and hepatoid epitheliomas were no longer classified 
as adenomas because they have a different prognosis as low malignant tumors. The newly 
classified sebaceous and meibomian ductal adenomas were separated from their previous 
classification as adenomas because of their origin in ductal epithelium. Squamous papilloma 
seceded from the old papilloma because it has no relation with viral infection and has a better 
prognosis (Goldschmidt et al., 1998, Goldschmidt and Hendrick, 2002). Some skin cysts such 
as isthmus, panfollicular and sebaceous ducts and the pressure point comedones were derived 
from the epidermoid cyst (Scott et al., 2001) and they are mentioned separately in the new 
WHO classification, probably due to their variable origin. 
Renamed tumors: 
In the new WHO classification many tumors are renamed, for example infundibular 
keratinizing acanthoma, pilomatricoma, infundibular cyst, fibroepithelial  “polyp” and 
peripheral nerve sheath tumor (Goldschmidt et al., 1998), which were previously named intra-
cutaneous cornifying epithelioma, necrotizing and calcifying epithelioma of Malherbe, 
epidermal cyst, cutaneous fibrous polyp and neurofibrosarcoma respectively (Weiss, 1974, 
Weiss and Frese, 1974); the reason is probably that these names were more descriptive of the 
origin of the lesions. 
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Newly discovered tumors: 
Descriptions of these tumors were published in the period between the two WHO 
classifications, and they are mostly very rare tumors such as tricholemmoma (Diters and 
Goldschmidt, 1983, Walsh and Corapi, 1986), dilated pore (Scott and Flanders, 1984, Luther 
et al., 1989), ciliated cyst (Goldschmidt and Shofer, 1992), melanoacanthoma (Gross et al., 
1992), nodular dermatofibrosis of the German shepherd dog (Lium and Moe, 1985, Moe and 
Lium, 1997), xanthoma (Fawcett et al, 1977, Gross et al., 1992), systemic (Moore, 1984), and 
malignant histiocytosis (Scott et al, 1979). Some lesions, as warty dyskeratoma, were new in 
the WHO classification, but the authors give no reference as to possible previous publications 
on these subjects (Goldschmidt et al., 1998). 
Many subtypes or variants of different tumors had also been newly published, for example 
feline ventral abdominal angiosarcoma (Swayne et al., 1989). 
Missdiagnosed tumors: 
We suppose this group existed, but was always wrongly diagnosed, for example, subungual 
keratoacanthoma, which is similar to well-differentiated squamous cell carcinoma. 
Collagenous hamartoma was probably previously identified as fibroma (Gross et al., 1992). 
Moreover, nodular fasciitis was probably missdiagnosed as fibrosarcoma because it has many 
clinical and histological features suggestive of a locally invasive fibrosarcoma as mentioned 
by Hendrick et al. (1998). 
 
5.3. Skin tumors and tumor-like lesions in our cases 
Under this heading we will discuss the skin tumors and tumor-like lesions investigated by us, 
individually and sometimes as groups that show definite characteristics or have been newly 
classified in the WHO classification. 
 
5.3.1. Basal cell tumors and trichoblastomas (Fig. 2a-2x) 
The term basal cell tumor has developed gradually in the history of the skin tumors of 
domestic animals. Its definition in the earlier literature was simple (Moultion, 1961), and it 
included trichoepithelioma as a subtype. Tumors which are now classified as trichoblastomas 
were described in the majority of the earlier publications as variants of basal cell tumors 
(Sedlmeier et al., 1967, Weiss and Frese, 1974, Stannard and Pulley, 1978, Seiler, 1982, 
Diters and Walsh, 1984, Madewell and Theilen, 1987, Pulley and Stannard, 1990, Yager and 
Wilcock, 1994), with only one exception, namely Gross et al. (1992), who defined and 
classified trichoblastomas separately. However, the new WHO classification by Goldschmidt 
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et al. (1998) reclassifies the majority of basal cell tumors of the dog and the spindle cell type 
of basal cell tumor of the cat as trichoblastomas and follows the classification by Gross et al. 
(1992). Sebaceous epithelioma, previously a variant of basal cell tumor (Yager and Wilcock, 
1994), is classified under sebaceous gland tumors in the new WHO classification. Keratotic 
basal cell carcinoma, which was a type of basal cell tumor (Gross et al., 1992), is classified 
under tumors of epidermis as basosquamous carcinoma in the new WHO classification. 
 
Canine basal cell tumor is an uncommon tumor according to the new WHO classification, and 
also in our study, where it constitutes 0.6 % (5 cases) of all skin tumors and tumor-like 
lesions. One of these cases was found at the perianal region and showed similarity to hepatoid 
gland epithelioma, because in one area it was mixed with hyperplastic hepatoid gland. 
However, because of the association with the overlying epidermis, the cystic degeneration and 
the presence of the hepatoid cells as masses in one area and not as individual cells, we 
diagnosed this case as a basal cell tumor (Fig. 2v-2x). 
Feline basal cell tumor is considered to be common in the new WHO classification, and it is 
the third most common skin tumor in our study, with about 6 % of all skin tumors and tumor-
like lesions. Basal cell tumors in the form of cystic variants were mentioned frequently in the 
literature (Diters and Walsh, 1984, Goldschmidt and Shofer, 1992, Goldschmidt and 
Hendrick, 2002), and 80% of basal cell tumors in the dogs and 73 % in the cats in our 
collection showed cystic degenerations. 
Clear cell basal cell carcinoma is an uncommon tumor (Goldschmidt et al., 1998, 
Goldschmidt and Hendrick, 2002), which occurs more frequently in cats and can be 
differentiated from sebaceous carcinoma only with difficulty (Gross et al., 1992). In human 
medicine, this is an unusual variant of basal cell tumor (Barr et al., 1993) and must be 
differentiated from other clear cell tumors such as balloon cell malignant melanoma, granular 
cell tumors and sebaceous neoplasms (Kao et al., 1992). In some reports, the term granular 
(clear) cell basal cell carcinoma (Kao et al., 1992) or just granular cell basal cell carcinoma 
has been used (Dundr et al., 2004). However, clear cell basal cell carcinoma was not found in 
our collection, and the 3 cases of sebaceous carcinomas that were found in our collection (2 
dogs and one cat) were histologically easy diagnosed without confusion with clear cell basal 
cell carcinoma. 
 
Trichoblastomas appear mostly as basal cell tumors in the literature (Madewell and Theilen, 
1987, Goldschmidt and Shofer, 1992, Bomhard, 2001, Goldschmidt and Hendrick, 2002) and 
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they are mentioned as a separate category only by Gross et al. (1992). According to these 
publications, trichoblastomas have no marked sex predilection. However, the majority of 
trichoblastomas and basal cell tumors were found in males in both, dogs and cats of our 
collection. This finding was more obvious with regard to trichoblastomas, in dogs as well as 
in cats (Table 39). 
 
Tab. 39: Basal cell tumors and trichoblastomas in dogs and cats 
 Dog Cat 
 n ♂ % ♀ % n ♂ % ♀ % 
Basal cell tumor 5 80 20 11 64 36 
Trichoblastoma 16 69 31 9 89 11 
Total/ Means 21 74.5 25.5 20 76.5 23.5 
 
The total numbers and the mean percentages in table (35) reflect the results for basal cell 
tumors according to the old WHO classification. 
Gross et al. (1992) mentioned that the prevalence of trichoblastomas in dogs was very close to 
the prevalence of basal cell tumors, which ranged from 3 % to 12 %, although it was difficult 
to estimate in cats because many other tumors such as apocrine ductal neoplasms and 
neoplasms of epidermal basal cell origin had been involved in the feline basal cell tumors 
(Gross et al., 1992). In spite of our search, we did not find any study carried out mainly on 
trichoblastomas. However, we describe here 16 cases of canine trichoblastomas and 9 cases of 
feline trichoblastomas. The prevalence of feline trichoblastomas (4.6 %) exceeded canine 
trichoblastomas (2 %). Trichoblastomas were found mostly at the head of dogs (60%), 
whereas it was more common at limbs of cats (67 %) in our study, while Goldschmidt and 
Hendrick (2002) mention that head and neck were the primary sites of occurrence of 
trichoblastomas in the dog and cat, and Scott et al. (2001) mention that lesions in cats occur 
most commonly on the cranial half of the trunk.  
There is no clear breed predilection in trichoblastomas, but the most common dogs were 
German shepherd dog and Westhighland white terrier. Ribbon type trichoblastoma was the 
most common variant (88 %) in the dogs in our collection, while trabecular was the most 
common variant (67 %) in the cats. Trichoblastomas seem to occur in young and old dogs 
from one to 14 years, with a mean age of 8 years, while it is a tumor of old cats between 6 and 
15 years, with a mean age of 11 years. In comparison with basal cell tumors in our study, we 
note that basal cell tumor is a tumor of aged dogs and cats of mean ages of 10 and 13 years, 
respectively. 
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5.3.1.1. Granular cell trichoblastoma (Fig. 2i-2l) 
This variant is very rare and only few cases have been described in dogs and rats (Seiler, 
1981, Courtney et al., 1992, Yoshitomi and Boorman, 1994). In our case as well as in the 
previously published cases (Seiler, 1981, Courtney et al., 1992, Yoshitomi and Boorman, 
1994), the tumor contains two different types of cells, basaloid cells and granular cells. All 
cases in dogs, including our case, showed mixed form, ribbon type and granular cell foci. The 
presence of the basaloid cells is the key to identify this kind of tumors easily, and according to 
our search, no any pure granular cell trichoblastoma was reported. Therefore we suppose that 
many pure granular cell trichblastomas might be miss-diagnosed as other granular cell 
tumors. 
In all the previous cases, including a similar case of granular cell basal cell tumor in human 
(Dundr et al., 2004), the tumor cells contained a varying amount of PAS positive granules. 
However, the nature of the cytoplasmic eosenophilic granules was considered to be secondary 
lysosomes (Seiler, 1981, Courtney et al., 1992, Yoshitomi and Boorman, 1994, Dundr et al., 
2004). Immunohistological technique was done in the human case and confirmed the 
lysosomal nature of the cytoplasmic granules by the expression of CD68 antigen, which is a 
glycoprotein associated with lysosomal membranes (Dundr et al., 2004). We applied for the 
first time an immunohistological technique on canine granular cell trichoblastoma. Ribbon 
and granular cells were expressed Cytokeratin and were negative for Vimentin, which 
confirmed the epithelial nature. A human case of granular cell basal cell carcinoma of the skin 
was reported with immunocytochemical positivity for lysozyme (Bosccaino et al., 1997), 
however, our case was negative lysozyme immunohistology. Additionally, S100 
demonstration was performed to exclude a granular cell tumor which is presumptively of 
Schwann cell origin (Hendrick et al., 1998). 
In conclusion, granular cell trichoblastoma is a rare epithelial tumor and can be easily 
diagnosed in the mixed cases with appearance of basaloid cells arranged in ribbons, 
otherwise, immunohistological techniques, especially the demonstration of Cytokeratin 
expression should be helpful for differentiation. 
 
5.3.1.2. Clear cell trichoblastomas (Fig. 2m- 2q) 
The development of adnexa is the result of intimate interaction between basal cells and 
mesenchymal cells. The basal cells become the germinative cells of the hair follicle that will 
give rise to the specialized components of the follicle, the hair shaft, the internal root sheath, 
and the external root sheath as well as, in the case of these tumors, to trichoblastomas 
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(Goldschmidt et al., 1998). Of these, the clear cell differentiation in our cases resembles a 
differentiation similar to the lower part of the external root sheath which itself is composed of 
cells that have a very pale cytoplasm and rich with glycogen. This part of the external root 
sheath can develop to the inferior type of a tricholemmoma that is characterized by islands of 
neoplastic cells with pale cytoplasm and central cells that have more abundent eosinophilic 
cytoplasm. The islands in tricholemmoma are surrounded by a prominent basal lamina zone 
that is positive in the periodic acid-Schiff reaction (PAS) and shows blue staining with the 
Masson’s  trichrome  stain  (Diters  and Goldschmidt,  1983, Walsh and Corapi, 1986). These 
features that are found in tricholemmoma were found in some areas in our cases. These 
features together with the presence of the PAS-positive cytoplasmic granules support the 
hypothesis that the cells in our cases showed differentiation towards the lower part of the 
external root sheath of the hair follicle. However, the significant population of small, 
trichoblastic (basaloid) epithelial cells helps differentiate this tumor from a tricholemmoma. 
In the only reported case of a human clear cell trichoblastma, however, no PAS positivity was 
mentioned. The author discussed lysosomal degenerative changes as cause of the clear cell 
morphology (Tronnier, 2001). 
The presence of the tumor cells near the base of a hair follicle in one of our cases may 
represent the origin of this tumor from the hair follicle. 
Sebaceous differentiation was found in our cases in form of scattered large cells that are 
similar to sebocytes. Normally, the sebaceous gland develops from a bulge at the superficial 
portion of an invaginated cord of epithelial cells that formed a hair follicle (Goldschmidt et 
al., 1998). Therefore, sebaceous and external root sheath differentiation in our cases may 
represent that trichoblasts have the ability to differentiate to the external sheath of the hair 
follicle as well as their adnexa, and we consider, that an apocrine differentiation which 
mentioned in some cases of human trichoblastmas (Usmani et al., 2002, Yu et al., 2005) 
might be occur in animals. 
Generally, the tumors described here showed a growth pattern similar to that of ribbon 
trichoblastoma but consisted mainly of clear cells, some basaloid cells and scattered 
sebaceous cells. Additionally, few nests of outer root sheath differentiation similar to inferior 
(bulb) tricholemmoma (i.e. thick basement membrane zone, PAS positivity, peripheral 
palisading of epithelial cells, central eosinophilic cells) were found. 
Because of the dominance of the clear cells in the described tumors, we prefer to use the term 
clear cell trichoblastoma in tumors which show the described features. 
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5.3.1.3. Cystic variant of trichoblastoma (Fig. 2r-2u) 
Cystic degeneration is common in basal cell tumors according to the litrature (Joeger, 1988, 
Miller et al., 1991, Goldschmidt and Hendrick, 2002), and this feature is mentioned as a 
central caseation necrosis in basal cell carcinoma and is not described in benign feline basal 
cell tumors (Gross et al., 1992, Scott et al., 2001). In our collection, 80% of basal cell tumors 
in dogs and 73 % in cats showed this feature, while only two cases of trichoblastoma showed 
this manifestation; these were one single case of ribbon and one of trabicular variant in cats. 
Because they were two cases out of 9 feline trichoblastomas in our collection (1 % of all 
feline skin tumors and tumor-like lesions), we assume that the cystic variant of trichoblastoma 
is common in cat, rare, or does not occur at all in dogs. In addition, the presence of this 
feature in trichoblastomas may be disproving that this feature related to basal cell carcinoma 
as mentioned by some authors (Gross et al., 1992, Scott et al., 2001). 
 
5.3.1.4. Malignant trichoblastoma 
Malignant trichoblastomas are not mentioned in the new WHO classification of tumors of 
domestic animals, but were first described by Mikaelian and Wong (2003) who described 
follicular stem cell carcinomas with metastasis, lymphatic invasion and necrosis in dogs. 
Neoplasms of follicular stem cells would reasonably be expected to resemble trichoblastomas 
and basal cell carcinomas, therefore, this publication was criticized by the authors themselves 
(Mikaelian and Wong, 2004) and by Walder (2005); they urge that this neoplasm be referred 
to as clear cell or balloon-cell sweat gland carcinoma. So far, we support the view, on the 
basis of the above description, that trichoblastomas are benign tumors in animals despite the 
fact that in human pathology, malignant trichoblastic carcinomas have frequently been 
reported (Rofagha et al., 2001, Kazakov et al., 2004). 
 
5.3.2. Other follicular tumors (Fig. 1a-1e, 2e-2u) 
This group comprises many new tumors and new nomenclatures of the new WHO 
classification. It includes infundibular keratinizing acanthoma, tricholemmoma, 
trichoepithelioma and pilomatricoma in addition to trichoblastoma which was discussed 
above (see 5.3.1.) (Goldschmidt et al., 1998, Goldschmidt and Hendrick, 2002). Only 
trichoepithelioma and pilomatricoma (under the name necrotizing and calcifying epithelioma 
of Malherbe) were classified under follicular tumors, while infundibular keratinizing 
acanthoma was classified separately and not as hair follicle tumor in the old WHO 
classification. 
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In our study, generally speaking, this group of tumors was more common in dogs (72 cases 
with 8.8 % prevalence) than in cats (10 cases with 5.0% prevalence). Trichoepithelioma and 
infundibular keratinizing acanthoma were the more common follicular tumor (31 % and 26 %, 
respectively). Trichoblastoma and pilomatricoma were also common, with 22 % and 19 % of 
the follicular tumors in dogs. Malignant follicular tumors were noticed only in one case of 
malignant trichoepithelioma, and therefore malignant follicular tumors seem to be uncommon 
skin tumors in dogs. 
These tumors are commonly located at the back, with the exception of trichoblastomas, 
which, in our study, are located more commonly on the head. The location at the back of 
infundibular keratinizing acanthoma was in agreement with the results of Abramo et al. 
(1999), while the other follicular tumors in our study differed from the results of that study. 
Regarding cats, two types of follicular tumors were found in our collection, namely 9 cases of 
trichoblastoma and one case of trichoepithelioma. 
 
5.3.2.1. Infundibular keratinizing acanthoma 
A common canine follicular tumor in our study was classified separately in the old WHO 
classification and was not classified as hair follicle tumor, as it is in the new one (Weiss and 
Frese, 1974, Goldschmidt et al., 1998). This tumor was designated keratoacanthoma in the 
U.S.A., but this name was not accepted in the old WHO classification (Weiss and Frese, 
1974). According to the new WHO classification, the diagnosis of keratoacanthoma should be 
reserved for tumors of subungual origin (Goldschmidt et al., 1998), and two cases of 
subungual keratoacanthoma in our study will be discussed under nailbed tumors (see 5.3.3.2.). 
The cyst with epithelial proliferation was considered an early stage of infundibular 
keratinizing acanthoma in the old WHO classification (Weiss and Frese, 1974); however, no 
lesion resembling this stage of infundibular keratinizing acanthoma was found in our 
collection. 
The tendency of infundibular keratinizing acanthoma to occur in male dogs, as mentioned by 
Stannard and Pulley (1975), was not supported by our study. The mean age in the literature so 
far and in our study differed slightly; it was 5.3 years in Stannard and Pulley (1975), 6 years 
in Abramo et al. (1999), 7.3 years in Goldschmidt and Shofer (1992) and 8 years in our study.  
We therefore consider infundibular keratinizing acanthoma a tumor of young adult dogs. The 
back was the most common location of infundibular keratinizing acanthoma as many authors 
have found (Stannard and Pulley, 1975, Abramo et al. (1999), and so have we in our study. 
However, the limbs were the second most common predilection sites in our study, and they 
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are mentioned as the most common location by Goldschmidt and Shofer (1992). Norwegian 
elkhounds were predisposed (Yager and Wilcock, 1994, Goldschmidt and Shofer, 1992, 
Goldschmidt and Hendrick, 2002), but Norwegian elkhound was not observed in our 
collection, and no clear breed predilection was observed. 
 
5.3.2.2. Tricholemmoma 
This tumor has been newly classified in the WHO classification, and only few cases have 
been reported in dogs (Diters and Goldschmidt, 1983, Walsh and Corapi, 1986). Trichilemmal 
carcinomas in man have frequently been reported (Allee et al., 2003, Lai et al., 2003), but no 
cases in animals. However, tricholemmoma is not found in our study and seems to be rare. 
 
5.3.2.3. Trichoblastoma 
A detailed discussion of this tumor is found above (see 5.3.1.). 
 
5.3.2.4. Trichoepithelioma 
It was the most common follicular skin tumor of dogs in our study. The back has been 
described as the most common predilection site by many authors (Madewell and Theilen, 
1987, Gross et al., 1992) as well as in our study. However, the limbs have been mentioned as 
the more common location by Goldschmidt and Shofer (1992), and additional other locations 
as neck and thorax have also been mentioned (Abramo et al., 1999, Goldschmidt and 
Hendrick, 2002). The tumor is more commonly present in young adult dogs according to most 
of the literature (Gross et al., 1992, Goldschmidt and Shofer, 1992, Abramo et al., 1999, 
Goldschmidt and Hendrick, 2002) and this has been confirmed by our study. Breed 
predilection for Munsterlaender was observed in our study, while Basset hound had an 
increased disposition as Goldschmidt and Hendrick (2002) have found. Trichoepithelioma 
shows slightly increased tendency to occur in female dogs in our results, which agrees with 
the findings of Goldschmidt and Shofer (1992). 
Dogs with malignant trichoepithelioma and metastasis in lymph node and lung have been 
reported (Sells and Conroy, 1976). One case in our study was diagnosed as a malignant 
trichoepithelioma because of its histological appearance, but no other masses or metastases 
were mentioned in the case history of the affected dog. 
A single case of trichoepithelioma was found at the shoulder of a 9-year-old male ESH cat in 
our collection, however, this tumor is uncommon in the cat and no breed or sex predilection 
have been reported (Goldschmidt and Hendrick, 2002). 
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5.3.2.5. Pilomatricoma 
This is a common canine follicular skin tumor that occurs relatively more frequently in 
younger dogs than other follicular skin tumors, as has been found in our collection and by 
other authors (Gross et al 1992, Goldschmidt and Shofer, 1992, Abramo et al., 1999, 
Goldschmidt and Hendrick, 2002). According to existing literature, Kerry blue terriers had the 
highest risk (Madewell and Theilen, 1987, Gross et al 1992, Goldschmidt and Shofer, 1992, 
Goldschmidt and Hendrick, 2002). In our study, however, just two Kerry blue terriers were 
found in the whole collection, and they had other kinds of skin lesions (one fibrosarcoma and 
one sebaceous hyperplasia); in our collection, Airedale terriers had the highest disposition for 
pilomatricoma. A clear sex predilection was observed in our collection (64 % female dogs), of 
which nothing is found in the aforementioned literature. Back and limbs were the most 
common locations in our study, but different locations were reported in the above literature. 
An aggressive malignant tumor with metastasis in bone, lung and lymph nodes was reported 
(Rodriguez et al., 1995), but no characteristics of malignancy were seen in the 14 cases of 
pilomatricomas in our collection. 
 
5.3.2.6. Trichofolliculomas 
These are rare benign neoplasms in dogs and cats (Gross et al., 1992, Scott et al., 2001), while 
they are the most common skin tumors in guinea pigs and represent 45 % of all their skin 
tumors (Frank and Frese, 1988). These neoplasms are considered to be highly structured 
hamartomas of the pilosebaceous unit (Gross et al., 1992, Scott et al., 2001) and they were 
classified as skin hamartomas in human pathology (Ackerman et al., 1993). The term 
trichofolliculoma does not appear in the new WHO classification, therefore, we assume this 
lesion was classified as fibroadnexal or follicular hamartoma or it may be missing in the new 
WHO classification. The lesions that were diagnosed as hamartomas in our collection were 
very simple and could not be confused with the trichofolliculoma mentioned in the previous 
literature, and we therefore have reported that trichofolliculoma was not found in our 
collection and might be a rare lesion in dogs and cats. 
 
5.3.3. Tumors of the epidermis and nailbed tumors (Fig. 4a-4d) 
5.3.3.1. Tumors of the epidermis 
This group of tumors includes papilloma (papillomatosis) and inverted papilloma as benign 
tumors (Campbell et al., 1988, Shimada et al., 1993). Actinic keratosis (Hargis and 
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Thomassen 1979), multicentric squamous cell carcinoma in situ or bowen-like disease (Baer 
and Helton, 1993), squamous cell carcinoma and basosquamous carcinoma represent the 
malignant tumors (Goldschmidt et al., 1998). 
Inverted papilloma and actinic keratosis were not observed in our collection and seem to be 
rare. 
 
5.3.3.1.1. Squamous cell carcinoma 
5.3.3.1.1.1. Dog 
The prevalence of squamous cell carcinoma varies between 1.7 % and 7.25 % in the literature 
(Frese, 1960, Eskens, 1983, Goldschmidt and Shofer, 1992, Bomhard, 2001) and it constitutes 
3 % of all skin tumors and tumor-like lesions in our study. However, according to the new 
WHO classification, squamous cell carcinomas represent 0.9 % of all skin tumors and tumor-
like lesions and seem to be uncommon in our study, although this tumor was reported as a 
common skin tumor in the new WHO classification (Goldschmidt et al., 1998). In contrast, 
subungual squamous cell carcinomas, which are listed under the common skin tumors, were 
observed in 2.1 % of all skin tumors and tumor-like lesions and seem to be common in our 
study as well as in the new WHO classification (Goldschmidt et al., 1998). Both types of 
squamous cell carcinomas show a marked tendency to occur in females, i.e. 67 % of 
squamous cell carcinoma and 61 % of subungual squamous cell carcinoma. This sex 
predilection agrees with the results of Goldschmidt and Shofer, (1992), but contradicts the 
results of Frese, (1960) and Bomhard (2001). A tendency of squamous cell carcinoma 
towards Schnauzer was reported by Goldschmidt and Hendrick (2002) and Bomhard (2001), 
but note that the results of Bomhard (2001) did not include the subungual squamous cell 
carcinoma and that means that these results may not reflect the tendency of squamous cell 
carcinoma precisely. However, in our study this tendency was shown only by the subungual 
tumor, while no clear tendency was observed in the other one. No difference in the mean age 
was observed between the two kinds of squamous cell carcinomas, which was 9 years, and 
that was in agreement with Bomhard's findings (2001). 
The acantholytic and spindle cell squamous cell carcinoma reported by Goldschmidt et al. 
(1998) and Goldschmidt and Hendrick (2002) and the signet-ring squamous cell carcinoma 
reported by Espinosa et al. (2003) were not found in our collection and seem to be rare. 
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5.3.3.1.1.1. Cat 
Squamous cell carcinoma was the most common epithelial skin tumor in the cat and 
represented 8.6 % of all skin tumors and tumor-like lesions in our study. 12 tumors out of 17 
were located at the head (mostly at auricle (70%) and eyelids (20%)). In most cases, ESH cats 
were affected. Our results partially agreed with those found in the literature (Goldschmidt and 
Shofer, 1992, Goldschmidt et al., 1998, Bomhard, 2001, Goldschmidt and Hendrick, 2002), 
with the exception that squamous cell carcinoma was the second most common epithelial 
tumor after basal cell tumor according to Bomhard (2001) and the third after basal and mast 
cell tumors according to Goldschmidt and Shofer (1992). The preponderance of basal cell 
tumors as the common epithelial skin tumor could be explained by the old WHO 
classification approach in these publications (Goldschmidt and Shofer, 1992, Bomhard, 2001) 
(see 5.3.1).  
 
5.3.3.1.2. Basosquamous carcinoma (Fig. 5d) 
This tumor was classified in the old WHO classification as a variant of basal cell tumor 
(Weiss and Frese, 1974) and considered as an epidermal tumor in the new WHO 
classification. No sex predilection has been noted by Goldschmidt and Hendrick (2002); in 
our study also, it was found in males in 63% out of 8 cases of basosquamous carcinoma. This 
finding may be related to the participation of the basaloid cells, which was observed in many 
other tumors in our study such as basal cell tumors, trichoblastomas and epitheliomas. No 
clear breed predilection was noted in our results, whereas Goldschmidt and Hendrick (2002) 
mention that Scotch terrier was at increased risk. Abdomen and limbs were the most common 
sites of basosquamous carcinoma in our study, while head and neck are mentioned by 
Goldschmidt and Hendrick (2002). This tumor was not found in cats in our collection and is 
not mentioned in cats in the literature (Goldschmidt et al., 1998, Goldschmidt and Hendrick, 
2002). 
 
5.3.3.1.3. Papilloma 
Papilloma is caused by infection with a papillomavirus (Shimada et al., 1993) and should be 
distinguished from a squamous papilloma (see 2.5.1.7.1., table 1 and 8.3.3.). In our collection, 
50% of all papillomas that were diagnosed according to the old WHO classification (Weiss 
and Frese, 1974) were reclassified as squamous papillomas and are discussed under tumor-
like lesions (see 5.3.8.). However, the other 50% were classified as viral papillomas, which 
represented 1 % of all skin tumors and tumor-like lesions in the dog, and were seen at 
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different ages, but more common in young dogs. They were found more commonly on the 
head especially on the lips with no marked breed predilection. 
Papillomas are uncommon in the dog and the cat according to Goldschmidt and Hendrick 
(2002), but they are relatively common in dogs and not found in the cats in our study. 
 
5.3.3.1.4. Multicentric squamous cell carcinoma in situ (Fig. 5a-5c) 
This is a form of carcinoma in situ which is considered to be uncommon in cats and rare in 
dogs by Scott et al. (2001), and in our study was found in a single case in a dog and in a cat, 
respectively. This tumor may progress to invade through the basement membrane and should 
then be classified as squamous cell carcinoma (Goldschmidt et al., 1998). The case of the cat 
in our study showed invasion of the tumor cells in the external root sheath of hair follicles, 
and in some areas the tumor edges were not sharp, therefore, we used an immunohistological 
technique (cytokeratin) to show the edges of the tumor and to confirm that no single cell 
invasion was present in this case. 
 
5.3.3.2. Nailbed tumors 
Gross et al. (1992) and Marino et al. (1995) have reported that larger dogs showed more digit 
masses than dogs of less weight. In 19 cases out of 117, digit masses (16 %) were subungual 
squamous cell carcinomas (Marino et al., 1995) and 9 from 21 canine nailbed epithelial 
neoplasms were subungual keratoacanthomas (Walder and Barr, 1984). These data suggest 
that benign neoplasms may be as common as malignant neoplasms of the nailbed. Subungual 
keratoacanthoma was not mentioned in the study of Marino et al. (1995) probably because 
this tumor was previously diagnosed as well-differentiated subungual squamous cell 
carcinoma (Gross et al., 1992, Yager and Wilcock, 1994). 
In our study, 20 cases out of 91 with digit masses (22 %) were nailbed tumors, represented by 
18 subungual squamous cell carcinomas and two subungual keratoacanthomas. Breed 
predilection of subungual keratoacanthoma is not mentioned by Goldschmidt et al. (1998) or 
Goldschmidt and Hendrick (2002), while Gross et al. (1992) state that no apparent breed 
predilection was found with regard to the affected dogs. However, this group of tumors 
generally shows a clear tendency towards some dog breeds in our results. Subungual 
keratoacanthoma was found only in two Standard schnauzer dogs. 50% of subungual 
squamous cell carcinomas were found in Schnauzer dogs (5 Standard schnauzer, 2 of each 
giant schnauzer and Schnauzer {breed not further specified}), and two cases were found in 
Scotch terrier. 
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The tendency of subungual squamous cell carcinoma to affect Giant schnauzer and Standard 
schnauzer was reported by Bomhard (2001) and Goldschmidt and Hendrick (2002). 
In spite of the small number of the subungual keratoacanthoma in our collection, and because 
of the above results, we consider that all nailbed tumors may have the same breed 
predilection, and the most common skin tumors in Standard schnauzer are nailbed tumors (see 
below). Because of the similarity between subungual keratoacanthoma and subungual 
squamous cell carcinoma and to avoid misdiagnosis, we compare both tumors in view of 
existing literature and of our results in order to facilitate accurate diagnosis (table 40). 
 
Tab. 40: Comparison between keratoacanthoma and well-differentiated squamous cell carcinoma 
Feature Keratoacanthoma well-differentiated squamous cell 
carcinoma 
Basaloid layer in proliferating 
endophytic lobules* 
Yes Variable; often none 
Penetration of basal lamina by 
neoplastic cells** 
No May occur 
Nature of keratotic plug* Often orthokeratotic Often parakeratotic 
Cellular necrosis* Infrequent Often present 
Glassy cytoplasm* Always Variable 
Glycogen content (PAS)*** High and regular Variable and irregular 
Cup-shaped architecture* Usually Variable 
Central keratine core*** Usually No 
Bone lyses*** May occur May occur 
Bone invasion*** No Common 
Single cell invasion of stroma* Only pseudoinvasion at periphery May be present 
Breed predilection**** Standard schnauzer Standard schnauzer, Giant 
schnauzer, Schnauzer (breed not 
further specified), and Scotch 
terrier 
*Murphy (1991), **Goldschmidt and Hendrick (2002), ***Gross et al. (1992), **** Our result 
 
Tumors in Standard schnauzer dogs: 
In our study were included 11 Standard schnauzer dogs with 12 tumors and tumor-like 
lesions, 7 of which were nailbed tumors (58 %), 5 subungual squamous cell carcinomas, two 
subungual keratoacanthomas and one case of papilloma at the paw. The other tumors were 
single cases of hepatoid gland adenoma at the perianal region, meibomian adenoma at the 
eyelid, sebaceous adenoma at the back and apocrine cyst at the chest. Therefore, we report 
that the main location of the tumors in this dog breed is paw (67 %), especially the subungual 
region. There was no possibility to compare our results because we did not find any study 
performed on and limited to the tumors in Standard schnauzer dogs. 
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5.3.4. Cysts (Fig. 6a-6f) 
Epidermal cyst has been classified in both WHO classifications and in our collection was the 
most common cyst in dogs and cats, and it is also named infundibular, epidermoid and 
epidermal inclusion cyst (Goldschmidt et al., 1998). In the old WHO classification, the 
majority of cutaneous cysts were follicular cysts (Weiss and Frese, 1974). Follicular cysts 
could be further categorized by the level of the follicle from which they develop as 
infundibular, isthmus, matrical and panfollicular cysts (Scott et al., 2001). In the above 
classification, infundibular cyst is part of the follicular cysts, while the old WHO 
classification described epidermal and follicular cysts separately, and in the new WHO 
classification, infundibular cyst is classified as epidermal cyst. Therefore, we could consider 
that infundibular cyst constituted a considerable part of both, the old follicular and new 
epidermal cysts. According to the division of follicular cysts by Weiss and Frese, (1974), 
Scott et al. (2001) and according to our understanding, follicular cysts in the new WHO 
classification were divided into infundibular, sebaceous duct, isthmus, panfollicular cysts and 
dialated pore. The infundibular cyst of the new WHO classification also includes epidermal 
cysts, probably because both look identical. 
Subungual epithelial inclusion cyst was reported under the tumors of bones and joints in the 
old WHO classification (Misdorp and Heul, 1976) and was the most common skin cyst type 
of the toe in dogs (63 %) (Frank et al., 1995). Our work showed a similar result with 4 skin 
cysts at toe in dogs, 2 of which were subungual epithelial inclusion cysts, the others werd one 
apocrine cyst and one sebaceous duct cyst. 
Apocrine and dermoid cysts have been classified in both WHO classifications and have been 
reported without any change. 
Generally, according to our results, skin cysts were common in the dog (10%) and occupied 
the third place among the skin tumors and tumor-like lesions after those with adnexal 
differentiation and histiocytic tumors. The most common skin cysts in dogs were infundibular 
(44 %), apocrine (21 %), panfollicular (10%) and sebaceous duct cysts (10%). Isthmus, 
dermoid (5 % each) and subungual epithelial inclusion cysts (2 %) were uncommon cysts. 
Dermoid cyst and follicular cyst were considered to be more common in young animals 
(Bomhard, 2001). In our study, dermoid cyst was present also in young dogs of a mean age of 
4 years. Infundibular, sebaceous duct, isthmus, panfollicular cysts and dialated pore, were 
observed at a mean age of 7 to 11 years, excluding isthmus cyst, which seemed to occur in 
younger dogs at a mean age of 5 years. 
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In cats, skin cysts were also common (1.5 %) but less than in dogs, and the most common cyst 
was infundibular cyst, which represents the only cyst type that was found in our collection (3 
cases). Other cysts such as ciliated cyst and dialated pore were not present in our collection 
and seem to be rare. 
Many other kinds of skin cysts have been reported in animals, especially in dogs and cats, but 
are not presented in the new WHO classification, despite the fact that they were reported in 
the time before the new WHO classification. These cysts were matrical cyst (Gross et al., 
1992), cysts with precarcinomatous epithelial transformation (Frese and Weiss, 1969) and 
branchial cyst (Karbe and Nielsen, 1965, Smith and Gunson, 1977, Clark and Kostolich, 
1989, Hance and Robertson, 1992, France et al., 2000, Scott et al., 2001). These cysts were 
not found in our collection and seem to be rare. 
 
5.3.5. Sebaceous and modified sebaceous tumors 
This group was very common in dogs and less common in cats according to our results as 
well as the literature (Stiglmair-Herb, 1987, Yager and Wilcock, 1994, Goldschmidt and 
Shofer, 1992, Weiss and Teifke, 1999, Scott et al., 2001, Goldschmidt and Hendrick, 2002). 
In the dog, it was found mainly at the head with the exception of hepatoid gland tumors, 
which were found mainly at the perianal region. 
Sex predilection varied between above publications. In our study, these tumors were found 
more frequently in males than females, with exception of meibomian adenoma and 
carcinoma, which occured mostly in females. 
 
Sebaceous ductal adenoma (Fig. 8c-8d) 
Among the 98 sebaceous and modified sebaceous gland tumors in the dogs of our collection, 
no sebaceous ductal adenoma was observed. However, among only 4 sebaceous and modified 
sebaceous gland tumors in cats in our collection, we found two (50%) sebaceous ductal 
adenomas. 
This tumor was newly classified, and the new WHO classification (Goldschmidt et al., 1998) 
is the only source which mentions that this tumor is common in dogs, uncommon in cats and 
rare in other animals. From our results, and in spite of the small sample, we consider that 
sebaceous ductal adenoma in cats is the common sebaceous and modified sebaceous gland 
tumor and is rare in dogs. 
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Epitheliomas (Fig. 8a-8b) 
According to our search, there has been no study that discusses epitheliomas separately from 
the related tumors. Goldschmidt and Hendrick (2002) mentioned that sebaceous and 
meibomian tumors have no sex predilection, but hepatoid gland tumors have a marked sex 
predilection toward males. In our study, we found 12 epitheliomas (5 sebaceous, 5 hepatoid 
gland and two meibomian) in dog, all of them found in male dogs (100%). Epitheliomas 
histologically showed a preponderance of basaloid reserve cells, and may have marked 
mitotic activity, little nuclear atypia with a variable degree of melanization and scattered well-
differentiatd cells (Goldschmidt et al., 1998). This histologic appearance of these basaloid 
cells is similar in many ways to the cells in basal cell tumor and trichoblastoma. With the 
above results for basal cell tumors and trichoblastomas, we consider that these basaloid cells 
are closely related as to their origin, and they have a tendency to occur in males rather than in 
females. 
Canine breeds that are predisposed to the formation of epitheliomas include Newfoundlands 
and huskies (17 % each). 
These tumors are of low grade malignancy in a small proportion of cases, but especially those 
arising from sebaceous gland on the head may show metastasis to the mandibular lymph 
nodes (Goldschmidt and Hendrick, 2002). This metastatic phenomenon was not noticed in our 
cases. 
 
Hepatoid gland angioadenoma and angioepithelioma (Fig. 8e-8f) 
Weiss and Frese (1974) subdivided hepatoid gland adenomas into adenomas with secondary 
vascularization and adenomas with transitional cell forms, which is more common. The 
second has been classified in the new WHO classification as hepatoid gland epithelioma 
according to our comparison of the histological appearances, while the former subtype is not 
mentioned in the new WHO classification. Weiss and Frese (1974) have described those 
hepatoid gland adenomas with vascularization, and mention that they are characterized by 
large glandular areas with small vessels and islands of soft tissue surrounded by reserve cells, 
and they recurred more frequently than others; and this was by comparison with the hepatoid 
gland epithelioma that is described in the new WHO classification as a tumor of low-grade 
malignancy. Goldschmidt and Hendrick (2002) describe that some hepatoid gland adenomas 
showed  extremely  ectatic  vessels  within  the  interlobular  stroma  and  the  term  “secondary 
vascularization” was not used in that publication. 
DISCUSSION 126 
In our study, we found this vascularization phenomenon in 9 out of 44 hepatoid gland 
adenomas (20%) and in 4 out of 5 hepatoid gland epitheliomas (80%), and the sex, age and 
breed division was the same as in the main group. We recommend using the terms hepatoid 
gland angioadenoma and angioepithelioma to define these variants and we suggest more 
research to evaluate their roll in the recurrence of these tumors. 
 
5.3.6. Apocrine and modified apocrine tumors 
These tumors were more common in cats (18 %) than in dogs (3%); the percentages refer to 
all skin tumors and tumor-like lesions in our study. These results did not agree with those 
reported by some authors (Scott et al., 2001, Goldschmidt and Hendrick, 2002), but agreed 
with those mentioned by Goldschmidt and Shofer (1992). Ceruminous gland tumors were 
found only in cats in our study, and most of them were malignant (87.5 %). 
 
Apocrine ductal adenoma and carcinoma 
Apocrine ductal adenoma was named papillary syringadenoma in the old WHO classification 
(Weiss and Frese, 1974). 
Apocrine ductal adenoma and carcinoma are reported separately from the other related 
adenomas and carcinomas by Goldschmidt and Shofer (1992), and Weiss and Frese (1974). 
Eskens (1983) and Bomhard (2001) do not mention these ductal tumors, which might be 
represented under apocrine adenoma and carcinoma. Goldschmidt and Shofer (1992) found 
that apocrine ductal adenoma was the less common apocrine tumor in dogs and cats. 
However, according to our results, apocrine ductal adenoma was a more common apocrine 
tumor in the dog (30%), and occurred commonly on the head (57 %) of females (71 %), while 
there were fewer apocrine adenoma and apocrine carcinoma in the cat, and they occurred 
commonly on the head (75 %) of females (75 %). 
 
5.3.7. Hamartomas (Fig. 7a-7c) 
This is a newly classified group which was not mentioned in the old WHO classification. 
Hamartomas are circumscribed congenital lesions of the skin, characterized by hyperplasia of 
one or more skin components, and are commonly reported in dogs and cats (Scott et al., 
2001). The term Hamartoma rather than the term naevus has been chosen in the new WHO 
classification to describe these lesions, in order to avoid any possible confusion with the 
melanocytic nevi in humans (Goldschmidt et al., 1998). Despite this new nomenclature, some 
authors still used the term nevi (Scott et al., 2001). Hamartomas are subclassified into 
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epidermal (pigmented epidermal naevus), follicular, sebaceous, apocrine and fibroadnexal 
hamartomas (adnexal naevus, focal adnexal dysplasia, folliculosebaceous hamartoma) 
(Goldschmidt et al., 1998). Yager and Wilcock (1994) mention many of these lesions. They 
use the term fibroadnexal dysplasias for fibroadnexal hamartomas, among them the so-called 
giant hair follicle disease or organoid naevus that seems in many ways similar to follicular 
hamartoma of our recommendation. 
13 collagenous hamartomas were diagnosed in our collection and have been discussed also 
under tumors of fibrous tissue (see 5.3.10.). 
According to our results, hamartomas in dogs (epithelial and mesenchymal) amount to 4.2 % 
and represent the ninth most common skin lesion of all skin tumors and tumor-like lesions in 
dogs, with a slight inclination toward females (53 %) and more common at the limbs (52 %). 
The more common hamartomas in dogs were collagenous (38 %), follicular (26 %) and 
fibroadnexal hamartomas (23 %). Sebaceous hamartoma was less common (11 %) and the 
apocrine hamartoma seems to be uncommon. Epidermal hamartoma was not found in our 
collection, and we consider it as rare hamartoma. 
Hamartomas are found in young and old dogs, perhaps because the animal owner overlooked 
them at an early age, or they are not only congenital lesions. 
Hamartomas were less common in cats (1 %) than in dogs (3 %); there were only two 
follicular hamartomas, which seem to be the more common hamartomas in old cats. 
 
5.3.8. Tumor-like lesions (Fig. 3c-3d) 
Not all tumor-like lesions have been included in this group in the new WHO classification, 
and this term covers only some epithelial skin lesions. They are different lesions and the only 
thing they have in common is that they are no tumors. This group took the sixth place among 
the skin tumors and tumor-like lesion in the dog in our collection. 
Sebaceous hyperplasia was the most common tumor-like lesion and represented 2.8 % of all 
skin tumors and tumor-like lesion in the dogs in our collection. This result agreed with the 
result of Goldschmidt and Shofer (1992). However, Eskens (1983) mentioned that sebaceous 
hyperplasia represented about 6 % of all skin tumors and tumor-like lesions. The slight 
inclination to females as mentioned by Goldschmidt and Shofer (1992) was also found in our 
collection (52 %). This inclination contradicted the findings of Weiss and Frese (1974) and 
Madewell and Theilen (1987). Limbs and head were the more common location in our study, 
and aged animals were more affected as has also been reported by other authors (Gross etal., 
1992, Goldschmidt and Shofer, 1992, Scott et al., 2001). 
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Sebaceous hyperplasia was the only tumor-like lesion found in the cats of our collection, 
which may be due to the small number of cats in our study. 
Fibropruritic nodule was the second most common tumor-like lesion in the dogs of our 
collection, and it seems to be more common in male dogs (64 %), with no clear breed 
predilection. Limbs and back were the more common location of this lesion. All cases found 
at the limbs (40%) are by preference named acral lick granulomas as described by 
Goldschmidt et al. (1998). However, the presence of the lesion at the back (30%) raises 
questions as to the cause for the arising and development of the lesion. 
Fibroepithelial polyp (Weiss, 1974) was a common lesion in dogs in our collection; it was 
named cutaneous fibrous polyp in the old WHO classification, where it was classified as 
mesenchymal lesion. It has been classified under epithelial lesion in the new WHO 
classification (Goldschmidt et al., 1998), probably, because of the exophytic appearance of 
the lesion and the share of the hyperplastic epidermis. This lesion seems to be one of old 
dogs, more common in females (75 %) and found mostly at the limbs and back according to 
our results. 
Squamous papilloma was also a common lesion in the dogs in our collection, which was seen 
in animals of different ages, but more commonly in young dogs. It is found more commonly 
on the limbs and the head with no marked breed predilection. This lesion is distinguished 
from a viral papilloma by many histological differences as shown in table 1 (see 2.5.1.7.1.) 
and figures 3a-3d (see 8.3.3). 
Pressure point comedone was an uncommon lesion in the dog in our collection (a single case). 
This lesion showed similarity to skin cysts, and we did not see any reason to classify it under 
tumor-like lesions rather than under skin cysts. 
Cutaneous horn and warty dyskeratoma were not found in our collection and seem to be rare 
lesions in dogs and cats. 
 
5.3.9. Melanocytic tumors and tumor-like lesions 
This group with 5.3 % of the tumor and tumor-like lesion groups in dogs took the eighth place 
in our study, but with 1.5 % it was uncommon in cats; the head was the most common 
location in both species. Older dogs had more malignant melanomas than younger dogs, and it 
was vice versa with regard to melanocytomas. Melanocytomas inclined toward males (60%) 
rather than toward females, while malignant melanomas inclined to females (55 %) rather 
than males, with no clear breed predilection. 
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Subungual malignant melanoma is a relatively common digital neoplasm in the dog 
(Goldschmidt et al., 1998). It was present in 7 cases, i.e. about 32 % of all malignant skin 
melanomas in the dogs in our study. However, the cases of subungual malignant melanoma 
represented 87.5 % of all subungual melanomas, while melanocytoma (benign melanoma) 
was present in only one case, which is 12.5 % of all subungual melanomas. 
Melanoacanthoma was not found in our collection. The tumor synonymes are not mentioned 
in the new WHO classification. In order to perform literature research, synonymes like 
melanocytoma-acanthoma were needed, because this tumor was published only under this 
synonyme (Gross et al., 1992, Espinosa et al., 2000). We therefore recommend stating all the 
synonymes, as far as possible, behind the respective tumors to facilitate search with regard to 
these tumors. 
Naevus has only been described as a human lesion and is not classified as a skin lesion of 
animals in the new WHO classifications. The term naevus is defined as a birthmark 
(Goldschmidt et al., 1998), and it is commonly used for describing pigmented melanocytic 
lesions of the epidermis and dermis in humans and is not used in veterinary dermatopathology 
(Smith et al., 2002). The old WHO classification described comparable conditions, which 
seemed to exist only in dogs and pigs (Weiss and Frese, 1974). Many pigmented skin lesions 
of dogs were comparable to a certain degree with human naevus. Among these, canine 
melanocytomas with junctional activity resemble the human compound naevus, some of the 
canine dermal melanocytomas resemble the blue naevus and canine epidermal 
hyperpigmentation (melanocytic hyperplasia) resembles naevus spili. Conditions comparable 
to the human junction naevus were not reported (Kraft and Frese, 1976b). This term (naevus) 
has not been accepted in the new WHO classification. However, melanocytic hyperplasia is 
mentioned as a newly classified skin lesion under the melanocytic tumors. It was first 
described in dogs by Kraft and Frese (1976a), and has been reported in orange and silver 
shorthair cats (Nash and Paulsen, 1990, Nesbitt, 1998, Scott et al., 2001). In an investigation 
of the necropsy of 594 dogs carried out by Kraft and Frese (1976b), 52 dogs had 244 lesions 
of circumscribed epidermal hyperpigmentation, and in 26 dogs 43 lesions of a lentigo-like 
proliferation of teat epithelium were recorded. These results did not agree with our results 
because no melanocytic-like lesions were found in dogs and cats in our collection, and the 
reason might be that these lesions looked harmless and were not operated. Therefore they are 
considered to be rare in the biopsy work and may be more common in the necropsy work if 
they are more often taken into consideration. 
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5.3.10. Tumors of fibrous tissue 
This group was the most common in cats with 40.0% and less common in dogs with 7.5 % of 
all the skin tumors and tumor-like lesions in our study. Malignant tumors were fibrosarcoma 
and myxosarcoma, which were present in both animals. However, they were more dominant 
in cats and represented 99 %, while in dogs they represented 60% of all fibrous tumors in our 
study. Fibrosarcoma was the most common skin tumor in cats in our study as well as in most 
of the literature (Stiglmair-Herb, 1987, Jorger, 1988, Goldschmidt and Shofer, 1992, 
Goldschmidt and Hendrick, 2002). However, it was less common than basal cell tumor, mast 
cell tumor and squamous cell carcinoma in another study (Miller et al., 1991). In the above 
publications, the prevalence of this tumor varied between 14.7 % and 43.9 %, and our 
prevalence was 37.6 %. This variation in the prevalence may be related to the differences in 
the vaccination programs implemented at the times and the places of these studies. In our 
study, the back was the most common location of feline fibrosarcomas followed by limbs and 
chest. Head and extrimities were the most common locations as reported by Goldschmidt and 
Hendrick (2002) while trunk and extrimities are mentioned by Gross et al. (1992). 
Fibromas have been mentioned as uncommon lesions in dogs and cats (Gross et al., 1992, 
Scott et al., 2001), however, they were most often seen in the dog in our study and also by 
Goldschmidt and Hendrick (2002). They have been reported in the cat (Gross et al., 1992, 
Scott et al., 2001, Goldschmidt and Hendrick, 2002), but some investigators believe that 
feline tumors that have the histological appearance of fibromas are actually well differentiated 
fibrosarcomas (Goldschmidt and Shofer, 1992). We therefore consider that this may be the 
reason for the absence of fibroma in cats in our results. 
Myxomas and myxosarcomas were rare and observed in middle-aged or older dogs and cats 
(Goldschmidt and Shofer, 1992, Gross et al., 1992, Goldschmidt and Hendrick, 2002). 
Myxomas in dogs and cats were rarely reported (Marolt et al., 1973, Machida et al., 2003) and 
in our study we found only a single case each in a dog and a cat. One other case in a dog 
showed empty areas, and was immunohistologically positive for vimentin and factor VIII-
related antigen. We therefore prefer to classify this case as an atypical myxoma or 
angiomyxoma. However, myxosarcomas, which we found in 5 dogs and 4 cats, seem to be 
more common than myxomas. 
We diagnosed 13 skin lesions as collagenous hamartomas according to the new WHO 
classification. Some investigators (Goldschmidt and Shofer, 1992) suggest that the term 
fibroma should be used rather than collagenous hamartoma, as it conforms to the standardized 
nomenclature of soft tissue tumors in domestic animals published in the old WHO 
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classfication. Location, size, pattern cellularity and growth form were used to reach an 
accurate diagnosis (Gross et al., 1992, Wilcock and Yager, 1994) as in table 2 (see 
2.5.2.1.1.2.) and figures 9a-9e (see 8.3.9.). These lesions were discussed above under 
hamartomas. 
Feline sarcoid is a newly reported rare neoplasm (Rest et al., 1997, Gumbrell et al., 1998, 
Schulman et al., 2001, Scott et al., 2001, Hanna and Dunn, 2003, Teifke et al., 2003) whose 
histological appearance resembles the equine sarcoid (Scott et al., 2001). Feline sarcoid was 
recently reported and is not found in either WHO classification; it was not observed in our 
collection. 
The newly classified malignant fibrous histiocytoma (Hendrick et al., 1998) as well as its 
benign variant in dogs (Scott et al., 2001) were not observed in our collection and considered 
to be rare. 
However, malignant fibrous histiocytoma in the cat is one histologic variant of postvaccinal 
sarcomas (Hendrick et al., 1998). Malignant fibrous histiocytoma and fibrosarcomas made up 
the majority of the postvaccinal sarcomas. Histologically, there was much overlap between 
fibrosarcomas with giant cells and malignant fibrous histiocytoma (Hendrick and Brooks, 
1994), therefore, all these tumors were classified as fibrosarcomas in our study. 
 
5.3.11. Tumors of adipose tissue  
Lipoma in dogs was found more commonly in females in our collection (63 %) as well as in 
some publications (Goldschmidt and Shofer, 1992, Bomhard, 2001), in contrast to the results 
of Frese (1960). In our collection, no clear breed predilection was noticed and the affected 
dogs were of middle and older ages. Chest was the most common place followed by limbs 
and abdomen. 
In our study, lipoma in cats was found more commonly in males (60%) and this was in 
agreement with the result of Goldschmidt and Shofer (1992). Limbs and back were the most 
common location and the affected cats were of middle and older ages. 
The infiltrative lipoma is a newly added variant (McChesney et al. 1980, Bergman et al., 
1994, Hendrick et al., 1998) that is uncommon in dogs and rare in cats (Gross et al., 1992). In 
our study, two cases were found in dogs, and none was found in cats. 
Liposarcomas, its well-differentiated, pleomorphic and myxoid variants (Weiss, 1974, 
Messick and Radin, 1989, Hendrick et al., 1998), the newly classified angiolipoma (Hendrick 
et al., 1998, Liggett et al., 2002) and the other lipomas, which are not mentioned in the new 
WHO classification but were reported as myxoid lipoma (Weiss, 1974), fibrolipoma (Gross et 
DISCUSSION 132 
al., 1992), chondrolipoma (Goldschmidt and Shofer, 1992), intermuscular lipomas (Thomson 
et al., 1999), and pigmented lipoma (Scott et al., 2001) were not found in our collection and 
considerd to be rare. 
 
5.3.12. Tumors of muscle 
Tumors of muscle include leiomyoma, leiomyosarcoma, rhabdomyoma and 
rhabdomyosarcoma (Weiss, 1974, Hendrick et al., 1998). Other variants, as fibroleiomyoma 
(Hendrick et al., 1998, Liu and Mikaelian, 2003), angioleiomyoma, angioleiomyosarcoma 
(Liu and Mikaelian, 2003) and embryonal rhabdomyosarcoma of the urinary bladder or 
botryoid sarcoma or sarcoma botryoides (Kuwamura et al., 1998, Takiguchi et al., 2002) were 
also reported. However, cutaneous tumors of smooth and striated muscles are extremely rare 
in dogs and cats in the veterinary literature (Roth, 1990, Goldschmidt and Shofer, 1992, Scott 
et al., 2001, Goldschmidt and Hendrick, 2002). In our collection, only one case of 
leiomyosarcoma was found at neck of 11-years-old male Cocker spaniel dog, and it was 
verified immunohistologically by demonstration of vimentin and smooth muscle actin. 
 
5.3.13. Tumors of vascular tissue 
Tumors of vascular tissue included hemangioma, lymphangioma, hemangiosarcoma, 
lymphangiosarcoma and scrotal vascular hamartoma (Weiss, 1974, Hendrick et al., 1998). 
Other lesions, as Kaposi-like vascular tumor, angiokeratoma, epithelioid 
haemangioendothelioma and a lesion that was similar to cutaneous bovine angiomatosis have 
also been reported in dogs (Yager and Wilcock, 1994, Hendrick et al., 1998, Machida et al., 
1998, Vala and Esteves, 2001, Goldschmidt and Hendrick, 2002, Vincek et al., 2004, Kim et 
al., 2005). In our results, hemangioma and hemangiosarcomas showed breed predilection for 
German shepherd dogs (31 %) and showed higher prevalence in male (63 %) than female in 
this breed compared to other breeds.  
We have not found any study that describes and discusses the sex and breed predilection of 
cutaneous hemangioma and hemangiosarcomas of the skin for the German shepherd dog. 
However, such predilection is mentioned by other authors for these tumors when occurring in 
internal organs (Appleby, 1991, Goldschmidt and Hendrick, 2002). 
One case of feline ventral abdominal angiosarcoma was found in our collection. Instead of the 
term feline ventral abdominal angiosarcoma, we prefer to use the term feline ventral 
abdominal lymphangiosarcoma, because this origin of the tumor was confirmed by Swayne et 
al. (1989) and Galeotti et al. (2004). However, this tumor seems to be uncommon in the cats, 
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while Kaposi-like vascular tumor, lymphangioma, angiokeratoma, epithelioid haemangio-
endothelioma, scrotal vascular hamartoma and cutaneous angiomatosis were not found in our 
study and seem to be rare in both dogs and cats. 
 
5.3.14. Tumors of peripheral nerves, synovium and mesothelium 
In dogs, malignant peripheral nerve sheath tumor and hemangiopericytomas have very similar 
histomorphologic features, and because of this similarity, the true prevalence of this tumor 
was unknown (Goldschmidt and Hendrick, 2002). In our study, we diagnosed two cases of 
malignant nerve sheath tumor in male dogs. From the immunohistological results as in table 
23 (see 4.1.8.15.), hemangiopericytoma and leiomyosarcoma could be not excluded in these 
cases if compared with that mentioned by Chijiwa et al. (2004), who reported additionally that 
the positivity with nerve growth factor receptor and the negativity with α-smooth muscle actin 
might be helpful for differentiating canine peripheral nerve sheath tumors from other 
sarcomas including rhabdomyosarcomas and canine hemangiopricytomas. However nerve 
growth factor receptor was not demonstrated in our work, but the presence of the nerve 
remnant in one case and the similarity of the histological appearance in both cases with that 
mentioned in the literature, i.e., the arrangement of the cells in small interwoven bundles 
(Hendrick et al., 1998, Goldschmidt and Hendrick, 2002) and the presence of spindle-shaped 
cells that exhibit nuclear palisading (Scott et al., 2001), combined with the expression of some 
immunohistological stains, especially GFAP and NSE, were enough to arrive at our diagnoses 
(Fig. 10a-10f). However, all hemangiopericytomas in our study were diagnosed only 
histologically because they appeared more typical to those reported in the literature (Hendrick 
et al., 1998, Goldschmidt and Hendrick, 2002). According to our results, tumors of peripheral 
nerves seem to be uncommon in dogs. 
 
According to the new WHO classification, the tumors of synovium consisted of synovial 
sarcoma only. Primary tumors of synovium are uncommon in the dog; however, synovial 
sarcomas occur most frequently in the stifle joint (Harasen, 2002) and appear to be more 
common in males than females (Pool and Thompson, 2002). In a recent study by Craig et al. 
(2002), more than 51 % of the intra-articular tumors were histiocytic sarcomas, while only 14 
% were recognized as synovial cell sarcomas. In addition, the authors hypothesized that intra-
articular histiocytic sarcoma arises from the dendritic cells found within the inflamed 
synovium associated with degenerative joint disease (Craig et al., 2002). However, two 
synovial sarcomas were found in two male dogs in our study, which supports the inclination 
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to male dogs that is mentioned by Pool and Thompson (2002) and were found in knee joint 
and toe and not in the stifle joint. According to our results, tumors of synovium seem to be 
uncommon in dogs. 
 
In cats, malignant peripheral nerve sheath tumor has been rarely reported (Summers et al., 
1995), and there is very little information about synovial tumors in cats in the literature 
(Silva-Krott et al., 1993, Pool and Thompson, 2002), however, Silva-Krott et al. (1993) state 
that most reported synovial cell tumors in cats were benign, and they report one case of 
synovial sarcoma at the cubital joint of a 9 year old male shorthair cat. In our study we 
observed no case of peripheral nerves and synovium tumors and therefore, they seem to be 
rare in cats. 
 
Tumors of mesothelium are classified under many organs in the new WHO classification, in 
skin and soft tissues (Hendrick et al., 1998), alimentary (Head et al., 2003), and respiratory 
system (Dungworth et al., 1999). Mesothelioma is the only tumor that has been mentioned in 
this group (Hendrick et al., 1998). It has been reported in dogs and cats (Head et al., 2002). 
However, no case of mesothelioma was found in dogs and cats in our collection, therefore, it 
seems to be rare in both, dogs and cats. 
 
Granular cell tumor: 
Granular cell tumor has been reported in dogs and cats (Patnaik, 1993) and is mentioned 
under tumors of peripheral nerves in the new WHO classification, because it has a 
presumptive Schwann cell origin (Hendrick et al., 1998). Some other authors mention this 
tumor as a neoplasm of uncertain origin (Cooper and Valentine, 2002). In our study we 
observed not any case of granular cell tumor and therefore, it seems to be rare in both dogs 
and cats. 
 
5.3.15. Mast cell tumors 
Canine mast cell tumor was the most common mesenchymal cutaneous neoplasm of dogs in 
the old WHO classification, while histiocytoma is the most common canine skin tumor in the 
new WHO classification (Weiss, 1974, Hendrick et al., 1998). In our study, canine mast cell 
tumor was placed in the second place with 6.9 % of all the skin tumors and tumor-like lesions 
after canine cutaneous histiocytoma. It is a malignant tumor and its biological behavior 
correlates with the histological grade (Hendrick et al., 1998, Goldschmidt and Hendrick, 
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2002). In our collection, we observed a gradual reduction in the percentages from grade I to 
grade III, which were 45, 39, and 16 % of grade I, II and III respectively. Most tumors 
occurred in middle-aged dogs and had no sex predilection. Boxer was the most common 
breed in our collection as well as in the literature (Madewell and Theilen, 1987, Goldschmidt 
and Shofer, 1992, Yager and Wilcock, 1994, Scott et al., 2001).  
In our study as well as in studies by other authors (Madewell and Theilen, 1987, Goldschmidt 
and Shofer, 1992, Goldschmidt and Hendrick, 2002), feline mast cell tumors are less common 
than in dogs. This tumor was represented in the tenth place with 3 % of all skin tumors and 
tumor-like lesions in cats in our collection. No sex predilection was found, and two out of 6 
cases were found in Persian cats in our collection. However, Scott et al. (2001) and 
Goldschmidt and Hendrick (2002) mentioned that Siamese cats had a higher risk of 
developing mast cell tumors. 
Feline mast cell tumor is mostly a benign tumor (Hendrick et al., 1998) and the prevalence of 
behaviourally malignant tumors was reported in about 2 % of the cases (Wilcock et al., 1986, 
Miller et al., 1991). Many cats with mast cell tumors will develop additional tumors, which do 
not occur at the site of previous surgery, but at sites distant from the primary tumor 
(Goldschmidt and Shofer, 1992). Mitotic activity seems to be the most effective prognostic 
tool for feline cutaneous mast cell tumor (Johnson et al., 2002, Lepri et al., 2003), and 
therefore we used only the mitotic activity to determine the malignancy of mast cell tumors in 
the cat histologically. We found only one case (almost 17 %) out of 6 cutaneous feline mast 
cell tumors that showed a high mitotic rate (3 to 5 per high power field of 40X), and one cat 
with a benign mast cell tumor showed additionally a lipoma. 
Feline histiocytic mast cell tumor variant (Hendrick et al., 1998) and the newly reported 
pleomorphic cutaneous mast cell tumor (Johnson et al., 2002) were not found in our collection 
and seem to be rare variants. 
 
5.3.16. Histiocytic tumors 
In our collection, these tumors were found commonly in dogs and no case was found in cats. 
Generally, histiocytic tumors are mainly canine tumors as is shown in most of the literature 
(Eskens, 1983, Goldschmidt and Shofer, 1992, Gross et al., 1992, Yager and Wilcock, 1994, 
Hendrick et al., 1998, Bomhard, 2001, Goldschmidt and Hendrick, 2002), however, few cases 
were reported in other animals such as cat, horse and cattle (Sutton and McLennan, 1987, 
Gafner and Bestetti, 1988, Court et al., 1993, Lester et al., 1993, Walton et al., 1997). Three 
cases of malignant histiocytomas were reported in cats. They represented 0.21 % of all the 
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feline skin tumors reported by Bomhard (2001) as in table 43 (see 8.1.), and we think that the 
author has used the term malignant histiocytoma as a synonyme of malignant histiocytosis. 
Canine cutaneous histiocytoma, which is named benign round cell sarcoma by Frese (1960) 
(Weiss and Frese, 1974), was the most common skin tumor type in most of the literature 
(Eskens, 1983, Goldschmidt and Shofer, 1992, Gross et al., 1992, Yager and Wilcock, 1994, 
Hendrick et al., 1998, Bomhard, 2001, Goldschmidt and Hendrick, 2002), with a standardised 
incidence rate of 337 per 100,000 dogs per year (Dobson et al., 2002). It was also the most 
common skin tumor in our study with 16.2 % of all skin tumors and tumor-like lesions. They 
were found to be more common on the head, with an inclination to male dogs (67 %) and with 
breed predilection for Dobermann, Boxer and Golden retriever, which is also mentioned by 
Goldschmidt and Hendrick (2002). Only three cases of cutaneous histiocytosis were found in 
male dogs in our collection and therefore it seems to be uncommon, while xanthoma and 
systemic histiocytosis were not found and seem to be rare. 
Terminologically, malignant histiocytosis, a newly classified tumor, was not found in the old 
WHO classification (Weiss, 1974, Hendrick et al., 1998).  Scott et al. (1979) reported one 
case of lymphoreticular neoplasia in a dog resembling malignant histiocytosis in humans and 
described this tumor similar to that found in the old WHO classification as histiocytic 
lymphosarcoma (Jarrett and Mackey, 1974). This tumor, which is mentioned in the old WHO 
classification, had unknown origin and was classified under lymphosarcoma only due to the 
anatomical distribution, which was similar to lymphosarcoma. These tumors, according to 
Scott et al. (1979) and Jarrett and Mackey (1974), in many ways resemble the malignant 
histiocytosis that is found in the new WHO classification. However, the multinucleated cells 
that are often present in large numbers, as is mentioned in the new WHO classification, are 
not described. Multinucleated large cells have been mentioned in many studies (Moore and 
Rosin, 1986, Hayden, 1993, Ramsey et al., 1996), but only the presence of binucleated cells 
was mentioned by Jarrett and Mackey (1974) and Scott et al (1979). We consider that 
malignant histiocytosis was the same tumor that was mentioned in the old WHO classification 
as histiocytic lymphosarcoma. However, in our study, all 4 cases were found in middle-aged 
Bernese mountain dogs (6 to 8 years), three females and one male. Three were located at 
limbs and one at the chest. This tumor seems to be uncommon and constitutes about 0.5 % of 
all skin tumors and tumor-like lesions in the dog. However, it was found in 16 % of all 
Bernese mountain dogs that occurred in our collection. 
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5.3.17. Calcinosis circumscripta 
Generally, calcinosis circumscripta is more common in the skin than in other locations such 
as the oral cavity and intestine (Tafti et al., 2005). It was described by some authors only in 
dogs (Weiss, 1974, Hendrick et al., 1998) and by others also in cats (Scott et al., 2001, Head 
et al, 2002). 
In our collection, we found this tumor in 13 dogs with 1.6 % of the all skin tumors and tumor-
like lesions; therefore, this lesion seems to be common in dogs and rare in cats. The ages of 
dogs ranged from one to 6 years, and the majority (67 %) were under two years of age, and 
this was in agreement with Gross et al. (1992). Most of the affected dogs were German 
shepherd and Rottweiler dogs in our collection and also in that of Tafti et al. (2005). 
 
Multicentric periarticular calcinosis: 
Calcinosis circumscripta is described as an identical lesion to tumoral calcinosis in humans in 
the new WHO classification. This was not accepted by Pool and Thompson (2002), who 
preferred to use the term multicentric periarticular calcinosis in animal for a lesion which 
seems to be like tumoral calcinosis in humans. Periarticular location distinguishes 
multicentric periarticular calcinosis from calcinosis circumscripta (Pool and Thompson, 
2002). Therefore only three lesions (23 %) out of 13 cases of calcinosis circumscripta in our 
collection should be regarded as multicentric periarticular calcinosis. These cases were 
located on two elbows and one tarsal joint of young dogs less than 2-years-old. 
 
5.3.18. Hemangiopericytoma 
In the new WHO classification, this tumor is still brought  under  “unclassified tumors” 
(Hendrick et al., 1998) in spite of the ultrastructural and immunohistochemical confirmation 
of its pericytic origin (Xu, 1986, Perez, 1996, Mazzei et al., 2002). According to this evidence 
and the histological appearance of this tumor, we recommend classifying it under vascular 
tumors. 
Hemangiopericytoma in animal occurs mainly in the skin of dogs (Goldschmidt and 
Hendrick, 2002, Mazzei et al., 2002), however, some primary noncutaneous lesions as spleen 
(Mazzei et al., 2002) and liver (Cullen and Popp, 2002) have been reported. Predilection for 
location on the limbs was observed in our study and also by Gross et al. (1992), Goldschmidt 
and Hendrick (2002) and Mazzei et al. (2002); this refers to almost 74 % of all 
hemangiopericytomas in our study. This tumor was common in dogs with 2.3 % of all skin 
tumors and tumor-like lesions in our study, and had no clear sex or breed predilection. 
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5.4. Classification problems of some skin lesions according to the new WHO 
classification 
Altogether, 37 of the skin lesions found in our collection, 25 in dogs and 12 in cats, were 
excluded because we followed the new WHO classification. In dogs, these were 8 
lymphosarcomas, 5 extramedullary plasmocytomas, 4 which could not be classified, three 
meibomian gland hyperplasias, two chondrosarcomas, one osteosarcoma, one hepatoid gland 
hyperplasia and one anal sac gland hyperplasia. 
In cats, these were 4 extramedullary plasmocytomas, 4 lymphosarcomas, three which could 
not be classified and one meibomian gland hyperplasia. 
Lymphosarcomas and extramedullary plasmocytomas have been classified under 
hematopoietic tumors (Valli et al., 2002), chondrosarcomas and osteosarcomas under bone 
and joint tumors (Slayter et al., 1994). Moreover, hepatoid gland hyperplasias have been 
classified under tumors of the alimentary system (Head et al., 2003), while the tumors that 
could not be classified, meibomian gland hyperplasias and anal sac gland hyperplasias are not 
found in the new WHO classification. 
 
5.5. Other skin tumors that are not found in the new WHO classification 
The new WHO classifications of the skin and soft tissue tumors in domestic animals were 
published in 1998. In the period of 8 years since then, many new skin tumors and tumor 
variants have been described in animals. For example, feline sarcoid (Scott et al., 2001, 
Schulman et al., 2001, Teifke et al., 2003) has also been reported frequently as a cutaneous 
fibropapilloma in the cat (Gumbrell et al., 1998, Schulman et al., 2001, Hanna and Dunn, 
2003). In addition, pigmented cutaneous papillomatosis or pigmented epidermal hamartomas 
have been reported (Tanabe et al., 2000, Narama et al., 2005). Another variant of squamous 
cell carcionoma has been described as signet-ring squamous cell carcinoma (Espinosa et al., 
2003) and histiocytic sarcoma has been classified by some authors (Scott et al., 2001, Affolter 
and Moore, 2002). Furthermor a benign variant of malignant fibrous histiocytoma has been 
described in dogs and cats (Scott et al., 2001) and cutaneous histiocytosis has also been 
reported (Affolter and Moore, 2000). Arrector pili hamartoma, angioleiomyoma and 
angioleiomyosarcoma have recently been reported in dogs and cats (Liu and Mikaelian, 
2003). Another variant of mast cell tumor named pleomorphic cutaneous mast cell tumor has 
been newly reported in the cat (Johnson et al., 2002). Cutaneous canine angiomatosis that is 
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similar to cutaneous bovine angiomatosis has been recently reported (Kim et al., 2005). The 
clear cell trichoblastoma and cystic trichoblastoma are newly mentioned variants in our study. 
Some other variants mentioned by other authors or found in the old WHO classification are 
not mentioned in the new WHO classification, such as many variants of lipomas, namely, 
myxoid lipoma (Weiss, 1974), fibrolipoma (Gross et al., 1992), chondrolipoma (Goldschmidt 
and Shofer, 1992), intermuscular (Thomson et al., 1999) and pigmented lipomas (Scott et al., 
2001), and angiokeratoma (Yager and Wilcock, 1994, Vala and Esteves, 2001).  
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6. SUMMARY  
 
A new or second edition of the international histological classification of skin, melanocytic 
and soft tissue tumors of domestic animals was published in 1998 with new entities and some 
new nomenclatures. For the period since then, we have not found a statistical study that 
discusses all these tumors in relation to the new WHO classification. Therefore, it has been 
the aim of this study to apply the new WHO classification in the epidemiology of the skin 
tumor entity. 
 
A statistical analysis of canine and feline skin tumors and tumor-like lesions was carried out 
using the diagnostic material of the Institute for Veterinary Pathology, Justus-Liebig-
Universitaet Giessen, Germany. These comprised 816 skin tumors and tumor-like lesions in 
768 dogs, and 197 skin tumors and tumor-like lesions in 194 cats. These lesions were 
classified according to the recommended WHO nomenclature and classification of tumors in 
domestic animals. Evaluation of the distribution of breed, age, sex, location and the tumor 
types was done in comparison with the prevalence of the same tumor in the literature. 
 
More than 25 % of the dogs in our collection were Mongrels, and the five most common 
breeds that were found in our collection were German shepherd dog, Boxer, Golden retriever, 
Westhighland white terrier and Cocker spaniel. 
The number of breeds in cats was less than in dogs, and the most common breed was Mongrel 
cats. The mean age of the skin tumor carriers in our collection was 7.5 years in dogs and 10.6 
years in cats. The dominant skin tumor origin was epithelial with 49.3 %, while tumors of 
mesenchymal origin were 45.3 % and of melanocytic origin 5.3 % of all skin tumors and 
tumor-like lesion in dogs. In cats, the mesnchymal tumors were always the dominant group 
with 54.0%, followed by the epithelial tumors with 40.5 % and the melanocytic tumors with 
1.5 % of all skin tumors and tumor-like lesions. The general sex distribution in dogs was 56.4 
% male and 43.6 % female, while it was 55.5 % males and 44.5 % females in cats. The most 
common locations of the skin tumors and tumor-like lesions were limbs and head in both, 
dogs and cats. 
 
In our collection, 62 tumor types were found in the dog. The 10 most common skin tumors 
and tumor-like lesions in dogs were canine cutaneous histiocytoma, mast cell tumor, lipoma, 
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hepatoid gland adenoma, infundibular cyst, fibrosarcoma, sebaceous hyperplasia, malignant 
melanoma, trichoepithelioma and melanocytomas, consecutively. 31 tumor types were found 
in the cat. The 10 most common skin tumors and tumor-like lesions in cats were 
fibrosarcoma, squamous cell carcinoma, apocrine adenoma, basal cell tumor, lipoma, 
trichoblastoma, ceruminous gland carcinoma, hemangiosarcoma, apocrine carcinoma and 
feline mast cell tumor, in this order. 
 
In our study, we have described for the first time the clear cell and cystic variants of 
trichoblastoma and reported the immunohistological expression of the canine granular cell 
trichoblastoma, which so far had been reported neither in the literature nor in the WHO 
classifications. 
We have discussed some other tumors and tumor-like lesions that are found in the literature 
and have not been classified in the new WHO classification. 
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8. APPENDIX 
 
8.1. Tables 
 
Tab. 41: Prevalence of skin tumors and tumor-like lesions in dogs by different authors 
Tumor Frese (1960) 
(n=389)(%) 
Eskens (1983) 
(n=4507)(%) 
Goldschmidt and 
Shofer (1992)(%) 
Bomhard (2001) 
(n=47008)(%) 
Basal cell tumor 2 5.84  3.7 5.9 
Basal cell carcinoma      0.3 0.01 
Basosquamous carcinoma     0.3   
Papilloma 2.75 0.09  0.3 1.41 
Squamous cell papilloma   0.62     
Fibropapilloma   0.51     
Squamous cell carcinoma 7.25 2.31  1.7 2.97 
Sebaceous adenoma  4.25 4.66  4.1 7.29 
Sebaceous carcinoma   0.27  0.7 0.11 
Hepatoid gland adenoma 17.75 9.19  9.2 5.91 
Hepatoid gland carcinoma   2.24  0.3 0.15 
Meibomian gland adenoma     3.1   
Meibomian gland carcinoma     0.3   
Apocrine adenoma, (Syringoma)*, (papillary 
apocrine adenoma)**, (Hidradenoma)**** 
0.25 0.31  1.7 1.36 
Apocrine ductal adenoma     0.3   
Cystadenoma   0.22     
Spiradenoma   0.13     
Apocrine mixed tumor**   0.29     
Fibrocystadenoma  0.25       
Fibroadenoma papilliform 0.5       
Adenoma 2       
Apocrine carcinoma (papillary)**   0.44  0.7 0.06 
Apocrine carcinoma (tubular)**   0.27     
Apocrine carcinoma (solid)**   0.44     
Apocrine malignant mixed tumor**   0.18     
Carcinoma 3.5       
Adenocarcinoma 3       
Ceruminal gland adenoma   0.22  0.3 0.03 
Ceruminal gland mixed tumor   0.02     
Ceruminal gland carcinoma   0.27  0.3 0.1 
Anal sac gland carcinoma     0.7 0.46 
Trichoepithelioma   3.17  4.1 2.6 
Epithelioma Malherbe 0.5 1.66  1.0 3.98 
Unclassified epithelioma   0.09     
Intracutaneous cornifying epithelioma 1.5 1.91  1.7 2.25 
Benign melanoma 5.5 4.19  3.2 4.12 
Malignant melanoma 5.5 1.18  0.8 1.94 
Fibroma 4 1.26  1.9 1.82 
Fibromyxoma   0.09     
Myxoma (Myxomatous tumors)*** 0.25    0.5   
Myxolipoma   0.02     
Hemangiopericytoma     6.8   
Fibrosarcoma 3.75 5.19  1.5 7.9 
Fibromyxosarcoma   0.11     
Lipoma 2.5 3.08  7.8 6.22 
Liposarcoma 0.25 0.24  0.5 0.21 
Hemangioma 3.75 2.95  4.4 3.09 
Perithelioma  0.25       
Lymphangioma  0.25 0.02  0.5   
Hemangiosarcoma (Angiosarcoma)*  0.25 0.75  1.0 1.29 
Leiomyoma (Myoma)* 0.25 0.09   0.14 
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Continue tab. 41 
Tumor Frese (1960) 
(n=389)(%) 
Eskens (1983) 
(n=4507)(%) 
Goldschmidt and 
Shofer (1992)(%) 
Bomhard (2001) 
(n=47008)(%) 
Leiomyosarcoma       0.01 
Neurofibroma       0.1 
Neurofibrosarcoma       0,02 
Neural tumors     0.5   
Mast cell tumor(not metastatic)** 6.5 10.12  9.7 7.99 
Metastatic mast cell tumor   0.16     
Malignant lymphoma 0.25 0.24  1.0 0.52 
Retothel sarcoma 0.25       
Mycosis fungoides       0.24 
Extramedullary plasmocytoma      1.5 1.37 
Histicytoma (benign round cell sarcoma)* 7.25 11.54  11.7 16.43 
Malignant histiocytoma       0.07 
Reticulosarcoma   0.22     
Osteochondroma   0.04     
Chondroma   0.04     
Fibrochondroma   0.02     
Osteosarcoma       0.39 
Osteochondrosarcoma   0.02     
Sarcoma  2.5 0.09     
Large cell sarcoma 1.25    0.5   
Round cell sarcoma 2.5       
Polymorph cell sarcoma 2.75       
Spindle cell sarcoma 3       
Unclassified tumors   0.62     
Ceruminal gland hyperplasia   0.13  0.1   
 (Ceruminal cyst/hyperplasia)***         
Sebaceous gland hyperplasia   5.99  2.5   
Meibomian gland hyperplasia     0.1   
Hepatoid gland hyperplasia   0.82     
Epidermoid cyst      2.3 3.85 
Dermoid cyst       0.15 
Follicle cyst   7.06  1.4 0.91 
Apocrine cyste      0.9 0.49 
Sweat gland hyperplasia   0.09     
Cutanous fibrous polyp   5.72     
Collagenous naevus       1.76 
Adnexal naevus (Organoid naevus)****     2.7  5.12 
Skin tag     1   
Calcinosis cutis   1.18     
Keloid   0.09     
Other cysts   1.26     
Others     0.5   
*Frese (1960), ** Eskens (1983), *** Goldschmidt and Shofer (1992), **** Bomhard (2001) 
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Tab. 42: Sex distribution in dogs by different authors 
Dog/ Litrature Frese, 1960, n=346 Goldschmidt, 1992 Bomhard, 2001 
Tumor/ Sex ♂ ♀ ♂ ♀ ♂ ♀ 
  % n % n % n % n % n % n 
Basal cell tumor 71 5 29 2 46.5 510 53.5 586 56.93 1510 43.07 1142 
Basal cell carcinoma                 61.00 3 39.00 2 
Basosquamous carcinoma 
        40.8 55 59.2 79         
Papilloma 67 6 33 3 42.9 18 57.1 24 50.32 316 49.68 312 
Squamous cell carcinoma 61 17 39 11 43.9 116 56.1 148 55.02 735 44.98 600 
Sebaceous adenoma (and 
hyperplasia)**** 
71 12 29 5 46 547 54 642 60.51 1987 39.49 1297 
Sebaceous carcinoma         50.5 105 49.5 103 58.00 29 42.00 21 
Hepatoid gland adenoma 89 58 11 7 76 2052 24 648 88.92 2385 11.08 297 
Hepatoid gland carcinoma         90.3 131 9.7 14         
Meibomian gland adenoma         44 385 56 491         
Apocrine adenoma , (Syringoma)*, 
(papillary-)**, (Hidradenoma)**** 100 1 0 0 45.1 208 54.9 253 59.78 368 40.22 248 
Apocrine ductal adenoma         44.4 63 55.6 79         
Fibrocystadenoma  
100 1 0 0                 
Fibroadenoma papilliform 50 1 50 1                 
Adenoma 
100 4 0 0                 
Apocrine carcinoma (papillary)**         40.9 88 59.1 127 51.85 14 48.15 13 
Carcinoma 90 9 10 1                 
Adenocarcinoma 67 6 33 3                 
Ceruminal gland adenoma         53.8 45 46.2 38 75.01 10 24.99 3 
Ceruminal gland carcinoma                 53.49 22 46.51 19 
Anal sac gland carcinoma         43.7 104 56.3 134 26.54 56 73.46 154 
Trichoepithelioma         34.1 407 65.9 788 52.07 604 47.93 556 
Epithelioma Malherbe 
100 2 0 0 47.1 124 52.9 139 45.09 802 54.91 977 
Intra-cutaneous cornifying 
epithelioma 
67 4 33 2 47.1 248 52.9 279 53.20 541 46.80 476 
Benigne melanoma 57 12 43 9 49.5 482 50.5 491 60.84 1125 39.16 724 
Malignant melanoma, (Canine 
cutanous)*** 
59 10 41 7 49.7 71 50.3 72 61.41 540 38.59 339 
Malignant melanoma, (Canine 
subungual)*** 
        44.8 43 55.2 53         
Malignant melanoma, (Lip)*** 
        53.6 161 46.4 139         
Fibroma 36 5 64 9 47.7 295 52.3 323 51.21 423 48.79 403 
Myxoma 100 1 0 0 22.2 2 77.8 7         
Myxosarcoma         40.6 71 59.4 104         
Hemangiopericytoma         34 659 66 1280         
 
 
APPENDIX 158 
Continue tab. 42 
Dog/ Litrature Frese, 1960 Goldschmidt, 1992 Bomhard, 2001 
Tumor/ Sex ♂ ♀ ♂ ♀ ♂ ♀ 
  % n % n % n % n % n % n 
Fibrosarcoma 
75 9 25 3 40.9 185 59.1 267 48.84 1725 51.16 1807 
Lipoma 
63 5 38 3 31.7 638 68.3 1375 31.14 876 68.86 1936 
Infiltrative lipoma 
        35.1 78 64.9 144         
Liposarcoma 0 0 100 1 51.9 41 48.1 38 70.22 67 29.78 28 
Hemangioma 38 5 62 8 43 559 57 742 49.03 686 50.97 713 
Perithelioma  0 0 100 1 45.7 132 54.3 157         
Lymphangioma  100 1 0 0 39.1 9 60.9 14         
Hemangiosarcoma 
(Angiosarcoma)* 0 0 100 1         65.10 373 34.90 200 
Leiomyoma (Myoma)* 100 1 0 0         23.08 15 76.92 49 
Leiomyosarcoma                 25.00 1 75.00 3 
Neurofibroma                 48.89 22 51.11 24 
Neurofibrosarcoma                 37.50 4 62.50 6 
Benign peripheral nerve sheath 
tumor         51.9 14 48.1 13         
Malignant peripheral nerve 
sheath tumor         44.3 43 55.7 54         
Mast cell tumor 68 17 32 8 39.4 982 60.6 1510 48.51 1753 51.49 1861 
Malignant lymphoma 100 1 0 0 44.6 116 55.4 144 55.51 131 44.49 105 
Mycosis fungoides                 56.25 56 43.75 44 
Extramedullary plasmocytoma         48.3 215 51.7 230 59.25 363 40.75 250 
Histicytoma (benign round cell 
sarcoma)* 69 18 31 8 52 1818 48 1679 59.23 4382 40.77 3017 
Malignant histiocytoma (Giant 
cell tumor of soft tissue)***         33.4 3 66.6 6 58.06 19 41.94 14 
Osteosarcoma                 47.71 84 52.29 92 
Sarcoma  88 7 13 1                 
Large cell sarcoma 40 2 60 3                 
Round cell sarcoma 70 7 30 3                 
Polymorph cell sarcoma 50 5 50 5                 
Spindle cell sarcoma 67 6 33 3                 
Sebaceous gland hyperplasia         41.3 290 58.7 413         
Epidermoid cyst         41.7 272 58.3 380 50.29 874 49.71 864 
Dermoid cyst                 55.22 38 44.78 31 
Follicle cyst         45.4 179 54.6 215 41.85 172 58.15 239 
Apocrine cyste         45 109 55 133 56.00 125 44.00 98 
Collagenous naevus                 45.62 365 54.38 435 
Adnexal naevus (Organoid 
naevus)**** 
        45.4 359 54.6 431 58.58 1354 41.42 957 
Skin tag         45.2 133 54.8 161         
Total 
69 238 31 108   13165   15147   24955   20357 
*Frese (1960), ** Eskens (1983), *** Goldschmidt and Shofer (1992), **** Bomhard (2001) 
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Tab. 43: Tumor distribution in cats by two authors 
Tumor Goldschmidt 
and Shofer 
(1992) % 
Bomhard 
(2001) % 
 Tumor Goldschmidt and 
Shofer (1992) % 
Bomhard 
(2001) % 
Basal cell tumor 14.2 15.39  Fibroma   1.25 
Basal cell carcinoma 1.3 0.52  Fibrosarcoma 16.6 43.89 
Papilloma   0.15  Myxomatous tumors 0.9   
Basosquamous carcinoma 0.4    Lipoma 5.5 4.17 
Squamous cell carcinoma 9.6 6.18  Liposarcoma 0.5 0.10 
Sebaceous adenoma  1.7 0.94  Hemangioma 1.8 1.03 
Sebaceous carcinoma 0.8 0.06  Hemangiosarcoma 2.8 1.95 
Meibomian gland adenoma 0.4    Lymphangioma 0.5   
Apocrine cyst 1.2 0.47  Leiomyosarcoma   0.01 
Apocrine adenoma 
(Hidradenoma)* 
2.9 5.63  Neurofibroma   0.81 
Apocrine ductal adenoma 2.1    Neurofibrosarcoma   0.15 
Apocrine carcinoma 2.5 0.09  Neural tumors (not further specified) 1.4   
Ceruminous gland adenoma 2.5 0.14  Mast cell tumor 12.4 5.52 
Ceruminous gland carcinoma 2.9 2.19  Malignant lymphoma 2.8 2.58 
Anal sac gland carcinoma 0.4 0.10  Mycosis fungoides   0.18 
Trichoepithelioma 0.8 0.10  Extramedullary plasmocytoma 0.5 0.20 
Epithelioma Malherbe 0.4 0.05  Malignant histiocytoma  0.21 
Intracutaneous cornifying 
epithelioma 
  0.10  Giant cell tumor of soft tissue 0.9  
Epidermoid cyst 3.7 2.54  Osteosarcoma   1.03 
Dermoid cyst   0.07  Adnexal naevus (Organoid naevus*)  0.1 0.24 
Follicle cyst 0.8 0.05  Collagenous naevus   0.21 
Benign melanoma 0.6 0.38  Ceruminous cyst/ hyperplasia 1.8   
Malignant melanoma 0.4 1.33  Sebaceous hyperplasia 1   
*Bomhard (2001) 
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8.2. Abbreviations  
 
ABC Avidin-Biotin-Complex 
BSA Bovine serum albumin 
DAB Diaminobenzidin-tetrahydrochlorid 
Diag. Diagram 
e.g. As example 
ESH cat European shorthair cat 
Fig. Figure 
GFAP Glial fibrillary acidic protein 
i.e. id est = that is 
Ig Immunglobulin 
M Molar 
min Minute 
MPNST Malignant peripheral nerve sheath tumor 
n Number 
NSE Neuron Specific Enolase 
PBS Phosphate-buffered saline 
rpm Round per minute 
sec. Second 
SS Swine serum 
Tab. Table 
TBS Tris-buffered saline 
TNM The extent of the primary tumor (T), the condition of the regional lymph nodes 
(N), and the presence or absence of distant metastasis (M) (Matyas, 1982) 
USA  United States of America  
WHO World Health Organisation 
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Fig. 1c: T732/00. Trichoepithelioma, with 
different cell population, basaloid (arrow 
head), granular (thick arrow) and 
tricholemmal differentiation (thin arrow). 
HE. (Obj.: 40X), dog 
Fig. 1b: T732/00. Trichoepithelioma, note 
the abortive trichogenic differentiation and 
abrupt and gradual keratinization. HE. 
(Obj.: 20X), dog 
Fig. 1d: T3384/00. Pilomatricoma, note 
the abrupt keratinization, the eosinophilic 
cytoplasm and the remnants of the cells 
nuclei. HE. (Obj.: 40X), dog 
Fig. 1e: T316/00. Infundibular keratinizing 
acanthoma, note the cords of epithelial cells 
(arrow head) and the stromal mucinosis 
(arrows). HE. (Obj.: 20X), dog 
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8.3.2. Basal cell tumor and trichoblastoma 
    
 
 
 
 
 
    
 
 
 
    
 
      
 
 
 
 
Fig. 2a: T1120/00. Basal cell tumor, 
solid type. HE. (Obj.: 40X), cat 
 
Fig. 2b: T1439/00. Basal cell tumor, 
cystic variant. HE. (Obj.: 2.5X), cat 
Fig. 2c: T1439/00. Basal cell tumor, 
cystic variant. HE. (Obj.: 20X), cat 
Fig. 2e: T2402/00. Trichoblastoma, 
ribbon type. HE. (Obj.: 20X), dog 
Fig. 2f: T1955/00. Trichoblastoma, 
medusoid type. HE. (Obj.: 10X), dog 
Fig. 2d: T1196/05. Infiltrative basal cell 
carcinoma. HE. (Obj.: 20X), cat 
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Fig. 2i: T681/00. Trichoblastoma, 
granular cell type. HE. (Obj.: 20X), 
dog 
Fig. 2g: T2183/00. Trichoblastoma, 
trabicular type. HE. (Obj.: 20X), cat 
Fig. 2h: T171/00. Trichoblastoma, spindle 
cell type. HE. (Obj.: 20X), cat 
Fig. 2j: T681/00. Trichoblastoma, 
granular cell type. HE. (Obj.: 40X), dog 
Fig. 2k: T681/00. Trichoblastoma, 
granular cell type with PAS positive 
cytoplasmic granules (arrows). PAS. 
(Obj.: 40X), dog 
Fig. 2l: T681/00. Trichoblastoma, 
granular cell type. Immunoperoxidase, 
Cytokeratin. (Obj.: 40X), dog 
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Fig. 2m: T2991/00. Trichoblastoma, clear 
cell variant, tumor mass with ribbon like 
pattern. Note the growing of the neoplastic 
cells at the base of a hair follicle (arrow). 
HE. (Obj.: 10X), dog 
Fig. 2n: T2991/00. Trichoblastoma, clear 
cell variant, neoplastic cells in small nests 
with many large vacuolated cells (sebocytes) 
(arrows) and other cells with pale cytoplasm 
(arrow head). HE. (Obj.: 40X), dog 
Fig. 2o: T2991/00. Trichoblastoma, clear 
cell variant, neoplastic cells in small 
islands have pale cytoplasm surrounded by 
sclerotic basal membrane (arrow heads). 
HE. (Obj.: 40X), dog 
Fig. 2p: T1310/00. Trichoblastoma, clear 
cell variant, neoplastic cells in small 
islands surrounded by PAS-positive 
sclerotic basal membrane. PAS (arrows). 
(Obj.: 40X), dog 
Fig. 2q: T2991/00. Trichoblastoma, clear 
cell variant, neoplastic cells in small 
islands surrounded by peripheral, blue, 
sclerotic basal membrane. Masson’s 
trichrome stain. (Obj.: 40X), dog 
Fig. 2r: T1462/00. Trichoblastoma, ribbon 
type with necrosis (arrow) (cystic type). 
HE. (Obj.: 10X), cat 
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Fig. 2s: T1462/00. Trichoblastoma, ribbon 
type with necrosis and calcification (cystic 
type). HE. (Obj.: 20X), cat 
Fig. 2u: T1166/00. Trichoblastoma, 
trabecular type with mucoid 
degeneration. HE. (Obj.: 40X), cat 
Fig. 2x: T3220/00. Basal cell tumor mixed 
with hepatoid  cells and with hepatoid 
gland hyperplasia. HE. (Obj.: 20X), dog 
Fig. 2v: T3220/00. Basal cell tumor 
associated with the overlying epidermis. 
HE. (Obj.: 10X), dog 
Fig. 2w: T3220/00. Basal cell tumor 
adjacent to hepatoid gland hyperplasia. HE. 
(Obj.: 20X), dog 
Fig. 2t: T1166/00. Trichoblastoma, 
trabecular type with mucoid degeneration 
(cystic type). HE. (Obj.: 10X), cat 
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8.3.3. Viral induced papilloma and squamous papilloma 
    
 
 
 
 
 
    
 
 
 
 
 
Fig. 3a: T1789/00. Papilloma. HE. 
(Obj.: 10X), dog. 
          
Fig. 3d: T2618/00. Squamous 
papilloma. HE. (Obj.: 40X), dog. 
          
Fig. 3c: T2618/00. Squamous 
papilloma. HE. (Obj.: 2.5X), dog. 
      
Fig. 3b: T1789/00. Papilloma. HE. 
(Obj.: X), dog. 
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8.3.4. Nailbed tumors 
    
 
 
 
 
 
       
 
 
 
 
 
    
 
 
 
  
Fig. 4d: T2886/00. Subungual squamous 
cell carcinoma. HE. (Obj.: 20X), dog. 
          
Fig. 4c: T2886/00. Subungual squamous 
cell carcinoma. HE. (Obj.: 2.5X), dog. 
Fig. 4a: T840/00. Subungual 
keratoacanthoma. HE. (Obj.: 2.5X), dog. 
          
Fig. 4b: T840/00. Subungual 
keratoacanthoma. HE. (Obj.: 20X), dog. 
          
Fig. 4f: T2886/00. Subungual squamous 
cell carcinoma. PAS. (Obj.: 20X), dog. 
Fig. 4e: T840/00. Subungual 
keratoacanthoma. PAS. (Obj.: 20X), dog. 
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8.3.5. Bowen-like disease and basosquamous carcinoma 
    
 
 
 
 
    
 
 
 
 
    
 
 
 
 
Fig. 5a: T1172/00. Bowen-like disease. 
HE. (Obj.: 10X), cat. 
         . 
Fig. 5b: T1172/00. Bowen-like disease. 
HE. (Obj.: 20X), cat. 
         . 
Fig. 5c: T1172/00. Bowen-like disease. 
PAS. (Obj.: 20X), cat. 
         . 
Fig. 5d: T885/00. Basosquamous 
carcinoma. HE. (Obj.: 40X), dog. 
         . 
Fig. 5c: T1172/00. Bowen-like disease. 
PAS. (Obj.: 40X), cat. 
         . 
Fig. 5c: T1172/00. Bowen-like disease. 
Immunoperoxidase, Cytokeratin. (Obj.: 
20X), cat. 
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8.3.6. Skin cysts 
    
 
 
 
 
 
    
 
 
 
 
 
 
    
 
 
Fig. 6a: T1417/00. Infundibular cyst. 
HE. (Obj.: 40X), dog. 
Fig. 6b: T824/00. Isthmus cyst, stratified 
squamous  epithelium lacks a granular 
layer. HE. (Obj.: 40X), dog. 
Fig. 6c: T1896/00. Panfollicular cyst. HE. 
(Obj.: 10X), dog. 
Fig. 6d: T1896/00. Panfollicular cyst, 
squamous epithelium transition to basaloid 
cell (above), basaloid cells with abrupt 
kerantization (below). HE. (Obj.: 40X), dog. 
 
 
Fig. 6f: T1236/00. Pressure point 
comedones. HE. (Obj.: 2.5X), dog. 
Fig. 6e: T1119/00. Subungual epithelial 
inclusion cyst. HE. (Obj.: 20X), dog. 
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8.3.7. Hamartomas and tumorlike lesions 
    
 
 
 
 
 
    
 
 
 
 
Fig. 7a: T1612/00. Fibroadnexal 
hamartoma. HE. (Obj.: 10X), dog. 
Fig. 7b: T3352/00. Sebaceous 
hamartoma. HE. (Obj.: 10X), dog. 
Fig. 7c: T1386/00. Follicular 
hamartoma. HE. (Obj.: 2.5X), dog. 
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8.3.8. Sebaceous and modified sebaceous gland tumors 
    
 
 
 
 
 
    
 
 
 
 
 
   
 
 
 
Fig. 8a: T1220/00. Sebaceous epithelioma. 
HE. (Obj.: 20X), dog. 
Fig. 8b: T1220/00. Sebaceous epithelioma. 
HE. (Obj.: 20X), dog. 
Fig. 8e: T3234/00. Hepatoid gland (angio-) 
adenoma. HE. (Obj.: 20X), dog. 
Fig. 8d: T4/04. Sebaceous ductal 
adenoma. HE. (Obj.: 40X), dog. 
 
Fig. 8c: T4/04. Sebaceous ductal 
adenoma. HE. (Obj.: 10X), dog. 
Fig. 8f: T442/00.Hepatoid gland (angio-) 
epithelioma. HE. (Obj.: 20X), dog 
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8.3.9. Fibroma and collagenous hamartoma 
 
 
 
    
 
 
 
 
    
 
 
 
Fibroma 
Collagenous 
hamartoma 
Epidermis 
Location 
Fig. 9d: T1253/00. Collagenous 
hamartoma. HE. (Obj.: 1.25X), dog. 
Fig. 9e: T1253/00. Collagenous 
hamartoma. HE. (Obj.: 10X), dog. 
Fig. 9b: T140/00. Fibroma. HE. (Obj.: 
2.5X), dog. 
Fig. 9c: T140/00. Fibroma. HE. (Obj.: 
20X), dog. 
Fig. 9a: Comparative figures between 
fibroma and collagenous hamartoma. 
Cellularity 
Collagen pattern 
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8.3.10. Peripheral nerve sheath tumors 
    
 
 
 
 
 
    
 
 
 
 
 
    
 
 
    
 
 
Fig. 10a: T2015/00. Neurofibrosarcoma. 
Palisading spindle-shaped cells with fine, 
wavy fibers. HE. (Obj.: 20X), dog. 
Fig. 10c: T1552/00. Neurofibrosarcoma, 
nerve remnant. Immunoperoxidase, 
Neurofilament. (Obj.: 10X), dog. 
Fig. 10e: T2015/00. Neurofibrosarcoma. 
Immunoperoxidase, NSE. (Obj.: 20X), 
dog. 
Fig. 10b: T2015/00. Neurofibrosarcoma. 
Immunoperoxidase, Aktin. (Obj.: 20X), 
dog. 
Fig. 10d: T2015/00. Neurofibrosarcoma. 
Immunoperoxidase, S100. (Obj.: 20X), 
dog. 
Fig. 10f: T1552/00. Neurofibrosarcoma. 
Immunoperoxidase,GFAP. (Obj.: 20X), 
dog. 
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